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Abstract 
The Aldo-Keto Reductases (AKR) are a group of oxidoreductase enzymes structurally 
and mechanistically distinct from the Alcohol Dehydrogenases (ADH).  The AKRs 
are of importance for their ability to produce industrially useful compounds including 
chiral secondary alcohols.  The ADH family have traditionally been exploited for 
chiral alcohol production; the AKR family have currently been underexploited for 
chiral alcohol production and present the opportunity to search for novel 
oxidoreductases with properties and substrate specificities distinct from the ADH 
enzymes.   
The AKR studied here, from the hyperthermophilic bacteria Thermotoga maritima 
has been characterised with respect to its biochemical and structural properties, and its 
potential as a biocatalyst evaluated.  This enzyme is the second example of a 
thermophilic AKR to have its three dimensional structure solved, the other also being 
from Thermot. maritima.  The AKR studied exhibits high stability with respect to 
temperature and moderate amounts of organic solvents.  A large preference for the 
reduction reaction compared to the oxidation reaction was found, which has 
previously been observed in other AKRs.  The X-ray crystal structure was solved to 
2.6Å resolution in the apo form.  The final structure has three loop sections which 
were not located due to disorder within the crystal, which are expected to become 
ordered upon cofactor and substrate binding.  A section of one of these missing loops 
was found to bind at the active site of the enzyme, with a glutamate occupying the site 
of substrate carbonyl binding.  The formation of a dimer, increased helix-dipole 
stabilisation and long distance ion pair interactions all act to increase thermostability 
of the AKR with respect to its mesophilic homologues.   
The X-ray crystal structure of Escherichia coli bacterioferritin has also been solved to 
1.9Å resolution, which was co-purified along with the recombinant AKR enzyme.  
This structure shows the symmetrical binding of a heme molecule on the local two-
fold axis between subunits and the binding of two metal atoms to each subunit at the 
ferroxidase centre.  These metal atoms have been identified as zinc by the anaylsis of 
the structure and X-ray data and confirmed by microPIXE experiments.  For the first 
time the heme has been shown to be linked to the internal and external environments 
via a cluster of waters positioned above the heme molecule.  This information has 
provided a greater insight into the function and mechanism of bacterioferritin. 
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1 Introduction 
1.1 Biotransformation 
Biotransformations are able to catalyse a chemical reaction to produce a specific 
product by the use of a whole cell or an isolated enzyme.  The most well known 
biotransformations are those carried out in the brewing and baking industries, where 
yeasts are utilised to produce alcohol during the brewing process or for CO2 
production to make bread light and airy.  These processes have been utilised for 
thousands of years without any detailed knowledge of their mode of action.  In the 
modern era, with a greater understanding of enzyme function, biotransformations are 
able to rival and even surpass many chemical synthetic reactions. 
1.1.1 Historical Perspective 
The nature and the date of the first biotransformations are unknown, but it is clear that 
biotransformation was being exploited before the beginning of recorded history.  The 
history of brewing probably dates back to around 6000BC.  Cheese production 
however may date back even further with some estimates putting it as early as 
8000BC.  The discovery of this particular biotransformation was probably an 
accidental one; sheep stomachs were commonly used to carry foods and if used for 
milk the rennet lining the stomach would begin the cheese making process. 
Another ancient biotransformation was during the tanning of leather, where the 
process of bating was carried out by pounding the hide with animal dung or soaking 
in a solution of animal brains.  These processes would introduce a mixture of 
amylases, proteases and lipases to the hide which would hydrolyse casein, elastin, 
albumin and globulin-like proteins leaving behind the collagen and keratin which 
make up the final leather. 
1.1.2 Modern Biotransformations 
The first successful preparative biotransformation was carried out in the 1930s, where 
Acetobacter suboxydans was utilised to convert D-sorbitol into L-sorbose as part of 
the synthesis of vitamin C (Reichstein and Grossner, 1934).  In the 1950s and 60s the 
field began to grow, particularly with steroid hydroxylation which cannot be carried 
out by chemical means (Holland, 2000).  The 1970s saw a trend begin for using 
isolated enzymes rather than whole cells.  The vast majority of biocatalysts utilised as 
isolated enzymes since the 1970s have been lipases, mainly due to their robustness 
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and lack of cofactor requirements.  With the advent of genetic engineering, 
recombinant DNA technology and genome sequencing the range of biocatalysts 
available has expanded, whilst the cost to produce them has decreased.  When an 
appropriate biocatalyst has been found, its properties may be modified by site directed 
mutagenesis or directed evolution to provide a catalyst with improved stability or 
varied substrate specificity.  Biotransformations are now utilised primarily in the 
production of a large range of pharmaceuticals in addition to finding applications in 
the fine and speciality chemical, foods, cosmetics, polymers and agrochemical 
industries (Fig 1.1) (Zaks, 2001; Huisman and Gray, 2002; Straathof, 2002).  The 
biotransformation industry continues to grow as the technologies are developed and 
its potential realised.  In 2000 the total enzyme market was worth $1.5billion (Kirk et 
al., 2002), up from $1billion in 1995.  By 2010, 70% of all chiral drug intermediates 
are expected to be produced using enzymes (Rouchi, 2002). 
Pharmaceuticals
53%
Other sectors
12%
Agrochemicals
9%
Feed
1%
Food
18%
Cosmetics
5%
Polymers
2%
 
Fig 1.1.  Application of biotransformation processes.  Figure adapted from Straathof 
et al., 2002. 
1.1.3 Advantages and Disadvantages 
1.1.3.1 Chirality 
The production of chiral compounds by traditional chemical catalysis methods is 
either impossible or at best a lengthy and expensive process.  This is where 
biotransformation has found its niche market.  Due to the inherent chirality present in 
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biocatalysts many of their products are optically pure.  Chirality exists when an object 
and its mirror image cannot be superimposed on each other.  The simplest example of 
this is for a person‟s hands.  The left and right hands are mirror images of each other 
and are non-superimposable, that is the left hand cannot be lined up in a way with the 
right hand so that all the features line up.  There is an inherent difference between the 
two hands and they are both enantiomers of each other.   
To aid in distinguishing between different enantiomers of a compound several naming 
conventions have been devised.  These include the R/S convention based on the Cahn-
Ingold-Prelog priority rules, where the substituent of lowest priority (lowest atomic 
number) is placed pointing away from the viewer and the order of priority of the 
remaining groups noted.  If the order of priority (Fig 1.2a) is from highest to lowest in 
a clockwise direction it is labelled R (Rectus) or if it is anticlockwise then it is 
labelled S (Sinister).  This system is commonly used in chemistry for its ability to 
distinguish between multiple chiral centres within an individual molecule.  An 
alternative system is commonly used for amino acids and sugars, and uses 
glyceraldehyde as a reference.  The two enantiomers of glyceraldehyde are labelled D 
and L.  A simple way to distinguish between the two enantiomers of amino acids is by 
the CORN rule (Fig 1.2b), the chiral centre is viewed from the hydrogen and the 
positions of the COOH, R and NH2 groups observed (where R is the amino acid side 
chain).  If the order proceeds in a clockwise direction then it is labelled the L-form or 
anticlockwise it is the D-form. 
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YX
z
XY
z
RCO
N
H
COR
N
H
 
Fig 1.2.  Naming conventions for chiral molecules.  a) R/S convention, order of 
priority is z,y,x for highest  to lowest.  b) D/L convention using the CORN rule. 
 
Chirality exists throughout the world of biology; most naturally occurring amino acids 
are of the L form and all sugars of the D form.  D amino acids are found in bacterial 
cell walls.  This preference for a single enantiomer leads to different interactions 
between a protein and the two enantiomers of a chiral compound.  This can be 
demonstrated by the taste of amino acids, where the D amino acid tastes sweet the L 
form is tasteless.  This is due to chirality present in the proteins which make up the 
taste receptors in a persons mouth distinguishing between the two enantiomers and 
responding only to the D-amino acids. 
Since proteins are made up of amino acids of a single enantiomer (L), they have the 
ability to select between the two enantiomers of a substrate.  This is termed 
stereospecificity.  Stereoselectivity exists when the enzyme produces a single 
enantiomer of a product.  Therefore a stereospecific process is always stereoselective 
but a stereoselective process is not necessarily stereospecific. 
Enantiomerically pure products are especially important in the pharmaceutical 
industry, since only one enantiomer of a drug will usually have the desired effect and 
the other may have no effect or often cause side effects.  This situation is exemplified 
by the case of thalidomide in the 1950s and 60s, where the S enantiomer is an anti-
emetic effective against morning sickness and the R enantiomer is teratogenic causing 
a) 
b) 
R S 
L D 
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birth defects.  In this case, use of the S enantiomer alone would not of prevented the 
side effects since the drug quickly racemises in vivo to give both the R and S 
enantiomers (Eriksson et al., 1995).  Due to this case all drugs possessing chiral 
centres are now required to be produced in >99.9% enantiomeric excess or both 
enantiomers must be proven to be safe. 
1.1.3.2 Other advantages 
1.1.3.2.1 Regioselectivity 
In addition to the chiral specificity of biocatalysts, they also possess regioselectivity.  
Regioselectivity is the ability to distinguish between the same chemical groups on a 
different part of a molecule.  This allows an enzyme to distinguish between the 
multiple hydroxyl groups of a sugar molecule and act upon just one of them.  To carry 
out a similar reaction using traditional chemical techniques would require multiple 
protection and deprotection steps to allow reaction with the desired functional group.  
The yield of the chemical method would decrease with each additional stage, whereas 
the biotransformation route could be carried out in a single step with the potential to 
reach 100% conversion.  The regioselectivity of a biocatalyst is due to the 3-
dimensional arrangement of the protein chain, and the particular shape of its active 
site.  The shape of the active site will only allow the substrate to enter in a particular 
orientation thereby excluding the possibility of a reaction occurring on additional 
substituents.  An additional advantage of the specificity provided by a biocatalyst is 
that fewer side products are formed reducing the need to remove these at a later stage 
and reducing the number of downstream processing steps required, further reducing 
waste and cost. 
1.1.3.2.2 Green Chemistry 
The conditions under which biocatalysts operate are usually very different from those 
of a chemical reaction.  A chemical process will usually require high temperatures and 
pressures, extremes of pH, strong oxidising/reducing agents and are often performed 
in organic solvents.  Biocatalysts are able to provide a „green‟ alternative to chemical 
processes using relatively mild conditions; they are able to perform reactions with 
moderate temperatures and pressures, at mild pHs and in an aqueous environment.  
The reduction in temperature and pressure serves to reduce the operational costs of a 
process linked to heating the reactor and leads to a reduction in energy usage and 
 19 
therefore reduced production of green house gasses.  By removing the need for strong 
oxidising and reducing agents, extremes of pH and the use of organic solvents, there 
is a reduction in the risk to human health and the environment and a reduction in the 
cost of processing, clean-up and disposal of dangerous or harmful waste products.  
The use of a biocatalyst also removes the need to use toxic metal catalysts further 
reducing the environmental impact of a process. 
As the use of biocatalysts for the production of chemical compounds increases so 
does the use of biocatalysts for removal of unwanted chemicals from the environment.  
Bioremediation of contaminants present in the environment further boosts the green 
credentials of biocatalysts, and this is a more cost effective and safer method of 
cleaning up environmental pollutants than by chemical means (Paul et al., 2005). 
1.1.3.3 Disadvantages 
Since biocatalysts are of biological origin and have generally evolved to work within 
the environment of the cell, they may behave unfavourably when introduced to 
process conditions.  It is desirable for cost reasons to increase the volumetric 
productivity by increasing the substrate concentration.  When the substrate 
concentration is increased a biocatalyst may loose activity, partially or wholly, due to 
inhibitory or toxic effects from the substrate or product.  The cost of the biocatalyst 
may also be high compared to the cost of a chemical catalyst, due to isolation and 
stability of the biocatalyst.  With improved cloning and expression systems the cost of 
producing a biocatalyst is reducing, and if immobilised this allows its easy recovery 
and costs are reduced even further.  Immobilisation may also improve the operational 
stability of the biocatalyst by increasing its  lifetime and profitability. 
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1.2 Oxidoreductases 
Approximately one quarter of known enzymes are classified as oxidoreductases (Kula 
and Kragl, 2000).  This large family of enzymes is structurally and catalytically 
diverse.  They are capable of catalysing the oxidation of one substrate linked to the 
reduction of another substrate and are often called dehydrogenases.  The most 
common oxidoreductases are those acting on alcohols and aldehydes.  
Oxidoreductases are of interest for use as biocatalysts for the production of chiraly 
pure alcohols, aldehydes and acids, production of polymers, and for use in biosensors 
and bioremediation (Hummel, 1999). 
1.2.1 Cofactor Recycling 
Enzymes such as oxidoreductases often require the use of a cofactor to carry out their 
reaction.  These cofactors can often be more expensive than the desired product, and 
stoichiometric use of the cofactor would render the biotransformation process 
uneconomical.  Due to the need for cofactor recycling there are few 
biotransformations carried out with purified oxidoreductases (Fig 1.3).  An efficient 
method is therefore required to regenerate the cofactor to reduce the costs of the 
process and can also alter the thermodynamic equilibrium of the reaction driving it to 
completion (Findrik et al., 2005). Of particular interest is the regeneration of 
nicotinamide adenine dinucleotide (NAD
+
) and nicotinamide adenine dinucleotide 
phosphate (NADP
+
) cofactors which are commonly utilised by the oxidoreductase 
enzymes.  Cofactor regeneration can be achieved by a number of methods including 
chemical, electrochemical, photochemical, microbial and enzymatic.  Probably the 
simplest method employed is the microbial approach which has been in use since 
brewing and baking were first introduced.  This approach utilises the enzyme of 
interest within a metabolically active cell, and given an appropriate energy source the 
normal biochemistry of the cell is able to regenerate the cofactor.  This method can 
often be limited by transfer of substrates and products across the cell membrane and 
may also suffer from side reactions due to the wide range of enzymes present with the 
cell.  The enzymatic method of cofactor regeneration utilises a second substrate which 
is used to drive regeneration of the cofactor and is often the most convenient method 
of regeneration (Koeller and Wong, 2001).  This step may be performed by the 
enzyme which carries out the synthetic step, and in which case it may be difficult to 
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achieve favourable reaction conditions for both the synthetic and regeneration 
reactions.  Alternatively a second enzyme may be added to carry out the regeneration 
step (Fig 1.4).  The second substrate may either be very cheap, easily regenerated or 
the second product be of value.  The most common second enzymes and substrates 
utilised are formate dehydrogenase and formate, alcohol dehydrogenase and 
isopropanol and glucose dehydrogenase with glucose.  The use of formate 
dehydrogenase with formate is attractive since the substrate if cheap, and the product 
is CO2 which is easily removed as a gas and effectively makes the reaction 
irreversible, driving it to completion. 
Oxidoreductases
3%
Transferases
12%
Hydrolases
37%
Lyases
12%
Isomerases
4%
Reducing cells
8%
Oxidising cells
24%
 
Fig 1.3.  Types of enzymes used in industrial biotransformation reactions.  Figure 
adapted from Straathof et al., 2002. 
 22 
 
OH
R'R
O
R'R
O
R'''R''
OH
R'''R''
NAD(P)H NAD(P)
E1
E2
 
Fig 1.4.  Enzymatic regeneration of NAD(P)H cofactor.  E1 and E2 may be the same 
enzyme (substrate coupled regeneration) or different enzymes (enzyme coupled 
regeneration). 
1.2.2 Alcohol Dehydrogenases 
There are three evolutionary, catalytically and structurally distinct types of NAD(P)
+
 
dependant alcohol dehydrogenases (ADH).  These are the classical alcohol 
dehydrogenases of which horse liver ADH is a member which are now referred to as 
medium chain dehydrogenases /reductases (MDR).  There are also the short chain 
dehydrogenases /reductases (SDR) which are often called „insect-like‟ since the first 
member of the family to be characterised was the Drosophila lebanonensis ADH 
(Villaroya et al., 1989).  The third type are the long chain dehydrogenases or iron 
dependant ADHs which were originally identified in Zymomonas mobilis (Conway et 
al., 1987) and yeast (Williamson and Paquain, 1987).  The structural diversity of the 
ADHs is shown in Figure 1.5.  The iron containing ADHs are generally not well 
characterised and represent a much smaller enzyme family than the MDR and SDR 
families.  They generally contain approximately 380 amino acid residues consisting of 
two domains, one with similarity to a dehydroquinate synthase like fold and the other 
a Rossmann fold like domain which binds the NAD(P)H cofactor.  The catalytic iron 
is coordinated by three histidine residues and one aspartic acid residue. 
The SDR family is a much larger protein family including lyases and epimerases in 
addition to the alcohol dehydrogenases.  The enzymes within the SDR family are 
usually 270 amino acids in length and consist of a single Rossmann fold domain and 
they bind either NADH or NADPH and lack any metal cofactor.  The active site 
contains a catalytic triad of Ser-Tyr-Lys, utilising the tyrosine as a catalytic acid-base.  
+ 
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The physiological function of the SDR family is though to be the reduction of 
aldehydes and ketones to their corresponding alcohols. 
The MDR family contains the majority of the ADH enzymes and is characterised by 
the binding of one or two zinc ions and a chain length of 370 amino acid residues 
forming a two domain structure, with one substrate binding domain and one 
nucleotide binding Rossmann fold domain.  The active site binds a catalytic Zn
2+
 and 
utilises serine and histidine in a proton relay system (Eklund et al., 1982), and a 
second zinc ion which has a structural role.  Under physiological conditions this 
family usually acts in the oxidation direction, converting the alcohol to the 
corresponding aldehyde or ketone. 
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Fig 1.5.  Figure showing the structural diversity of the alcohol dehydrogenase family.  a) Short-chain dehydrogenase/ reductase family, SDR (D. 
lebanonensis alcohol dehydrogenase; PDB: 1B14). b) Medium-chain dehydrogenase/ reductase family, MDR (Horse liver alcohol 
dehydrogenase; PDB: 3BTO) c) Iron containing alcohol dehydrogenase family (Thermotoga maritima iron containing alcohol dehydrogenase; 
PDB: 1VLJ).  The α-helices are coloured in red, the β-sheets in yellow and the loops in green.  The zinc ions are shown as grey spheres, iron 
ions as red spheres and NAD(P)
+
 as stick models.  (Figure produced using PyMOL, Delano Scientific USA).
a) b) c) 
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1.2.3 Aldo-Keto Reductase 
It might be expected that the diversity present within the ADH family would fully 
account for the cells ability to reduce ketones and aldehydes.  The aldo-keto reductase 
(AKR) family of enzymes is also capable of carrying out the same function and is 
present in all domains of life.  The AKR family contains enzymes capable of reducing 
aldehydes and ketones as well as aldose reductases, xylose reductases and 
hydroxysteroid dehydrogenases.  AKRs in mammals have been implicated as a factor 
in diabetic retinopathy, and are also though to play a role in the stress response.  Many 
organisms contain multiple AKRs with overlapping substrate specificities which has 
lead to difficulties in assigning cellular functions.  This is demonstrated by the yeast 
Saccharomyces cerevisiae which contains six different AKR genes.  Knock-out 
studies performed on any one of these genes failed to yield a phenotype presumably 
due to functional redundancy between the six AKRs, when three of these genes were 
knocked out then a phenotype sensitive to heat stress was observed (Chang et al., 
2003). 
The AKR family of enzymes are able to perform similar reactions to the ADH family 
described above, but are structurally very distinct.  They are approximately 320 
residues long, forming a single domain structure which folds into an (α/β)8 barrel 
which usually binds NADPH with the nicotinamide ring pointing towards the centre 
of the barrel (Fig 1.6).  They are similar to the SDR enzymes in being single domain 
enzymes lacking any metal ion binding ability, but differ from all the ADHs by 
lacking a Rossmann fold like domain.  Further similarity exists in the catalytic 
mechanism of the AKRs and the SDR enzymes.  Both utilise a catalytic acid-base 
mechanism with a tyrosine residue as the general acid.   
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Fig 1.6.  Figure showing the common structural fold adopted by the AKR family.  The 
(α/β)8 barrel common to all AKRs with α-helices in red, β-sheets in yellow and 
NADP
+
 as a stick model.  Structures a) and b) are related by a 90° rotation around the 
x-axis.  The structure shown is that of AKR2B5, Candida tenuis xylose reductase 
(PDB: 1K8C).  (Figure produced using PyMOL, Delano Scientific USA). 
a) 
b) 
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1.2.3.1 Catalytic Mechanism 
Within the active site of the AKRs is a catalytic tetrad (Fig 1.7) of residues (Tyr-Asp-
Lys-His) in close proximity forming a hydrogen bonded network.  Due to the 
proximity of the histidine and tyrosine to the C4 of the nicotinamide ring (Wilson et 
al., 1992) it was not known which of these formed the catalytic residue.  The tyrosine 
has now been established to be the catalytic residue by mutagenesis and kinetic 
studies on a range of family members (Mayr and Nidetzky, 2002; Penning, 1999; 
Schlegel et al., 1998; Tarle et al., 1993).  The arrangement of the lysine and aspartic 
acid within the tetrad leads to a decrease in the pKa for the tyrosine and facilitates 
proton donation to the substrate carbonyl.  The location of the histidine may create an 
oxyanion hole (Jez et al., 1997) which could stabilise an oxyanion intermediate.  In all 
binary complexes of AKRs a water molecule is seen bound between the histidine and 
tyrosine residues at the location which would be occupied by the substrate carbonyl. 
 
 
Fig 1.7.  Figure showing the spatial arrangement of the catalytic residues and the 
cofactor within the AKR active site.  A water molecule is found occupying the 
presumed location of the substrate carbonyl binding.  Hydrogen bonds between the 
catalytic residues and water are shown as blue dashed lines.  Structure shown is that 
of AKR2B5, C. tenuis xylose reductase (PDB: 1K8C).  (Figure produced using 
PyMOL, Delano Scientific USA). 
 
Cofactor and substrate binding occurs in a stepwise, ordered Bi-Bi method.  In the 
rate limiting step, the NADPH cofactor binds first with the nicotinamide portion in the 
C4 
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centre of the barrel.  Cofactor binding promotes a conformational change where the A 
and B-loops (loops 1 and 7 respectively, see chapter 6) close in around the cofactor 
and the B-loop specifically interacts with the pyrophosphate portion of the NADPH 
and locks it into position (Ehrensberger and Wilson 2004; Jez et al., 1997).  The 
conformational changes observed upon cofactor binding have led to the loops A and B 
being termed the „safety belt‟ due to the way they „lock-in‟ the cofactor.  After the 
cofactor has bound the substrate binds into the active site cleft created by the 
movement of loops A and B.  After the reaction is complete, the product leaves first 
followed by the cofactor. 
 
The spatial arrangement of the catalytic residues is highly conserved throughout the 
AKR family and the catalytic mechanism is therefore thought to be highly conserved 
too.  It is thought that the catalytic mechanism proceeds partially or fully step wise 
with hydride transfer occurring before proton transfer (Nidetzky et al., 2001; Penning, 
1999; Grimshaw et al., 1995).  A hydride ion (H
-
) is donated from the 4-pro-R 
position of the cofactor NAD(P)H to the substrate carbonyl forming an oxyanion 
intermediate stabilised by the nearby histidine residue (Fig 1.8).  A proton (H
+
) is then 
donated to the oxyanion intermediate from the catalytic tyrosine acting as a general 
acid to produce the alcohol product.  The mechanism of the oxidation reaction 
proceeds in the reverse of the reduction reaction where the catalytic tyrosine acts as a 
general base (Mayr and Nidetzky, 2002).  Some AKR family members show a large 
preference for reduction over oxidation (Nidetzky et al., 2001), making the reduction 
reaction almost irreversible. 
The catalytic mechanism of the AKRs may be altered by a single amino acid change 
(Jez et al., 1997).  The 3-oxo-5β-steroid 4-dehydrogenases contain a glutamic acid 
replacing the histidine of the catalytic tetrad; this substitution alters the activity of the 
enzyme from carbonyl reduction to carbon-carbon double-bond reduction.  The 
substitution is thought to alter the mechanism by allowing the stabilisation of a 
carbonium-ion intermediate following proton transfer, with hydride transfer occurring 
by Markovnikov addition from the 4-pro-R position of NADPH. 
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Fig 1.8.  Figure showing the acid-base catalytic mechanism of aldehyde reduction by 
the AKR family enzymes.  The reaction may occur fully stepwise with a) proton 
transfer from NADPH and formation of an oxyanion intermediate, prior to b) hydride 
transfer occurring from the enzyme tyrosine residue (Figure adapted from Mayr and 
Nidetzky, 2002). 
1.2.3.2 AKRs in Biotransformations 
The production of chirally pure pharmaceuticals is of high importance to the chemical 
industry, including the production of chiral secondary alcohols.  There are several 
enzymatic routes available to achieve chirally pure alcohols including kinetic 
resolution by lipases, carbon-carbon bond formation by lyases and ketone reduction 
by oxidoreductases.  The traditional ADHs have been exploited thus far, and have 
produced enzymes capable of yielding product with greater than 99% enantiomeric 
excess (Hildebrandt et al., 2002).  The AKRs represent an enzyme family which is 
capable of carrying out the reduction of a wide range of substrates, from steroids to 
sugars.  The family all contain an (α/β)8 (TIM barrel) fold which is the most common 
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fold amongst known enzymes (Wierenga, 2001) making protein engineering decisions 
more reliable.  Some of the enzymes within the family show preference for the 
reduction reaction to such an extent that the overall reaction is almost irreversible 
(Penning, 1999; Mayr and Nidetzky, 2002), driving any biosynthetic process towards 
completion. 
In addition to chiral secondary alcohol synthesis for pharmaceutical manufacture the 
AKRs have roles in other industrially relevant processes such as vitamin C 
biosynthesis (Anderson et al., 1985; Ji and Goa, 2001), polyketide biosynthesis (Ikeda 
et al., 1999), xylose metabolism (Hahn-Hagerdal et al., 1991; Aristidou et al., 2000) 
and steroid metabolism (Takikawa et al., 1987).  The AKRs are also of interest for 
their role in diabetic complications (Kador et al., 1988), cardiovascular disease and 
other related oxidative stress diseases (Uchida et al., 2000; Iuchi et al., 2004) where 
the human enzymes are of interest for inhibitor design.  
 31 
1.3 Extremophiles 
A mesophile is any organism which has optimum growth conditions which we 
consider „normal‟, that is moderate temperature (20°C - 50°C), relatively neutral pH 
(3 - 9), low salt concentrations (<2M) and near atmospheric pressure.  Any organism 
which thrives outside of these „normal‟ conditions is considered an extremophile.  The 
halophiles are able to survive in high concentrations of salt, and are found in places 
such as the Dead Sea and continental salt pans.  Some extreme halophiles are able to 
survive in saturated salt conditions.  Two methods are employed by the halophiles to 
survive such conditions.  Either the salt can be excluded from the cell, in which case 
organic co-solutes are accumulated within the cell to increase the osmolarity and 
prevent efflux of water.  Or alternatively the halophile may allow the salt to enter the 
cell and adapt their proteins to cope with such an environment (Madigan and Oren, 
1999).  Piezophiles are able to withstand high pressures, and are usually found on the 
ocean bed where pressures can reach over 1000atm (1000 times atmospheric 
pressure).  At these high pressures the cell contents becomes more viscose so the 
organism must adapt all its components to become more flexible. 
Acidophiles and alkaliphiles are able to resist extremes of pH, low or high 
respectively.  The alkaliphiles survive by pumping protons from the environment 
across their membrane into the cytoplasm, allowing them to maintain a more neutral 
internal environment.  The acidophiles may perform the opposite process, exporting 
protons to maintain a less acidic internal environment.  Alternatively the acidophiles 
can adapt their enzymes to be resistant to such an environment. The thermophiles are 
organisms which grow between 50°C and 80°C; any organism able to grow beyond 
this temperature is classified as a hyperthermophile.  The most extreme 
hyperthermophile dubbed „strain 121‟ (Kashefi and Lovley, 2003) is able to grow 
within an autoclave at 121°C giving rise to its nickname.  This organism has been 
found to remain viable up to 130°C, and was most closely related to the archaea 
Pyrodictum occultum and Pyrobaculum aerophilum.  Thermophiles and 
hyperthermophiles are often found in geothermally heated regions of the world such 
as deep-sea volcanic vents, hot springs and solfataric fields.  At the other end of the 
scale are the psychrophiles.  These organisms grow optimally below 15°C and are 
often found in arctic regions.  Generally the thermophiles have more interactions 
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increasing overall rigidity, whereas the psychrophiles have reduced rigidity and 
increased flexibility. 
The majority of extremophiles are micro-organisms belonging to either the bacteria or 
the archaea.  Several higher organisms also possess extremophilic properties, most 
notably the Pompeii worm (Alvinella pompejana) (Fig 1.9a) which lives at 
temperatures up to 80°C (Cary et al., 1998).  The worm attaches itself by its tail to a 
hydrothermal vent and is thought to have a symbiotic relationship with the vent 
bacteria and archaea.  In this way the tail is at 80°C and the head is at approximately 
20°C.  The Pompeii worm is able to live in temperatures up to 80°C, but an animal 
which usually lives under mesophilic conditions has proven to be the most extremo-
tolerant organism known.  The Tardigrades or „water bears‟ (Fig1.9b) are usually 
found in moss and lichens but are able to survive almost any environmental extreme 
(Jonsson, 2007), including temperatures as low as -200°C for days or even -272°C 
(1K) for just a few minutes up to temperatures of 150°C, the low pressure of a 
vacuum up to 6000atm pressure (Seki and Toyoshima, 1998), high doses of radiation 
and desiccation for up to ten years.  Tardigrades are able to survive such extreme 
environments by forming a „tun‟ where the animal curls up into a ball, and replaces 
most of its water with trehalose and enters a state of crytobiosis (Goldstein and 
Blaxter, 2002) where its metabolism is 0.1% of normal. 
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Fig 1.9.  a) The A. pompejana or the „Pompeii Worm‟ live with their head at 20°C and 
the tail attached to deep-sea hydrothermal vents at 80°C.  (Image from 
http://www.udel.edu/PR/UDaily/2005/dec/extreme120304.html). b) SEM of a 
Tardigrade or „water bear‟, usually found living in mosses.  The water bear can 
survive almost any environmental extreme including space.  (Image from 
http://www.fcps.edu/islandcreekes/ecology/water_bear.htm). 
1.3.1 Thermophiles 
The thermophiles and hyperthermophiles are often considered the most extreme 
microorganisms.  As more become discovered the known limits within which life can 
exist is changing.  The highest growth temperature found of any hyperthermophile is 
121°C (see section 1.3) the previous record holder was Pyrolobus fumarii at 113°C 
(Blochl et al., 1997).  The upper limit may never be conclusively known due to 
difficulties with culturing many microorganisms, but it is likely to lie between the 
known limit (121°C) and 150°C (Stetter, 1999).  Life may find it hard to live beyond 
the current limit due to rapid degradation of many of the small biomolecules essential 
to life (Phipps et al., 1991) such as ATP and NAD
+
 which hydrolyse rapidly at high 
temperatures.  The temperature limit to life may depend upon the ability to prevent 
this degradation and ensure the rapid re-synthesis of these essential compounds. 
Thermophiles have adapted themselves to living in an extreme environment through 
adaptation of their proteins (section 1.4) but also through their DNA and cell 
membrane lipids.  The enzyme reverse gyrase is able to introduce positive 
supercoiling into the thermophiles DNA, which increases its stability (Kikuchi and 
a) b) 
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Asai, 1984).  In addition the thermophilic archaea possess histone like proteins which 
can drastically increase the melting temperature of the DNA (Sandman et al., 1990).  
The cell membranes of the archaea are chemically unique compared to bacteria and 
eukaryotes (Fig 1.10).  The lipids which make up the archaeal membrane are 
composed of a different enantiomer of glycerol (L rather than D), have ether linkages 
rather than ester linkages to the fatty acid tail and the tail is also chemically different 
being composed of isoprenoid units which create branching.  The ether linkages in 
archaea are more stable to thermal and acid hydrolysis than the ester linkages of 
bacterial and eukaryal cell walls.  The branching of the isoprenoid fatty acid tails may 
allow for two sidechains to join creating transmembrane phospholipids or 
intramolecular rings, both of which may increase the rigidity and stability of the cell 
wall and are often found in thermophilic species of archaea. 
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Fig 1.10.  Figure showing the cell membrane phospholipids as found in a) archaea and 
b) bacteria and eukaryotes.  The archaeal phospholipids contain L glycerol, with ether 
linked isoprenoid chains, whereas other organisms have D glycerol, with ester linked 
unbranched fatty acids. 
1.3.2 Thermotoga maritima 
Thermotoga maritima (Fig 1.11) is one of the most thermophilic species of bacteria, 
growing at a maximum of 90°C (optimum 80°C) metabolising simple and complex 
carbohydrates such as glucose, sucrose, starch, cellulose and xylan.  Originally 
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isolated from geothermally heated marine sediment at Vulcano, Italy (Huber et al., 
1987).  The organism is rod shaped and has a sheath like „toga‟ structure (Fig 1.11) 
which forms an outer cell wall.  The whole genome of Thermot. maritima has been 
sequenced (Nelson et al., 1999) and is now the subject of a large scale structural 
genomics project (Canaves et al., 2004).  The complete genome sequence revealed a 
large proportion of the genome, 24%, showing high similarity to archaeal genomes.  
These archaeal like sequences are clustered into 15 regions within the genome, which 
maintain their gene order are probably a result of lateral gene transfer.  Many of the 
archaeal like genes are associated with transport, electron transport, and conserved 
hypothetical proteins.  Many of the genes associated with transcription, translation, 
DNA replication and cell division are related to the bacterial homologues.  The 
Thermot. maritima also shares similarity with archaea in its cell membranes, where it 
contains novel glycerol ether lipids (see section 1.3.1) which increase the stability of 
the membrane at high temperatures compared to the ester lipid present in other 
bacteria. 
 
 
Fig 1.11.  An ultrathin layer electron microscope image of a Thermo. maritima cell.  
Image taken from http://microbewiki.kenyon.edu/index.php/Petrotoga.  
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1.4 Protein Thermostability 
An enzyme will retain its catalytic activity whilst it is able to maintain a conformation 
shape appropriate to its function.  With the exception of disulfide bonds most proteins 
in the cytoplasm are held together by a combination of non-covalent forces including 
hydrogen bonds, ion pairs, hydrophobic interactions and Van der Waals interactions.  
As the temperature is increased these non-covalent forces fail to hold the protein 
structure together and the protein begins to unfold and denature.  Once the protein is 
unfolded, hydrophobic residues which usually reside in the core of a protein may 
become exposed causing the protein to aggregate via interaction with other exposed 
hydrophobic residues.  In addition, once unfolding occurs the protein is more 
susceptible to covalent modifications such as reduction of disulfide bonds, cysteine 
oxidation, deamidation of asparagine and glutamine residues and peptide bond 
hydrolysis. 
Deamidation of asparagine and glutamine residues may occur by two different 
mechanisms (Wright, 1991), either a general acid-base mechanism or via a β-aspartyl 
mechanism.  In the acid-base mechanism (Fig1.12a) the amide group of the side chain 
becomes protonated by a general acid.  The carbonyl carbon of the protonated side 
chain is then attacked by a general base forming a tetrahedral oxyanion intermediate, 
which collapses to a carboxylic acid with removal of the amide group.  In the β-
aspartyl mechanism (Fig 1.12b) the peptide nitrogen residue n+1 acts as a nucleophile 
attacking the amide to produce a succinimide intermediate, which breaks down to 
form an α or β-linked amino acid.  Peptide bond hydrolysis often occurs on the C-
terminal side of asparagine residues by a β-aspartyl shift like mechanism (Fig 1.12c).  
The asparagine amide acts as a nucleophile, attacking the main chain carboxyl carbon 
of the same residue, breaking the peptide bond (Hensel et al., 1992). 
Under alkaline conditions β-elimination of the disulfide bond may occur, leading to 
production of thiocysteine and dehydroalanine (Fig 1.12d). The dehydroalanine may 
then further react with nucleophilic groups such as lysine to produce lysinoalanine.  
Reduction of disulfide bonds may occur under reducing conditions, breaking the bond 
and leading to further disruption of the protein structure.  When not present as 
disulfide bonds, cysteines are the most reactive of all amino acids and are easily auto-
oxidised and may lead to the formation of disulfide bonds or sulfenic, sulfinic or 
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sulfonic acid.  Therefore the number of free cysteine residues is often reduced in 
thermophilic proteins, so this oxidation does not occur. 
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Fig 1.12.  Figure showing the covalent modification mechanisms that occur in protein 
denaturation. a) Deamidation of asparagine and glutamine by general an acid-base 
mechanism, where the amide is protonated by a general acid, before a general base 
attacks the carbonyl carbon to form an oxyanion tetrahedral intermediate.  b) 
Deamidation by the β-aspartyl mechanism where the side chain is attacked by a 
nucleophilic nitrogen of the neighbouring amino acid, forming a succinamide 
intermediate which breaks down to give either an α-linked (Asp) or a β-linked residue 
(IsoAsp).  c) Peptide chain cleavage occurs by nucleophilic attack by side-chain 
amide onto its own peptide carbonyl leading to chain cleavage.  d) Disulfide bond 
cleavage under alkaline conditions occurs via β-elimination and yields thiocysteine 
and dehydroalanine. 
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The unfolding and inactivation of a protein occurs in a way described by the 
equilibrium model of thermal inactivation (Eisenthal et al., 2006).  The fully folded 
and active enzyme (Eact) is in a rapid equilibrium with a partially denatured inactive 
form (Einact) which is on the pathway to fully denatured irreversible inactivation (X) 
(Eq 1.1).  The kinetics of the pathway is described by the constants Keq and Kinact.  
Where Kinact is the rate constant for irreversible inactivation of partially unfolded 
enzyme to fully denatured protein characterised by the activation energy of 
inactivation, ΔG*inact.  Keq is characterised by the enthalpy of equilibrium, ΔHeq, and 
the thermal parameter, Teq, which is the temperature at which the concentrations of 
active (Eact) and inactive (Einact) enzyme are equal, thereby making Teq the thermal 
equivalent Km. 
 
The overall stability of an enzyme may be affected by altering ΔG*inact, thereby 
altering the constant Kinact.  The equilibrium model shows that an increase in ΔG*inact 
does not necessarily give an increase in activity at higher temperatures, since the 
equilibrium Keq is not affected.  An increase in Teq however will shift the equilibrium 
in favour of Eact and increase the activity at elevated temperatures (Daniel et al., 
2007).  The energy difference between the folded state (both Eact and Einact) and the 
fully denatured protein is represented by ΔGstab and is usually equal to between 5-
15kcal mol
-1
 for a mesophilic protein at 25°C (Jaenicke, 1991).  ΔGstab can be plotted 
against temperature to produce a profile for a given protein (Fig 1.13).  In 
thermophilic proteins this ΔGstab curve can theoretically be altered in three ways to 
give the thermophilic protein it‟s increased stability at higher temperature (Fig 1.13).  
Either the ΔGstab value can be increased whilst still occurring at the same temperature 
optimum, the temperature of the highest ΔGstab value can be shifted towards higher 
temperatures, or ΔGstab may have the same value at the same optimum temperature 
but the curve may be flattened increasing stability at higher temperatures.  Whilst 
mixtures of all three methods are commonly utilised by proteins to increase stability, 
the most commonly found mechanism is to increase the value of ΔGstab (Vieille and 
Zeikus, 2001). 
 
Eact Einact X 
 
Keq Kinact 
Eq 1.1 
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Fig 1.13.  Figure to show the alteration of ΔGstab vs temperature to give increased 
thermostability.  The curve for a mesophilic protein is shown in blue.  The three 
mechanisms for increasing thermostability are shifting the curve to higher 
temperatures (Green curve), increasing ΔGstab value and keeping the same temperature 
optimum (Black curve) or peak ΔGstab occurs at the same value but the curve is 
flattened (Red curve).  Figure adapted from Vieille and Zeikus, 2001. 
 
There are a number of structural adaptations which are known to increase the thermal 
stability of thermophilic and hyperthermophilic proteins.  It has become clear from 
high resolution structures of thermostable proteins that there are no finite rules 
regarding which adaptations are utilised for thermostability, where one protein may 
utilise a particular mechanism of thermal stabilisation another may use an alternate 
mechanism to give the same degree of thermostability.  The most commonly observed 
methods with which proteins achieve thermostability are discussed below. 
1.4.1 Primary Structure 
The relative abundance of certain amino acids has long been thought to affect the 
thermostability of proteins.  Trends have been identified for increased incidence of 
charged residues, consistent with an increase in the number and size of ionic 
networks, and also for replacement of glycine with alanine and lysine with arginine.  
Alanine has a high propensity for forming α-helices, and would therefore increase 
stability by decreasing strain in α-helices.  While arginine is thought to be less 
susceptible to chemical attack than lysine and is able mediate more ionic interactions 
increasing thermostability (Mrabet et al., 1992).  Asparagine and glutamine, as 
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discussed previously (section 1.4), are readily deamidiated and might be expected to 
be of lower incidence in thermophilic proteins.  Thermophilic phosphoglycerate 
kinase (PGK) enzymes have been shown to have a reduction in the number of 
asparagine residues in comparision to their mesophilic homologues (Hess et al., 1995; 
Fleming and Littlechild, 1997).  Also a trend for decreased asparagine and glutamine 
content with increasing optimum temperature was observed with type II xylose 
isomerases (Vieille et al., 1995).  Some thermophilic enzymes show the opposite 
trend, Sulfolobus solfataricus 5‟-methylthioadenosine phosphorylase (optimally active 
at 120°C) contains twice as many asparagines as the Escherichia coli enzyme 
(Cacciapouti et al., 1994) but probably protects them from deamidation by positioning 
them in locations and conformations which are not susceptible to deamidation. 
Genome sequencing suggests however that overall there is not a preference for certain 
amino acids in thermophilic and hyperthermophilic genomes.  In a comparison of 
eight mesophilic and seven hyperthermophilic genomes only minor trends were 
observed (Vieille and Zeikus, 2001), such as replacement of uncharged polar residues 
for charged residues, and an increase in hydrophobic and aromatic residues.  Also a 
general reduction in cysteines was observed, especially in aerobic hyperthermophiles.  
The cysteines which were found in the aerobic hyperthermophiles were generally 
found to occur in essential interactions such as disulfide bridges, catalytic centres or 
metal chelation sites and were rarely found to occur otherwise. 
1.4.2 Ion pairs 
A study of 127 orthologous mesophilic/ thermophilic protein groups (Alsop et al., 
2003) found a clear link between thermostability and the presence of stabilising acid-
base pairs on the surface of the protein.  When an ion pair is formed there is an 
unfavourable change in the free energy of desolvation (ΔΔGdesolvation), which may not 
be compensated for by the electrostatic energy of the ion pair.  The ΔΔGdesolvation 
decreases as temperature increases, so the penalty is smaller for thermophilic proteins.  
In addition to forming large ion pair networks the desolvation penalty is further 
reduced since formation of each additional ion pair in a network requires the 
desolvation of only one additional residue.  The ion pairs in thermophilic proteins are 
often seen in large networks of up to 24 residues (Yip et al., 1995).  The glucose 
dehydrogenase (GDH) from the thermophile Pyrococcus furiosus was compared to 
the GDH from the mesophile Clostridium symbiosum.  The P. furiosus GDH has 
 42 
fewer ionic networks containing less than 4 residues, but showed a large increase in 
the number of networks with more than 4 residues (Vieille and Zeikus, 2001).  The 
ADH from Aeropyrum pernix is stabilised by ion pair networks at the subunit 
interfaces by four intersubunit ionic bonds (Fig 1.14) at each interface giving a total of 
16 ionic bonds across the tetramer (Guy et al., 2003b).  Another example of ionic 
networks in thermophilic proteins is the Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) from S. solfataricus which contains an ion pair network of 15 residues 
extending from the subunit interface to the active site (Isupov et al., 1999).  This 
sequence is conserved in thermophilic GAPDH sequences but not in mesophilic 
homologues. 
 
Fig 1.14.  Figure showing the intersubunit ionic bonds in A. pernix ADH.  Glu301 
from one subunit interacts with His122, Arg175 and Lys179 from another subunit of 
the tetramer.  Glu119 and Glu314 from the second subunit are also involved in the six 
residue ionic network.  (PDB: 1H2B) (Figure produced using PyMOL, Delano 
Scientific USA). 
His122 
Glu301 
Glu119 
Glu314 
Arg175 
Lys179 
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1.4.3 Hydrogen Bonds 
Hydrogen bonding in thermophilic proteins has not been extensively studied due to 
the lack of structures of sufficiently high resolution.  The evidence available shows 
that hydrogen bonding can have a large contribution towards stability with charge-
neutral hydrogen bonds thought to be the most important.  A study on hydrogen 
bonding in GAPDH enzymes found a strong correlation between thermostability and 
the number of charge-neutral hydrogen bonds (Tanner et al., 1996).  Such a hydrogen 
bond is formed between a side-chain atom of a charged residue and either a main-
chain atom or a side-chain atom of a neutral residue.  The hydrogen bond formed 
between two neutral residues is weaker than a charge-neutral hydrogen bond since the 
charge-dipole interaction is stronger than the dipole-dipole interaction.  Charge-
neutral hydrogen bonds have also been found to contribute to the stability of Thermo. 
maritima ferredoxin by stabilising the structure of turns and anchoring turns to one 
another (Macedo-Ribiero et al., 1996).  The effect of hydrogen bonds on 
thermostability has been thoroughly studied in RNase T1, where 86 H-bonds were 
found and through the use of mutagenesis and calorimetry were found to contribute a 
similar stabilising effect to that of hydrophobic interactions (Shirley et al., 1992). 
1.4.4 Disulfide Bridges 
Disulfide bridges are able to stabilise a protein through an entropic effect, reducing 
the number of conformations the protein can adopt and hold different structural 
elements together through covalent modification.  Disulfide bridges are however 
susceptible to hydrolysis at high temperatures, and lead many to believe that 
disulfides would not contribute towards stability in hyperthermophilic proteins.  
Disulfides have been found to be present in many proteins from hyperthermophiles 
with activity over 100°C.  The 5‟-methylthioadenosine phosphorylase from S. 
solfataricus when expressed in E. coli had a different arrangement of disulfide bridges 
and reduced activity suggesting that the disulfides in the native protein contribute 
towards the stability (Cacciapouti et al., 1994).  Disulfide bridges in pyrrolidone 
carboxyl peptidase (Pcp) from Thermococcus litoralis were found (Singleton et al., 
1999) which were not seen in the Pcp of the mesophile Bacillus amyloliquefaciens 
(Odagaki et al., 1999).  When the cysteines were mutated to alanine the melting 
temperature and temperature optimum both dropped (Connelly, 2006).  Conversely 
when these cysteines were introduced into the B. amyloliquefaciens Pcp the stability 
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was increased (Kabashima et al., 2001), suggesting a role for these cysteines in 
stabilising the protein. 
1.4.5 Hydrophobic Interactions 
Proteins bury their hydrophobic residues within their core and offer an increase in 
stability of 1.3 kcal mol
-1
 per methyl group buried away from the solvent (Pace, 
1992).  Evidence showing the importance of hydrophobic interactions in protein 
stability comes from a combination of X-ray structures and mutagenesis studies.  
Mutation of an isoleucine in the hydrophobic core of T4 lysozyme produced changes 
in the thermostability which correlated with the hydrophobicity of the residues 
substituted in place of the isoleucine (Matsumura et al., 1988).  Hydrophobic 
interactions have been observed at subunit interfaces in the X-ray structures of many 
thermophilic proteins.  The Pcp from Thermoc. litoralis utilises four hydrophobic 
residues from each subunit to stabilise its tetrameric structure (Singleton et al., 1999).  
Mutation of these residues has been shown to reduce the melting temperature of the 
enzyme (Littlechild et al., 2007).  Also the 3-isopropylmalate dehydrogenase from 
Thermus thermophilus shows the addition of hydrophobic subunit interactions 
compared to the E. coli enzyme (Kirino et al., 1994).  Mutation of these residues 
decreased the stability of the Thermu. thermophilus enzyme whilst introduction of 
hydrophobic residues at the same position in the E. coli enzyme increased stability.  
However the magnitude of the hydrophobic effect varies with temperature (Pace and 
Tanford, 1968).  The effect of this is to reduce the hydrophobic contribution to 
stability at extremely high (and extremely low) temperatures.  The Gibbs energy of 
hydrophobic interactions reaches a peak at 75°C (Makhatadze and Privalov, 1995), 
meaning that in hyperthermophiles the hydrophobic effect may be reduced at 
temperatures above 100°C.  In the hyperthermophilic Pyroc. furiosus tryptophan 
synthase α-subunit, hydrophobic interactions in the protein interior did not contribute 
to the enzymes increased stability compared with the same enzyme from the 
mesophilic Salmonella typhimurium, instead the 33°C increase in melting temperature 
was attributed to an increase in ionic interactions (Yamagata et al., 2001).  Some 
hyperthermophilic enzymes do still utilise increased hydrophobic interactions at 
temperatures around 100°C.  A small 7kDa protein „7d‟ was studied from the 
hyperthermophiles Sulfolobus acidocaldarius (Sac7d; Tm = 90.7°C), and 
S. solfataricus (Sso7d; Tm = 99°C).  The increased stability of Sso7d over Sac7d was 
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attributed to additional hydrophobic interactions within the core (Clark et al., 2004), 
demonstrating that even at such high temperatures hydrophobic interactions may still 
play a role. 
1.4.6 Helix-Dipole Stabilisation 
The α-helices in proteins contain an intrinsic dipole where the C-terminal end is 
partially negatively charged and the N-terminal end carries a partial positive charge.  
This dipole is induced by the directional nature of the helix as all the main-chain 
carbonyls are arranged pointing forward along the helix and the main-chain nitrogen 
faces backwards along the helix.  By placing residues with a side-chain carrying an 
opposite charge to the dipole at the appropriate end of a helix, the capping residue 
may form hydrogen bonds to the main-chain of the helix stabilising the dipole (Fig 
1.15).  Dipole stabilisation has been observed in PGK enzymes from Bacillus 
stearothermophilus and Thermot. maritima in contrast to the yeast and pig enzymes 
(Auerbach et al., 1997).  Both the thermophilic enzymes contained more helices 
stabilised at their N and C termini by oppositely charged residues.  Helix dipole 
stabilisation may also be achieved by placing helices next to each other in an anti-
parallel configuration so that their N and C termini pair up together and cancel out 
each others dipole.  This has been shown to contribute to the stabilisation of a protein 
in contrast to packing helices in a parallel configuration which is destabilising 
(Sheridan et al., 1982).  Helix dipole stabilisation has been attributed to increased 
thermostability, but its contribution is often marginal. 
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Fig 1.15.  Figure showing the helix dipole stabilisation in Thermot. maritima 
phosphoglycerate kinase, showing the N-terminal cap with proline and aspartate 
stabilising the helix.  The protein structure is shown as a cartoon representation with 
the residues involved in dipole stabilisation shown as sticks (PDB code: 1VPE) 
(Figure produced using PyMOL, Delano Scientific USA). 
1.4.7 Structural Elements 
There are a number of adaptations of the overall structure which are thought to 
contribute to thermostability.  At a given temperature thermophilic enzymes are 
generally more rigid and less flexible than their mesophilic counterparts.  Increased 
rigidity has been demonstrated experimentally through a reduction in hydrogen-
deuterium exchange rates.  At 20°C, less of a thermophilic enzyme‟s amide protons 
are exchanged for deuterium than a mesophilic enzyme, as the temperature is 
increased then the thermophilic enzyme begins to exchange protons (Bonisch et al., 
1996).  At each enzymes optimum temperature the percentage of exchanged protons is 
roughly equal, suggesting that at their optimum temperatures each enzyme has a 
similar amount of flexibility. 
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Loop structures are generally of reduced length in thermophilic proteins, while those 
that remain are often better anchored to the structure reducing conformational 
flexibility and the entropy of unfolding.  The same applies to the N and C-termini, by 
anchoring the termini to each other or individually to the core conformational 
flexibility is reduced.  The crystal structure of citrate synthase from Pyroc. furiosus 
forms a dimer and has an extension at the C-terminal end which wraps around the 
other monomer of the pair and is anchored in place (Russell et al., 1997).  The 
extension wrapping around the other monomer increases the number of intersubunit 
interactions and is in contrast to the citrate synthases from less thermostable 
organisms.  Better packing and reduction of internal cavities is not a common 
thermostabilisation mechanism but has been observed in some thermophilic proteins.  
This has been shown by site directed mutagenesis to contribute to the thermostability 
of histone proteins.  In the mesophile Methanobacterium formicium the Ala31Ile and 
Lys35Met mutations increased the stability while the opposite mutations (Ile31Ala 
and Met35Lys) in the thermophile Methanothermus fervidus reduced its stability (Li 
et al., 1998).  A reduction in the solvent accessible hydrophobic surface area has also 
been observed.  In S. acidocaldarius superoxide dismutase, 18% of its accessible 
surface area is hydrophobic whereas in mesophilic enzymes 26.8% of the accessible 
surface area is hydrophobic (Knapp et al., 1999). 
1.4.8 Extrinsic 
The stability of a protein may be affected by the specific conditions under which it is 
studied.  Intracellular enzymes reside within a controlled environment and may be 
stabilised by several extrinsic factors due to the composition of the cytosol.  The 
presence of cofactor, substrate or some inorganic salts has been shown to increase the 
stability of a range of mesophilic and thermophilic enzymes.  The effect of salt is 
dependant upon the enzyme and the salt present.  Binding of cofactor or substrate is 
thought to act by protecting the active site from structural rearrangements.  These 
factors appear to be as equally important to mesophilic proteins as they are in proteins 
from thermophiles.  Pressure can also increase the thermostability of a protein (Robb 
and Clark, 1999).  Since many thermophiles are naturally found in high pressure 
environments this may contribute to their stability.  The stabilising effect is greatest in 
proteins stabilised by hydrophobic forces, and those stabilised by ionic interactions 
are often destabilised (Michels et al., 1997) 
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1.5 Protein Structure Determination 
The 3-dimensional structure of biological macromolecules provides a wealth of data 
which can provide information on protein function, mechanism of action, interactions 
with other proteins, nucleic acids or small molecules and are able to provide 
information of distant evolutionary relationships not detectable by amino acid 
sequence similarity.  The structures of proteins have also provided a large amount of 
information relating to mechanisms of thermostability (as discussed in section 1.4).  If 
a structure is of high enough resolution and the protein participates in a disease 
mechanism then predictions can be made on the proteins interactions with drug 
molecules and structure based drug design carried out. 
The first protein structure to be solved was that of sperm whale myoglobin (Kendrew 
et al., 1958) which was solved using X-ray crystallography techniques.  This first 
structure took nearly ten years to solve, but with developments in crystallisation 
techniques, X-ray sources, data collection techniques, and computer processor power 
the time required to solve a protein structure has been dramatically reduced.  In 1971 
the Protein Data Bank (PDB) was established with seven structures at the Brookhaven 
National Laboratory.  On the 8
th
 of April 2008 in its 37
th
 year the PDB reached the 
milestone of containing over 50,000 structures (Fig 1.16).  The growth of the PDB has 
been such that it has doubled in size since 2004, and with it currently receiving 25 
new structures on average each day it is expected to triple in size by 2014 to contain 
over 150,000 macromolecular structures.  Of the structures available in the PDB 85% 
were produced by X-ray crystallography methods (Fig 1.16), the other 15% were 
produced by NMR, electron microscopy and other methods (theoretical models are no 
longer stored in the PDB).  The structures held within the PDB are freely available 
and are used by crystallographers, biochemists, molecular biologists and 
computational biologists from academia, industry and government. 
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Fig 1.16.  Figure showing the growth of the Protein Data Bank since 1980.  The total 
number of structures in the PDB is shown in brown, with those solved by X-ray 
diffraction methods in orange and by NMR methods in mustard yellow.  Figures for 
2008 are year to 8
th
 April.  (Statistics from www.rcsb.org) 
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1.6 Previous Work 
The work presented within this thesis is a continuation of a previous PhD project 
(Guy, 2004).  This previous work included the cloning of an ADH from A. pernix, 
along with three putative oxidoreductases from A. pernix, Thermot. maritima and P. 
furiosus.  The ADH belonged to the MDR family of zinc containing ADHs and was 
studied with respect to its biochemical and structural properties.  It was found that the 
ADH was catalytically active towards a range of primary, secondary and cyclic 
alcohols and their respective ketones and aldehydes, showing a preference for cyclic 
alcohols.  In addition to a broad substrate range the ADH enzyme is very stable with 
respect to temperature and organic solvents, showing a half life of 2 hours at 90°C and 
greater than 50% activity in 60% (v/v) acetonitrile or dioxane.  X-ray crystallographic 
studies were carried out (Guy et al., 2003a) on the ADH and the structure solved by 
multi wavelength anomalous dispersion methods using the native zinc atoms (Guy et 
al., 2003b).  The cofactor NADH and inhibitor octanol were found in the active site.  
This thesis has investigated the putative oxidoreductase from Thermot. maritima. 
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1.7 Aims of the Project 
The oxidoreductase gene from Thermot. maritima previously cloned (Guy, 2004) has 
been investigated within this project.  This oxidoreductase shows similarity to the 
Aldo-Keto Reductase (AKR) family of enzymes and is hereafter referred to as 
TmAKR. 
 
The aims of the project were: 
 
 To carry-out the expression and purification of the active TmAKR protein. 
 To characterise the catalytic activity of the enzyme.  Properties relating to the 
potential use of the enzyme will be particularly focused upon such as the 
substrate specificity and stereoselectivity and the stability of the enzyme. 
 To obtain diffraction quality crystals of the enzyme. 
 To solve the 3-dimensional structure of the enzyme by X-ray diffraction 
methods 
 
The work presented within this thesis is the expression and purification, biochemical 
characterisation and X-ray crystallographic studies of the TmAKR enzyme.  In 
addition the structure of E. coli bacterioferritin has been solved as a result of this 
project and is discussed within. 
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2 Expression and Purification 
2.1 Introduction 
To obtain large enough quantities of a protein for crystallisation a suitable source of 
the protein is required along with an efficient purification protocol to separate the 
protein of interest from any contaminant proteins.  Before the advent of cloning and 
recombinant protein expression a protein could only be studied if it was present in 
high concentrations within the host organism or organ.  An expression system consists 
of a host organism (bacteria, yeast, insect cell or mammalian cell) containing a vector 
harbouring the gene of interest.  The choice of host organism depends upon the 
properties of the protein of interest and the requirements of the final product regarding 
secretion, glycosylation, proteolytic cleavage and other post-translational 
modifications.  The vector carries along with the gene of interest promoters and 
regulators which control the level and time of gene expression, and antibiotic 
resistance markers allowing for selection of hosts containing the vector and the gene 
of interest. 
After sufficient quantities of the protein have been produced it is necessary to separate 
it from the contaminating proteins present in the expression host whilst retaining the 
protein in an active state.  Depending on the application it may be necessary to 
compromise on the purity or the yield of the protein.  For instance when the protein is 
to be used for crystallisation a high quality and purity of protein is required therefore 
the overall yield may be sacrificed to remove impurities.  Alternatively if the protein 
were to be used in a biocatalytic process obtaining high purity protein can be a waste 
of time and money so purity will usually be sacrificed for retention of the activity of 
interest. 
Whatever the final application for the protein of interest it is important to choose the 
correct purification steps to give the most efficient procedure to help maximise yield.  
If a procedure consisting of five steps has a 75% yield of active target protein at each 
step then at the end of the procedure less than 25% of the target protein will be 
remaining.  To provide an efficient protocol it is often useful to exploit a different 
property of the protein at each step.  Common properties to exploit can be ionic 
charge of the protein, hydrophobicity, size/oligomeric state, heat stability, solvent 
resistance and ligand specificity. 
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2.2 Materials and methods 
2.2.1 Transformation of TmAKR plasmid 
The Thermot. maritima AKR (TmAKR) gene was cloned into the vector pTRC99 by 
Dr. Jodie Guy (Guy, 2004) and the purified plasmid was stored at -80°C.  The plasmid 
was transformed into chemically competent E. coli BL21 by incubation on ice of 50 
µL of competent cells with 1 µL of plasmid for 10 minutes, followed by heat shock 
for 60 seconds at 42°C before returning to ice for a further 2 minutes.  200 µL of LB 
medium was added and the samples incubated at 37°C for 1 hour prior to spreading 
the sample onto LB agar plates (with 0.1 g L
-1
 ampicillin) and incubated at 37°C 
overnight.  Colonies were picked from the transformation plates and used to inoculate 
10mL of LB media (with 0.1 g L
-1
 ampicillin) and grown overnight.  Cultures were 
divided into 1mL aliquots and centrifuged (13000rpm, 10 minutes).  Supernatants 
were removed and the pellets resuspended to 20% glycerol and flash frozen in liquid 
nitrogen prior to storage at -80°C until required. 
2.2.2 Induction Studies 
10 mL of LB medium containing 0.1 g L
-1
 ampicillin was inoculated with one 
glycerol stock of transformed E. coli BL21 containing the pTRC99 expression vector 
harbouring the TmAKR gene (see section 2.2.1) to provide an overnight starter 
culture.  This culture was incubated with shaking (300rpm, 32mm orbit) at 37°C 
overnight for approximately 16 hours.  Four 200 mL conical flasks containing 100 mL 
of LB medium and 0.1 g L
-1
 ampicillin were inoculated from an overnight starter 
culture.  The flasks were incubated in an orbital shaker (300rpm, 32mm orbit) at 37°C 
and induced with 1mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) at a specific 
OD595.  1 mL samples were taken at regular intervals post induction to determine the 
optimum optical density at induction and the optimum post-induction time before 
harvesting.  One flask remained uninduced to provide a basal level of expression, 
whilst the other flasks were induced at ODs of 0.6, 1 and 1.5.  Induction was 
continued overnight.  Samples were centrifuged at 13,000rpm for 10 minutes and the 
pellets stored at -20°C until all samples were collected.  Pellets were resuspended in 
200 µL of Bugbuster (Invitrogen) to lyse the cells and extract the soluble protein.  
Samples were centrifuged (13,000rpm, 10 minutes) to remove the cell debris and the 
soluble protein was analysed by SDS-PAGE. 
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2.2.3 Growth of Microorganisms 
Six sterile 2 L conical flasks containing 1 L of LB medium and 0.1 g L
-1
 ampicillin 
were inoculated from an overnight starter culture of E. coli BL21 containing the 
pTRC99 expression vector harbouring the TmAKR gene.  The flasks were incubated 
at 37°C, shaking (300rpm, 32mm orbit) for 8 hours (until OD595 ~1.5) prior to 
induction of the TmAKR gene by addition of 1 mL 1M IPTG to each flask followed 
by incubation for a further 16 hours at 37°C with shaking (300rpm, 32mm orbit).  
Cells were then harvested by centrifugation at 12,000g for 20 minutes (4°C) and the 
pellets stored at -20°C until required. 
2.2.4 Sodium-Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) 
2.2.4.1 Stock Solutions 
Acrylamide solution: 30% (w/v) in water (37.5 acrylamide: 1 bisacrylamide) 
Stacking gel buffer: 0.5M Tris-HCl pH 6.8 
Separating gel buffer: 1.5M Tris-HCl pH 8.8 
SDS Solution: 10% (w/v) SDS in water 
Ammonium persulfate (APS) solution: 10% (w/v) APS in water 
Running buffer: 0.05M Tris-HCl, 0.38M glycine, 0.1% (w/v) SDS, pH 8.8 
Sample loading buffer: 125mM Tris-HCl pH 6.8, 2% (w/v) SDS, 20% (v/v) glycerol, 
0.001% (w/v) bromophenol blue, 0.005% (v/v) β-mercaptoethanol 
Microwave coomassie stain: 0.05% (w/v) Coomassie brilliant blue, 50% (v/v) 
methanol, 10% (v/v) acetic acid, in water 
2.2.4.2 Preparation of Gels 
A Mini-protean
®
 II gel apparatus (Bio-Rad Laboratories, UK) was set up as per the 
manufacturers instructions.  The separating gel (12.5%) consisted of 4.2 mL 
acrylamide solution, 2.5 mL separating gel buffer, 1 mL SDS solution, and 2.3 mL 
deionised water.  10 µL Tetramethylethylenediamine (TEMED) and 100 µL APS 
solution were added to begin polymerisation of the acrylamide, and the separating gel 
solution poured between the gel plates up to a height of approximately 50mm and 
water saturated isobutanol applied on top.  Once set the butanol/water was washed off 
the top of the separating gel.  The stacking gel (6%) consisted of 2 mL acrylamide 
solution, 2.5 mL stacking gel buffer, 1 mL SDS solution, 4.5 mL deionised water.  10 
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µL TEMED and 100µL APS solution were added to begin polymerisation and the 
stacking gel solution was poured onto of the separating gel to the top of the plates and 
a 10 well square toothed comb inserted and the gel allowed to polymerise. 
2.2.4.3 Preparation of Protein Samples 
20 µL of protein loading buffer was mixed with 20 µL of protein sample and 
incubated at 110°C for 20 minutes to ensure complete denaturation of the protein. 
2.2.4.4 Molecular Weight Standards 
To estimate the subunit size and easy identification of proteins during the purification, 
molecular weight standards were used.  Precision plus pre-stained standards 
(Bio-Rad) were used which consist of 10 distinct protein bands with the following 
molecular weights 250, 150, 100, 75, 50 (Reference band), 37, 25, 20, 15, 10 kDa. 
 
2.2.4.5 Running Procedure 
The gel was inserted into the electrophoresis tank as per the manufacturer‟s 
instructions.  Buffer reservoirs were filled with running buffer.  Each sample to be 
analysed was loaded into a well in the gel using a Hamilton syringe and 5 µL of 
molecular weight standards was loaded into a well.  The gel was run at 200 Volts for 
55 minutes. 
2.2.4.6 Staining Procedure 
The gel was removed from the apparatus and placed into a 1 L beaker containing 50 
mL of microwave coomassie stain and microwaved on full power (750W) for 3 
minutes.  The stain was removed and 700 mL of deionised water added and heated on 
full power for 10 minutes.  After heating the gel was rinsed in deionised water and 
placed in fresh deionised water overnight to finish destaining at room temperature. 
2.2.5 Activity Assay 
The enzyme was assayed spectrophotometrically by monitoring the consumption of 
NADPH at 340nm using a Shimadzu UV2100 spectrophotometer at 50°C in a pre-
warmed quartz cuvette.  The reaction buffer, 50mM imidazole pH 6 (adjusted at assay 
temperature, and degassed), was incubated at 50°C for 5 minutes prior to performing 
the assay.  2 µL 1,2,3,6-tetrahydrobenzaldehyde (THBA) and 20 µL NADPH (5mM 
stock) was added to 960 µL of the preheated assay buffer and 20 µL enzyme sample 
 56 
added to start the reaction.  Assays were carried out for 5 minutes and the change in 
absorbance at 340nm followed.  Assays were performed in triplicate and initial rates 
were calculated from the resulting curve and specific activities calculated using the 
protein concentration estimated from A280 readings and the extinction coefficient. 
2.2.6 Protein Purification 
All steps were performed at 4°C unless stated.  Chromatographic procedures were 
performed on an ÄKTApurifier™ (GE Healthcare). 
2.2.6.1 ExPASy 
To aid in purification some parameters such as subunit molecular weight, isoelectric 
point (pI) and extinction coefficient (280nm) are useful to know.  The protein 
sequence was input into the Protparam server (Gastieger et al., 2005) from ExPASy 
tools (Gastieger et al., 2003).  The server output is shown in appendix 1. 
2.2.6.2 Preparation of Cell Free Extract 
Frozen cell pellets (section 2.2.4) were resuspended to 10% (w/v) in 20mM Tris-HCl 
pH 7.5.  The optimum temperature and time period for the heat lysis step was 
determined by performing trials on 1 mL samples of the resuspended pellets and 
incubating these at a range of temperatures for varying periods of time.  The samples 
were centrifuged (13000rpm, 10 minutes) and analysed by SDS-PAGE.  For all 
following purifications the cell suspension was subjected to a heat lysis step at 80°C 
for 20 minutes and cell debris removed by centrifugation (12000g, 20 minutes).  
2.2.6.3 Hydrophobic Interaction and Ion Exchange Chromatography 
A 60 mL Phenyl-Sepharose hydrophobic interaction chromatography column (XK24; 
GE Healthcare) and a 10 mL Fast Flow Q-sepharose (FFQ) ion exchange column 
(XK16; GE Healthcare) were equilibrated with 2 column volumes of 20mM Tris-HCl 
pH 7.5, 2M KCl and 20mM Tris-HCl pH 7.5 respectively.  The cell free extract was 
made to 2M with respect to KCl and centrifuged (12000g, 20minutes) to remove any 
particulate material.  The cell free extract was then loaded onto the hydrophobic 
interaction column and washed with high salt buffer (20mM Tris-HCl pH 7.5, 2M 
KCl) to remove any unbound protein, and a gradient of 2-0M KCl over 400 mL was 
applied.  At the end of the gradient the 10 mL FFQ was attached to the bottom of the 
first column and 180 mL of no salt buffer (20mM Tris-HCl pH 7.5) used to elute the 
protein from the Phenyl-Sepharose column and to bind it to the FFQ.  At this point the 
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hydrophobic column was removed and a gradient of 0-0.5M NaCl applied over 10 
column volumes of the FFQ to elute the protein of interest.  10 mL fractions of eluted 
protein were collected from the Phenyl-Sepharose column and 5 mL samples 
collected from FFQ and the A280 recorded throughout. 
2.2.6.4 Size Exclusion Chromatography 
Fractions containing the TmAKR protein were pooled together and concentrated to a 
total volume of 2 mL using a Vivaspin centrifugal concentrator (Sartorius, UK) with a 
30kDa cut-off membrane and loaded onto a pre-equilibrated Superdex200 gel 
filtration column (XK16; GE Healthcare) with 20mM Tris-HCl pH 7.5, 0.1M NaCl.  
120 mL of buffer was used to elute the protein and 1 ml fractions collected whilst 
monitoring the A280. 
2.2.6.4.1 Estimation of Native Molecular Weight 
The elution profile from the Superdex 200 column can be used to predict the native 
molecular weight of a protein and therefore its oligomeric state.  Seven proteins of 
known molecular weight are loaded onto the column and a calibration chart 
(Appendix 2) produced using LogMW and Kav values for each protein. 
Kav is calculated as: 
 
Where Ve = Elution volume, V0 = Void volume, Vt = Total Volume 
2.2.7 Bacterioferritin Purification 
Frozen cells (section 2.2.4) were resuspended to 10% (w/v) in 20mM Tris-HCl 
pH 7.5.  Resuspended cells were sonicated on ice using a Soniprep 150 (Sanyo) five 
times for 30 second periods with 30 second breaks to prevent overheating of the 
suspension.  Sonicated cells were centrifuged (12000g, 20 minutes) to remove cell 
debris.  The supernatant was incubated for 30minutes at 37°C with 1 U mL
-1
 
benzonase and for a further 30 minutes at 4°C with the addition of 1 mg mL
-1
 
protamine sulfate.  The sample was centrifuged (12,000g, 20 minutes) to remove 
precipitated nucleic acids.  The sample was then heat treated at 80°C for 20 minutes 
prior to centrifugation (12000g, 20 minutes) to remove precipitated E. coli proteins.  
Hydrophobic interaction chromatography, ion exchange chromatography and size 
Ve – V0 
Vt – V0 
Kav  = 
Eq. 2.1 
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exclusion chromatography were all carried out as described for the TmAKR protein 
(sections 2.2.6.3 and 2.2.6.4) 
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2.3 Results and Discussion 
2.3.1 Induction Studies 
To optimise protein expression levels the post-induction time and the optical density 
at induction were varied and the results analysed by SDS-PAGE (Fig 2.1).  Without 
any induction of the TmAKR gene the SDS-PAGE analysis shows a low level of 
expression of the gene.  Induction levels were shown to increase with longer 
expression times and with initial induction at higher optical densities.  An overnight 
induction (16 hours) with induction at an optical density of approximately 1.5 was 
chosen for all subsequent expression of the TmAKR protein. 
 
M     1       2      3       4                 M      5       6       7       8     9      10
TmAKR
50KDa
37KDa
 
Fig 2.1.  Figure showing the SDS-PAGE analysis of induction studies of TmAKR. 
M – Protein molecular weight markers (see 2.2.5) 
Lane 1 – Induction at OD 0.6, 0hrs induction 
Lane 2 – Induction at OD 0.6, 2hrs induction 
Lane 3 – Induction at OD 0.6, 4hrs induction 
Lane 4 – Induction at OD 0.6, 20hrs induction 
Lane 5 – Induction at OD 1.0, 0hrs induction 
Lane 6 – Induction at OD 1.0, 2hrs induction 
Lane 7 – Induction at OD 1.0, 4hrs induction 
Lane 8 – Induction at OD 1.0, 19hrs induction 
Lane 9 – Induction at OD 1.5, 16hrs induction 
Lane 10 – No induction 24hrs growth 
2.3.2 Purification 
From the program Protparam, the subunit molecular weight of the TmAKR was 
calculated to be 37.5 kDa (37538 Da), the pI was estimated as 5.56 and the extinction 
coefficient at 280nm to be 41160 M
-1 
cm
-1
 (Absorbance 1 g L
-1
 = 1.09).  Knowing the 
subunit molecular weight allows us to identify the protein throughout purification on 
SDS-PAGE more reliably.  The extinction coefficient can be used to estimate the 
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protein concentration from the absorbance at 280nm.  The predicted pI of 5.6 can be 
used to design the purification procedure.  By using a buffer with a pH of 
approximately 7.5 the protein should be negatively charged and be able to bind to an 
anion exchange resin.  To simplify the procedure and remove the need to exchange 
buffers, Tris-HCl with a pH of 7.5 was chosen to use throughout the purification. 
The source organism for the AKR, Thermot. maritima has an optimum growth 
temperature of 80°C and therefore many of its enzymes would be expected to be 
stable up to and above this temperature.  Due to this property of the enzyme it is 
possible to heat up the sample to high temperatures and remove large quantities of the 
native E. coli proteins.  Heat lysis trials were performed at a range of temperatures 
and times and the remaining soluble protein analysed by SDS-PAGE (Fig 2.2).  The 
SDS-PAGE analysis shows that at 80°C a large proportion of the AKR remains but at 
higher temperatures and longer times the AKR is slowly denatured without 
significantly removing extra E. coli proteins.  Incubation at 80°C for 20 minutes 
provided the best compromise for removal of E. coli proteins and retention of the 
TmAKR activity.  By performing this procedure on the intact E. coli cells it was 
possible to disrupt the cell wall and carry out the first two stages of the purification in 
one step. 
50KDa
37KDa TmAKR
M    1      2      3      4      5     6      7     8
 
Fig 2.2.  Figure showing the SDS-PAGE analysis of heat lysis trials of TmAKR. 
M – Protein molecular weight markers (See 2.2.5) 
Lane 1 – 80°C, 20 minutes 
Lane 2 – 80°C, 30 minutes 
Lane 3 – 85°C, 10 minutes 
Lane 4 – 85°C, 20 minutes 
Lane 5 – 85°C, 30 minutes 
Lane 6 – 90°C, 10 minutes 
Lane 7 – 90°C, 20 minutes 
Lane 8 – 90°C, 30 minutes 
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The semi-purified protein from the heat lysis step was loaded onto a Phenyl-
Sepharose column and the TmAKR bound successfully to the column as can be seen 
from the activity profile (Fig 2.3) and SDS-PAGE (Fig 2.4) analysis of the eluted 
proteins.  There is a small amount of activity at the end of the gradient from the 
Phenyl-Sepharose column before the FFQ is connected; the SDS-PAGE shows that 
this activity is due to the presence of the TmAKR.  A minimal amount of protein is 
lost at this stage which is not recovered; this loss is outweighed by the gains made by 
performing these two column chromatography steps in tandem.  The TmAKR can be 
directly eluted onto the FFQ column since it elutes at the end of the salt gradient and 
contains very little salt to prevent it binding to the ion exchange media.  The AKR 
elutes from the FFQ column approximately half way through the gradient in a roughly 
symmetrical peak (Fig 2.5) showing the success of the first two purification steps and 
is easily identified by its activity and presence on SDS-PAGE (Fig 2.5, 2.6). 
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Fig 2.3.  Figure showing the A280 elution profile (Blue) and Activity profile (Red) of 
hydrophobic interaction chromatography of the TmAKR protein.  The KCl gradient is 
shown in a black dashed line from 2M – 0M (scale not shown) 
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50KDa
37KDa TmAKR
M     1       2     3     4     5     6     M
 
Fig 2.4.  Figure showing the SDS-PAGE of hydrophobic interaction chromatography, 
and ion exchange chromatography of TmAKR. 
M – Protein molecular weight markers (See 2.2.5.) 
Lane 1 – HIC 200-210ml 
Lane 2 – HIC 800-810ml 
Lane 3 – FFQ 10-15ml 
Lane 4 – FFQ 55-60ml 
Lane 5 – FFQ 105-110ml 
Lane 6 – FFQ 210-215ml 
 
0
200
400
600
800
1000
1200
1400
1600
0 50 100 150 200 250 300
Volume (ml)
A
2
8
0
 (
m
A
u
)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
A
c
ti
v
it
y
 (
U
/m
l)
 
Fig 2.5.  Figure showing the A280 elution profile (Blue) and Activity profile (Red) of 
ion exchange chromatography of the TmAKR protein.  A gradient of 0 – 0.5M NaCl 
is shown in a black dashed line (scale not shown) 
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M     1     2      3      4     5      6     7      8      9
50KDa
37KDa TmAKR
 
Fig 2.6.  Figure showing the SDS-PAGE analysis of the ion exchange 
chromatography of TmAKR. 
M – Protein molecular weight markers (See 2.2.5.) 
Lane 1 – FFQ 220-225ml 
Lane 2 – FFQ 225-230ml 
Lane 3 – FFQ 230-235ml 
Lane 4 – FFQ 235-240ml 
Lane 5 – FFQ 240-245ml 
Lane 6 – FFQ 245-250ml 
Lane 7 – FFQ 250-255ml 
Lane 8 – FFQ 255-260ml 
Lane 9 – FFQ 270-275ml 
 
The pooled fractions from the ion exchange chromatography were concentrated to 
2 mL and loaded onto the Superdex200 gel filtration column.  This step does not 
provide much noticeable purification when analysed by SDS-PAGE (Fig 2.8), but the 
elution profile (Fig 2.7) shows that higher molecular weight aggregates have been 
removed providing the high quality and purity of protein required for crystallisation.  
The peak at 63 mL (240 kDa) contains enzymatic activity and a large proportion of 
TmAKR and corresponds to twice the molecular weight of the main peak suggesting 
this could be beginning to form aggregates.  Therefore the protein from the peak at 
76 mL (112 kDa) was pooled together without that from any other peak.  
Approximately 12 mg of purified protein was produced from this purification protocol 
starting with six litres of culture medium. 
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Fig 2.7.  Figure showing the A280 elution profile (blue) and activity profile (red) of the 
size exclusion chromatography of the TmAKR protein. 
 
50KDa
37KDaTmAKR
1      2      3      4      5     6      7      8     M
 
Fig 2.8.  Figure showing the SDS-PAGE analysis of size exclusion chromatography 
of the TmAKR protein. 
Lane 1 – GF 40-41ml 
Lane 2 – GF 62-63ml 
Lane 3 – GF 66-67ml 
Lane 4 – GF 68-69ml 
Lane 5 – GF 70-71ml 
Lane 6 – GF 72-73ml 
Lane 7 – GF 74-75ml 
Lane 8 – GF 76-77ml 
M – Protein molecular weight markers (See 2.2.5) 
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2.3.3 Bacterioferritin Purification 
Early on in developing the purification protocol for TmAKR it was noticed that on 
some occasions the TmAKR co-purified with an E. coli protein in moderate quantities 
and they were separated by size exclusion chromatography.  The purification 
procedure was identical to that described above for the TmAKR protein except the 
cells were lysed by sonication prior to heat treatment at 80°C.  The difference in the 
two purification protocols was due to the further development of the TmAKR 
protocol.  The bacterioferritin was purified twice with the protocol described (section 
2.2.8) and despite efforts to repeat the purification with identical conditions the 
bacterioferritin was not found again.  At this stage the identity of the bacterioferritin 
was not known and was not identified as E. coli bacterioferritin until solution of the 
X-ray crystal structure (Chapter 5) 
The elution profile of the Superdex 200 gel filtration chromatography of such 
purifications can be seen in Fig 2.9 and the corresponding SDS-PAGE analysis (Fig 
2.10) 
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Fig 2.9.  Figure showing the A280 elution profile (blue) of TmAKR and 
Bacterioferritin separated by gel filtration chromatography on Superdex 200.  The 
TmAKR activity for pooled fractions is shown as red bars. 
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37KDa TmAKR
BFR
M    1     2     3     4    5     6     7
 
Fig 2.10.  SDS-PAGE of size exclusion chromatography from Fig 2.9.   
M – Protein markers (see 2.5.5) 
Lane 1 – 41-42ml 
Lane 2 – 54-55ml 
Lane 3 – 58-59ml 
Lane 4 – 62-63ml 
Lane 5 – 71-72ml 
Lane 6 – 73-74ml 
Lane 7 – 75-76ml 
 
As can be seen from the SDS-PAGE analysis of the gel filtration all peaks contain the 
AKR in significant proportions.  The peak containing the bacterioferritin eluting at 
approximately 56 mL corresponds to a molecular weight of 458 kDa and can be seen 
to contain both the active AKR and another protein with a subunit molecular weight 
of 15 – 20 kDa.  This larger molecular weight peak corresponds to four times the 
weight of the main AKR peak (76 mL; 112 kDa) with the intermediate peak (63 mL; 
220 kDa) corresponding to twice the molecular weight of the main peak and could 
correspond to progressively higher order aggregates on the route to insoluble 
aggregation.  The AKR may be interacting with a contaminating protein affecting its 
retention time, or could be due to a higher oligomeric state of the TmAKR protein.  
Due to the presence of AKR activity, this peak (at 56 mL) was pooled and taken 
forward to crystallisation trials (Chapter 3).  The intermediate peak at 63 mL was not 
pooled as too little protein was present for crystallisation trials. 
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3 AKR Characterisation 
3.1 Introduction 
To evaluate the TmAKR enzyme for use as a biocatalyst in biotransformation 
reactions it is required to characterise the enzyme with respect to several important 
properties.  It is preferable for an enzyme to be active and stable at elevated 
temperatures.  This allows the process to be performed at higher temperatures, and 
also gives an indication of the potential long term stability of the enzyme and the 
possibility of recycling it for reuse.  The substrate used in a biotransformation may be 
only sparingly soluble in aqueous media, therefore an organic co-solvent may be 
required to solubilise the substrate to increase the enzyme‟s performance in such a 
system.  The enzyme also needs to have broad substrate specificity so it may be used 
in a wide range of reactions, and in the case of oxidoreductases the enzyme needs to 
be high enantioselectivity towards production of chiral secondary alcohols. 
The conversion of a carbonyl to the alcohol is referred to here as the forward reaction, 
and the reverse reaction as the conversion of an alcohol to the corresponding 
carbonyl. 
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3.2 Materials and Methods 
TmAKR used for characterisation experiments was from purified protein after gel 
filtration chromatography (Section 2.2.7.3) which was stored at -20°C at 0.5 mg mL
-1
.  
Once defrosted, the enzyme concentration was re-estimated by absorption at 280nm.  
Screening experiments were performed with partially purified TmAKR from the heat 
lysis (section 2.2.7.1) which was stored at -20°C.  All graphs were produced using 
Sigmaplot 10.0 (SYSTAT software).  One unit of activity is defined as one µmole of 
NADPH reduced in one minute. 
3.2.1 Activity Assay 
Standard activity assays were performed as previously described in section 2.2.6. 
3.2.2 Substrate Screening 
Substrate screening was performed in 96 well plates and the change in absorbance at 
340nm followed over a period of 20 minutes on a Tecan rainbow 96 monochromatic 
microplate reader.  Substrates were prepared to 30% (v/v for liquids or w/v for solids) 
in dimethyl sulfoxide (DMSO) in a 96 well microplate containing glass vial inserts 
(Chromacol).  75 µL of 50mM Imidazole pH 6.5 containing 15mM NADPH was 
added to each well of a 96 well plate.  5 µL of each substrate was added into the 
appropriate well, and the reaction started by addition of 20 µL TmAKR (heat treated 
extract).  A list of the substrates tested is shown in table 3.1 and the structures of these 
are shown in appendix 3. 
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1,2,3,6-tetrahydrobenzaldehyde ethyl benzoylacetate 
2-chloro-3',4'-dihydroxyacetophenone propiophenone 
dichlorobenzophenone 2-acetyl pyridine 
1,4-dibromo-2,3-butanedione 4-acetylbenzonitrile 
2-bromoacetophenone 3-hexanone 
1,3-dimethylimidazolidinone cyclopentanone 
2-butanone 3-acetylpyridine 
cyclohexanone acetophenone 
2-cyclohexen-1-one 2-chloroacetophenone 
2-hexanone 3,5-bis(trifluromethyl)acetophenone 
4-acetylpyridine p-anisaldehyde 
acetonylacetone m-anisaldehyde 
3-octanone benzaldehyde 
2'-chloroacetopenone acetone 
2'-(trifluromethyl)acetophenone  
Table 3.1.  Ketone and aldehyde substrates used for screening assays with TmAKR. 
 
Potential substrates identified from spectrophotometric screening were scaled up and 
analysed by GC to confirm activity.  1 mL of 1M Tris-HCl pH 7.6 containing 8 mg 
NADPH, 100 mg D-glucose and 0.28 mg Glucose Dehydrogenase (CDX901, 
Codexis) were placed in a scintillation vial with 100 µL DMSO, 20 mg substrate and 
1 mL TmAKR (heat treated extract).  Reactions were incubated at 25°C shaking 
overnight.  200 µL samples were taken, and reaction products extracted into 1 ml 
MTBE.  Samples were analysed for substrate depletion and product accumulation by 
GC, using a generic method with a DEX CB column at an initial temperature of 60°C 
for 2 minutes, ramping to 220°C at 10°C per minute and holding for 2 minutes.  
Substrate and product identity was confirmed by comparison of retention times for 
commercially available pure samples. 
3.2.3 pH Optimum 
Assays were performed in a Shimadzu UV2100 double beam spectrometer at 50°C.  
A range of assay buffers were prepared, covering the pH range from 5.5 - 11 and 
adjusted to the appropriate pH at the assay temperature.  Each buffer was incubated at 
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50°C for 5 minutes prior to the assay being carried out.  For the forward reaction 
960 µL of the assay buffer was placed in a quartz cuvette with 2 µL THBA and 20 µL 
of 5mM NADPH.  For the reverse reaction 960 µL of the assay buffer was placed in a 
quartz cuvette with 2 µL 3-cyclohexene-1-methanol and 20 µl of 20mM NADP. The 
assay was started with the addition of 20 µL TmAKR and the change in absorbance at 
340nm followed for 5 minutes.  Initial rates were estimated from the resulting curve 
and specific activities calculated using the protein concentration estimated from A280 
readings and the extinction coefficient.  All assays were performed in triplicate. 
3.2.4 Temperature Optimum 
Assays were performed in a Shimadzu UV2100 double beam spectrometer.  50mM 
Imidazole pH 6.5 was incubated at the appropriate assay temperature for five minutes 
prior to the assay being carried out.  The buffer was adjusted to the correct pH at the 
appropriate assay temperature.  960 µl of the assay buffer was placed in a quartz 
cuvette with 2 µl THBA and 20 µL NADPH (5mM).  20 µL TmAKR was added to 
start the reaction and the change in absorbance at 340nm followed for 5 minutes.  
Assays were performed in triplicate and initial rates were calculated from the resulting 
curve and specific activities calculated using the protein concentration estimated from 
A280 readings and the extinction coefficient.  The assay was performed at 30°C and at 
5° intervals from 40°C to 70°C.  Operational limits of the equipment prevented 
measurement of activity at higher temperatures. 
3.2.5 Temperature Stability 
The TmAKR was incubated in a water bath at a range of temperatures (70-90°C) for 
between 30 and 300 minutes.  After the incubation period was over the sample was 
removed to ice and allowed to cool for 30 minutes prior to being assayed.  Assays 
were performed as per the standard assay described in section 2.2.6.  Assays were 
performed in triplicate and remaining activity calculated with reference to an 
unincubated sample from the same batch. 
3.2.6 Solvent Stability 
TmAKR was incubated at room temperature with 5, 20, 40 and 60% of a range of 
organic solvents (isopropanol, butan-1-ol, acetonitrile and DMSO).  The appropriate 
amount of organic solvent was mixed with 50mM Imidazole pH 6.5 to a volume of 
960 µL, 2 µL of THBA and 20 µL of enzyme was added and mixed gently.  The 
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sample was then incubated at room temperature for 30 minutes.  After incubation the 
sample was immediately placed in a quartz cuvette at 50°C for 5 minutes.  20 µL 
NADPH (5mM) was added to start the reaction and the change in absorbance at 
340nm followed for 5 minutes.  Assays were performed in triplicate and remaining 
activity calculated with reference to an unincubated sample from the same batch. 
3.2.7 Michaelis-Menten Kinetics 
The kinetics of the TmAKR catalysis of THBA was investigated.  Assays were 
carried out as described in section 2.2.6, except the substrate concentration was varied 
from 0.44µM to 22µM.  20µl of 0.204 mg mL
-1
 protein was used per assay, and 
assays were performed in triplicate.  Initial rates were calculated and Sigmaplot10.0 
(SYSTAT software) used to calculate Km and Vmax values by linear regression. 
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3.3 Results and Discussion 
3.3.1 Substrate Screening 
Substrates used in screening reactions were chosen to provide a range of varying 
chain length, branched, non-branched and aromatic substrates.  Acetone was 
specifically chosen to investigate substrate coupled cofactor recycling (section 1.2.1). 
Spectrophotometric screening identified nine substrates which should be investigated 
further as potential substrates.  These were benzaldehyde, 3,5-
bis(trifluoromethyl)acetophenone, 2‟-(trifluoromethyl)acetophenone, 2-cyclohexen-1-
one, THBA, 4-acetylpyridine, dichlorobenzophenone, acetonylacetone and para-
anisaldehyde.  These substrates identified from initial spectrophotometric screening 
were subject to further screening reactions and analysis by GC.  Three substrates were 
identified to exhibit activity with the TmAKR enzyme (Fig 3.1).  The three substrates 
identified (Fig 3.2) were benzaldehyde, THBA and para-anisaldehyde.  All substrates 
are aldehydes containing a bulky phenyl group or a partially hydrogenated phenyl 
group.  No activity with acetone was found, and therefore substrate coupled cofactor 
regeneration would not be an option unless the activity could be engineered to 
accommodate acetone/isopropanol.  The enzyme has shown specificity for aldehydes 
and not for ketones, limiting the enzyme to the production of primary alcohols.  
Therefore any product would not be able to possess a chiral centre at the carbonyl 
carbon, but chiral centres may be present at other locations within the substrate or 
product.  One of the substrates THBA, possesses a chiral centre at C1 (Fig 3.2) due to 
the partially hydrogenated nature of the aromatic ring.  GC analysis was unable to 
resolve the different enantiomers of the substrate and product; therefore it was not 
possible to determine if the enzyme was selective towards one enantiomer of this 
substrate.  The specificity of the enzyme towards aldehydes and the lack of activity 
with ketones suggest there may be steric hindrance in the corresponding part of the 
enzyme precluding any activity towards ketones and secondary alcohols. 
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Fig 3.1.  Confirmation of activity of TmAKR towards potential substrates from GC 
analysis, showing conversion of the three substrates identified from screening to the 
corresponding alcohol product.  The percentage abundance is measured relative to the 
starting abundance of the substrate carbonyl. 
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Fig 3.2.  Substrates to which TmAKR has been shown to be active.  * - Chiral centre  
 
3.3.2 pH Optimum 
The pH optima for the forward and reverse reactions were investigated and are shown 
in Fig 3.3 and Fig 3.4 respectively.  The forward reaction shows preference towards 
activity at lower pH values and exhibits a pH optimum around pH 6.5 in 50mM 
imidazole buffer.  Activity in phosphate buffer was found to be reduced, and may be 
due to interference with cofactor binding, as the buffer may be able to occupy sites 
associated with the NADP
+
 phosphate binding.  The activity of TmAKR in imidazole 
buffer appears to be shifted towards higher pH values in relation to the activity in 
phosphate buffer.  This shift in activity may be due to some unknown specific 
interaction of imidazole with the enzyme.  The reverse, carbonyl to alcohol, reaction 
appears to have a pH optimum around pH 8.5 in BICINE buffer.  The activity 
observed is marginally above the lower limit of detection for this method, therefore 
the pH optimum could not be accurately determined and the true pH optimum may be 
within the pH 8.5 to pH 10 region.  The reverse reaction shows much lower activity 
(20 fold less) than the forward reaction, suggesting this enzyme is only utilised in 
alcohol to carbonyl metabolism under physiological conditions.  Due to this low 
activity for the reverse reaction and the errors associated in measuring this, all further 
characterisation concentrated on the forward, carbonyl to alcohol reaction. 
 
* 
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Fig 3.3.  The pH optimum of the forward reaction catalysing the conversion of alcohol 
to carbonyl. 
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Fig 3.4.  The pH optimum of the reverse reaction catalysing the conversion of 
carbonyl to alcohol.  Note differing scale from Fig 3.4. 
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3.3.3 Temperature Optimum 
The effect of temperature on the rate of reaction was investigated from 30°C upto the 
experimental limits of the equipment.  The results (Fig 3.5) show a consistent increase 
in activity over the range studied and the reaction does not reach a maximum over this 
range.  There is a noticeable increase in the error observed at higher temperatures due 
to the increased rate of degradation of NADPH cofactor at higher temperatures.  
Therefore all characterisation assays were performed at 50°C. 
 
Temperature Optimum
Temperature (
o
C)
20 30 40 50 60 70 80
A
c
ti
v
it
y
 (
U
/m
g
)
0
2
4
6
8
10
12
14
16
S
p
e
c
if
ic
 A
c
ti
v
it
y
 (
U
/m
g
)
A
c
ti
v
it
y
 (
U
/m
g
)
S
p
e
c
if
ic
 A
c
ti
v
it
y
 (
U
/m
g
)
 
Fig 3.5.  The temperature optimum for the alcohol to carbonyl reaction of TmAKR. 
3.3.4 Temperature Stability 
The thermal inactivation of the TmAKR enzyme was investigated over a period of 5 
hours and with temperatures ranging from 70°C to 90°C.  At 70°C there is very little 
activity lost over the first 1 or 2 hours, with only 20% being lost after 5 hours.  
Between 70°C and 80°C there is only a small increase in the amount of enzyme 
activity lost, but above this temperature there is a large decrease in the stability of the 
enzyme.  At 85°C almost all the activity has been lost after 5 hours compared with 
just 40% loss at 80°C for the same time.  At 90°C all the activity has been lost after 
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only 90 minutes.  These results suggest that a vital stabilising element is lost at 
temperatures above 80°C causing the rate of thermal inactivation to increase.  The 
TmAKR is stable at temperatures up to 80°C for long periods and therefore would be 
potentially useful in biocatalytic processes as it would be able to withstand the 
increased temperatures of process conditions. 
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Fig 3.6. The temperature stability of TmAKR over a range of incubation times and 
temperatures. 
3.3.5 Solvent Stability 
The ability of the enzyme to catalyse reactions in the presence of organic solvents is 
important if the enzyme is to be used as a biocatalyst since many substrates will 
require a co-solvent due to low solubility in aqueous media.  The results of these 
experiments are shown the figure 3.7. 
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Fig 3.7.  Stability of TmAKR with respect to a variety of organic solvents over a 
range of concentrations. 
 
The enzyme showed no activity above 60% in any organic solvent tested probably due 
to loss of water from the structure of the enzyme leading to denaturation of the 
protein.  By comparing the stability of the enzyme in each solvent with the polarity 
index (Snyder, 1974) a general trend can be seen for higher stability in solvents with 
higher polarity index values (Table 3.2).  The only deviation from this trend being 
isopropanol, which performs favourably but has the lowest polarity index. 
Solvent Polarity Index Activity Rank 
Butan-1-ol 4.0 5 
Acetonitrile 5.8 4 
Isopropanol 3.9 3 
DMSO 7.2 2 
Water (no solvent) 10.2 1 
Table 3.2.  Table showing the polarity index of solvents tested, ranked in order 
TmAKR activity. 
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3.3.6 Michaelis-Menten Kinetics 
A simple one substrate one product enzyme catalysed reaction may be described as in 
Eq. 3.1, where free enzyme (E) and substrate (S) form the complex ES (k1), which 
may either dissociate to give free enzyme and substrate (k-1), or may undergo catalysis 
to give free enzyme and product (k2). 
 
For a reaction which obeys Michaelis-Menten kinetics, the initial rate of reaction (V0) 
may be described by the Michaelis-Menten equation (Eq. 3.2).  Where Vmax is the 
maximum rate of reaction, [S]0 is the initial substrate concentration, and Km is the 
Michaelis constant.  A plot of V0 against [S] will produce a rectangular hyperbola for 
an enzyme reaction obeying Michaelis-Menten kinetics.  
 
0
0max
0
][
][
SK
SV
V
m 

   Eq. 3.2 
The Michaelis constant (Eq. 3.3) describes the breakdown to the ES complex and is 
the substrate concentration where the reaction velocity is equal to Vmax/2.  At high 
substrate concentrations the product formation step (k2) is the rate limiting step, here 
k2 is small and the Michaelis constant (Km) approximates to k-1/k1, the dissociation 
constant (kd) for the ES complex.  At lower substrate concentrations formation of the 
ES complex becomes rate limiting and the rate becomes directly proportional to the 
substrate concentration.  A low Km value signifies that the enzyme has a high affinity 
for the substrate (k1 > k-1). 
1
21
k
kk
Km

 
   Eq. 3.3 
 
The catalytic constant of an enzyme (Kcat), gives the number of molecules of substrate 
turned over per unit time, and is defined as; 
E + S      ES  E + P 
k1 k2 
k-1 
Eq. 3.1 
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    Eq. 3.4 
Where ET is the total enzyme concentration.  If the reaction obeys Michaelis-Menten 
kinetics then Kcat is equal to k2.  The Kcat/Km value may be used as a measure of an 
enzymes catalytic efficiency, allowing us to directly compare the performance of 
different enzymes. 
 
The Km and Vmax values for the TmAKR enzyme have been calculated for the 
turnover of 1,2,3,6-tetrahydrobenzadlehyde (Fig. 3.8).  Kcat and Km/Kcat were also 
calculated (Table 3.3).  In comparison to the most closely related (by sequence 
identity) AKRs, AKR11A and AKR11B from Bacillus subtilis (Ehrensberger and 
Wilson, 2004) and AKR11C from Bacillus halodurans (Marquardt et al., 2005), the 
TmAKR enzyme has a much lower Km (µM range rather than mM) but has a slower 
turnover of approximately 0.3 S
-1
 rather than 1-5 S
-1
 for the other AKRs with the 
substrate benzaldehyde.  The Kcat/Km value for TmAKR is in the region of 100 fold 
higher than that for AKR11B, meaning that the TmAKR enzyme is more efficient 
than its related enzyme. Therefore this enzyme appears to be catalytically slower, but 
has a higher affinity for its substrate making it overall more efficient than the related 
enzymes. 
 
 81 
[THBA] uM
0 5 10 15 20 25
s
p
e
c
if
ic
 a
c
ti
v
it
y
 (
U
/m
g
)
0
1
2
3
4
5
6
 
Fig. 3.8.  A plot of initial velocity against substrate concentration for TmAKR, 
showing rectangular hyperbola from linear regression used to calculate Km and Vmax.  
Error bars show 1 standard deviation.  THBA – 1,2,3,6-tetrahydrobenzaldehyde 
 
 Vmax 
(µmoles min
-1
 mg
-1
) 
Km 
(µM) 
Kcat 
(S
-1
) 
Kcat/Km 
(S
-1
 µM
-1
) 
THBA 5.48 1.1561 0.3 0.266 
Table 3.3.  Summary of kinetic parameters of the TmAKR enzyme with respect to 
THBA (1,2,3,6-tetrahydrobenzaldehyde). 
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4 Crystallisation 
4.1 Introduction 
To produce protein structures by X-ray diffraction methods requires the production of 
high quality diffracting crystals of the macromolecule of interest.  These crystals are a 
highly ordered three dimensional arrangement of the protein molecules in the solid 
phase.  The transition of the protein from solution to this highly ordered solid phase is 
dependant upon a number of factors and needs to be controlled carefully to ensure 
crystals form with sufficiently high order and to the required size.  Crystal growth is 
dependant upon the concentration of all of the ingredients in the crystallisation 
solution (protein, buffer, precipitants and additives), purity of the protein, solution pH, 
precipitant type, incubation temperature, and the method of crystallisation used 
(microbatch, vapour phase diffusion). 
4.1.1 Crystallisation Techniques 
There are a number of ways to produce diffraction quality crystals but two main 
methods have been used here and will be focused on.  In vapour diffusion (Fig 4.1) a 
small volume of the protein is mixed with a precipitant solution and placed either on a 
micro-bridge (sitting drop) or on an inverted cover slip (hanging drop).  In this 
method each well contains a reservoir of the precipitant solution and is sealed with a 
cover slip and grease.  The concentration of protein and precipitant in the drop slowly 
increases over time via diffusion of water in the vapour phase until both the drop and 
reservoir reach equilibrium. 
Reservoir
Sealing Grease
Micro-bridge
Crystallisation drop
Hanging DropSitting Drop
 
Fig 4.1.  The vapour phase diffusion method of protein crystallisation, showing sitting 
drop and hanging drop techniques.  The protein solution either sits on a micro bridge 
or is suspended by surface tension on a cover slip. 
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Alternatively with the microbatch method (Fig 4.2) a drop of protein is placed in a 
well with the precipitant and covered in paraffin oil.  This simple to setup experiment 
provides the protein and precipitant drop at its final concentration from the start, but 
does not give any significant concentration of the drop and is therefore not useful for 
sparse matrix screening.  By adding silicone oil to the paraffin oil (a mixture often 
referred to as Al‟s oils) the evaporation rate can be increased so a similar 
concentration effect to vapour phase diffusion is achieved (D‟arcy, 1996), allowing 
screening to be performed more successfully. 
 
Fig 4.2.  Microbatch crystallisation.  In each condition both protein and precipitant are 
pipetted simultaneously by a 2 bore tip.  The dispensed drop is then covered with 
paraffin oil. 
 
The phase diagram (Fig 4.3a) is important in understanding what happens during 
crystallisation and how to alter the crystallisation conditions to achieve better crystals.  
When a solution is under-saturated all the components are fully soluble and no 
crystals will grow.  If crystals are added to this phase they will usually shrink or 
completely disappear.  To produce crystals it is necessary to have a supersaturated 
solution.  If however the solution is too highly supersaturated then precipitation will 
occur and crystals are unlikely to grow.  To begin crystallisation the drop must be 
within the nucleation zone.  This is at a high enough concentration to overcome the 
energy barrier to formation of a small cluster of protein molecules which is the 
nucleus from which the crystal will grow.  In the nucleation zone crystals will also 
grow as well as nucleate, but once a small number of growing crystals have formed 
then it is favourable to leave the nucleation zone and enter the metastable zone where 
crystals will only grow and no new nuclei will form.  This allows the maximum 
amount of protein to be available for crystal growth rather than for further nucleation.  
This transition from nucleation to growth will usually occur naturally due to protein 
2-Bore Tip 
Crystallisation drop 
Oil 
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moving from the soluble phase into crystals (solid phase) reducing the protein 
concentration and the nucleation rate (Fig 4.3b,c). 
 
Fig 4.3.  Figure showing phase diagrams for protein crystallisation.  a) Phase diagram 
showing solubility curve and undersaturated, metastable, nucleation and precipitation 
zones.  b) Effect of vapour phase diffusion, initially crystallisation drop is in 
metastable zone, concentration of the drop increases until nucleation occurs (red star) 
where protein concentration begins to drop and passes back into metastable zone and 
growth continues.  c) In microbatch no significant concentration occurs, starting 
condition must give nucleation for growth to occur, protein concentration drops after 
nucleation into metastable zone.  By using microbatch with „Al‟s oils‟ a concentration 
effect similar to b) occurs. 
c) 
a) 
b) 
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4.2 Materials and Methods 
4.2.1 Sample Preparation 
Pure protein (>95%) from gel filtration chromatography was pooled together and 
concentrated to the required concentration (10mg ml
-1
 for vapour phase diffusion, 
20 mg mL
-1
 for microbatch) using a Vivaspin centrifugal concentrator (Sartorius, UK) 
with a 30 kDa molecular weight cut off.  The sample was centrifuged at 13,000g for 
10 minutes to remove any precipitates, prior to crystallisation. 
4.2.2 Crystallisation methods 
4.2.2.1 Sitting Drop Vapour Phase Diffusion 
Vapour phase diffusion crystallisation was carried out in 24-well plates (Greiner) with 
a microbridge (Molecular Dimensions Ltd) positioned in each well.  500 µL of 
reservoir solution was placed in each well, 1 µL of protein solution was placed on the 
microbridge and mixed with 1 µL of reservoir solution by pipetting.  Each well was 
sealed with grease and a cover slip (Molecular Dimensions Ltd).  Plates were 
incubated at 20°C and investigated regularly to check for formation of protein crystals 
4.2.2.2 Microbatch  
Crystallisation by the microbatch method was carried out using an ORYX-6 robot 
(Douglas Instruments).  For crystallisation trials each precipitant solution is 
transferred by a 2-bore tip from a stock plate and is pipetted simultaneously with an 
equal volume of protein solution.  After pipetting each condition, „Al‟s oil‟ (1:1 
silicone oil: paraffin oil) was placed on top of the drop. 
Optimisation experiments were designed using X-step software (Douglas 
instruments).  Optimisation experiments were performed using a 5-bore tip with each 
channel containing a different ingredient (protein, 2 buffer, precipitant, water).  The 
ingredients were pipetted into each well and mixed with one stir of the tip and „Al‟s 
oil‟ placed on top. 
4.2.3 Crystallisation Trials 
4.2.3.1 Bacterioferritin 
Protein at 10 mg mL
-1
 (section 4.2.1) was used for crystallisation trials using the 
sitting drop vapour phase diffusion method (as described 4.2.2.1).  Reservoir solutions 
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were set up over a range of ammonium sulfate concentrations (50-80% saturation) 
each containing 20mM Tris-HCl pH 7.5 and 0.1M NaCl, 1 µL of protein solution was 
mixed with 1 µL reservoir solution on a microbridge and the well sealed.  Plates were 
then incubated at 20°C. 
4.2.3.2 TmAKR 
Crystallisation trials using the sitting drop vapour diffusion method were performed 
using protein at 10 mg mL
-1
 (section 4.2.1).  Trials were performed using the MDL1 
and MDL2 structure screens (Molecular Dimensions Ltd) (Appendix 4).  1 µL of 
protein was mixed with 1 µL of reservoir solution on a microbridge and the wells 
sealed and incubated at 20°C. 
Microbatch crystallisation trials were performed with 20 mg mL
-1
 protein (section 
4.2.1) using pHclearI, pHclearII and PEG1 structure screens (Qiagen) (Appendix 4).  
1µl of protein was mixed with 1 µL of precipitant solution in a 96 well Douglas 
microbatch plate (Douglas Instruments), covered with a 1:1 mixture of silicone oil and 
paraffin oil and incubated at 20°C. 
4.2.4 Crystallisation Optimisation 
Where crystallisation trials yielded crystals, conditions around these were investigated 
to improve crystal quality.  Optimisation experiments were designed using the X-step 
software (Douglas Instruments).  Stock buffer solutions were made to 1M 
concentrations, salt precipitants were made to saturation and PEG precipitants were 
made to 50% (w/v). All optimisations were performed by the microbatch method. 
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4.3 Results and discussion 
4.3.1 Crystallisation Trials 
4.3.1.1 Bacterioferritin 
Bacterioferritin crystals grew overnight across the whole range of ammonium sulfate 
concentrations using the vapour phase diffusion method.  No further optimisation was 
required.  The best crystals grew in 60% ammonium sulfate (Fig 4.4) to a size of 
approximately 0.125x0.125x0.125mm and exhibited a bright red colour. 
 
Fig 4.4.  A single crystal of E. coli bacterioferritin grown in 60% ammonium sulfate, 
20mM Tris-HCl pH 7.5, 0.1M NaCl. 
4.3.1.2 TmAKR 
TmAKR crystals grew over a 2 month period from the pHclearI (Qiagen) structure 
screen.  Crystals (Fig 4.5) were observed in 3 conditions (numbers 32, 55 and 56), 
10% (w/v) PEG6000 0.1M Citric acid pH 5.0 (Fig 4.5a) and 1.6M ammonium sulfate 
0.1M citric acid pH 5.0 (Fig 4.5b) and pH 4.0 (Fig 4.5c). 
All crystals were found in citric acid at either pH 4 or 5, those grown from ammonium 
sulfate were found as single crystals and the ones from PEG6000 grew as needles.  
The crystals grown at pH 4 in ammonium sulfate grew under a heavy brown 
precipitate suggesting this low pH may not be a favourable environment for the 
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protein, however crystals were of a similar morphology to those grown in similar 
conditions at pH 5, suggesting the pH range between these two conditions may be 
worth investigating. 
 
 
A
CB
 
 
Fig 4.5. Figure showing crystals of TmAKR obtained from microbatch screening.  
Screening solutions were a) 0.1M citric acid pH 5.0, 10% (w/v) PEG6000 b) 0.1M 
citric acid pH 5.0, 1.6M ammonium sulfate c) 0.1M citric acid pH 4.0, 1.6M 
ammonium sulfate.
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4.3.2 Crystallisation Optimisation 
4.3.2.1 TmAKR 
Optimisation of crystal growth conditions were performed in microbatch and 
experiments designed around those conditions identified from screening using the 
Xstep optimisation software (Douglas Instruments).  The pH, precipitant 
concentration, and protein concentration were all investigated to improve crystal 
quality.  The ammonium sulfate grown crystals were optimised to produce the best 
crystals from 0.9M ammonium sulfate, 50mM citric acid pH 5.1 with 7mg ml
-1
 
protein (Fig 4.6), all optimised crystals grown in ammonium sulfate grew in a 
different habit, preferring a more circular or half moon appearance to the triangular 
form discovered from screening. 
 
Fig 4.6.  Optimised crystals of TmAKR grown in 50mM citric acid pH 5.1, 0.9M 
ammonium sulfate, 7 mg mL
-1
 protein. 
 
Using these optimised crystals as a starting point it was attempted to co-crystallise in 
the presence of 1.2 molar equivalents of NADPH to provide a holo structure of the 
protein.  Optimisation was carried out starting at the final conditions from previous 
optimisation by once again varying the pH, precipitant and protein concentrations.  
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The buffer composition was also changed to acetic acid to investigate this additional 
variable.  Another crystal form was discovered after changing the buffer to acetic acid 
(Fig 4.7).  The best crystals of this type were grown from 1.6M ammonium sulfate, 
50mM acetic acid pH 4.5 with 7.5 mg mL
-1
 protein.  These crystals grew as large thin 
plates with maximum dimensions 0.5 x 1 x 0.01 mm and appeared to look more like 
the original ammonium sulfate crystals from screening (Fig 4.5B) rather than the 
optimised crystals (Fig 4.6). 
 
Fig 4.7.  Further optimised crystal of TmAKR grown in 1.6M ammonium sulfate, 
50mM acetic acid pH 4.5, 7.5 mg mL
-1
 protein and 1.2 Molar equivalents NADPH. 
 
The needle like crystals discovered in screening (Fig 4.5A), were also optimised by 
varying the pH, protein and precipitant concentrations and altering the buffer 
composition.  These crystals proved harder to grow consistently and to a practical size 
for X-ray diffraction.  Long needles (Fig 4.8 A) were grown but did not produce good 
faces (indicated by red circle), and become over dried by the time of harvesting.  
Slightly shorter but thinner needles were also grown (Fig 4.8 B).  These crystals could 
be used but needed to be separated from the clusters of needles growing off them.  In 
certain conditions the nucleation rate had increased (Fig 4.8 C, D) leading to many 
smaller crystals and more clusters of crystals.  These drops however do contain a few 
single short needles which could be used for X-ray diffraction. 
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Fig 4.8.  Figure showing the variety of crystals produced from optimisation of „needle 
like‟ TmAKR crystal conditions.  The red circle highlights poor growth towards the 
end of the needle.  Initial crystallisation conditions for each are shown. 
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5 X-ray Diffraction and Structure Determination 
5.1 Introduction 
Using a conventional light microscope it is possible to view details as small as 
approximately 0.5 µm.  This limit is due to the wavelength of the light used since 
features closer together than approximately one wavelength cannot be resolved.  To 
view finer detail light with a shorter wavelength is required.  X-rays with a 
wavelength of between 0.5 and 1.6Å (0.05-0.16nm) will interact with matter on the 
correct scale to allow resolution of details on the atomic scale.  For X-rays the 
refractive index of most materials is close to that of a vacuum therefore X-rays cannot 
be focused like visible light in a conventional light microscope.  Being unable to focus 
the X-rays means the phases of the X-rays cannot be directly observed.  This has 
become known as the phase problem and is discussed in section 5.1.3. 
In 1912 it was demonstrated by Max von Laue that crystals of copper sulfate could 
diffract a beam of X-rays and by 1913 Lawrence Bragg had developed methods to 
interpret these scattered X-rays. Bragg subsequently solved the first X-ray structure, 
that of sodium chloride.  The structure of sperm whale myoglobin was the first 
macromolecular structure to be solved, but it was not until the late 1950‟s that this 
occurred due to its complexity and computational requirements (Kendrew et al., 
1958).  The structure of sodium chloride was so simple that Bragg was able to derive 
its structure by reasoning alone and produce the structure straight from the diffraction 
image.  The macromolecular structures solved today still rely on the same basic 
principles developed by Bragg. 
5.1.1 X-ray Sources 
To produce X-rays in the laboratory a rotating anode generator may be used.  Here 
electrons are accelerated through a vacuum from a cathode towards a rotating anode 
(Fig 5.1).  When the electrons strike the anode their energy is absorbed causing 
transitions in the electronic state of the metal atoms.  The absorbed energy is then 
released by the atoms as X-rays of a range of wavelengths. Specific wavelengths of 
high intensity are produced and can be used for macromolecular structure 
determination.  A rotating anode generator with a copper anode will produce 
characteristic radiation of 1.54Å alternatively a molybdenum anode may be used to 
produce X-rays with a wavelength of 0.71Å.  The electron beam hitting the anode 
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creates a large build up of heat and by rotating the anode this heat build up is spread 
over a larger surface area dissipating the heat.  Cold water is also supplied to the 
inside of the anode to aid with cooling. 
 
 
Fig 5.1.  Figure showing a schematic representation of a rotating anode X-ray 
generator.  Electrons are produced at the cathode and accelerated towards the anode 
where X-rays are produced which exit through beryllium windows (transparent to X-
rays).  The rotating anode is cooled from the inside by a water supply (Adapted from 
Blow, 2002) 
 
A much more intense source of X-rays is available at synchrotrons, allowing for faster 
data collection to a higher resolution.  At a synchrotron, electrons are generated from 
a cathode and accelerated by electric fields down a linear accelerator and through a 
booster ring where they are accelerated further.  They finally enter the storage ring 
where they will reach speeds of over 99% the speed of light.  Whilst travelling round 
the storage ring the electrons paths are affected by a series of large powerful 
electromagnets which serve to keep the electrons on a circular path.  These magnets 
along with insertion devices know as undulators and wigglers cause the electrons to 
release energy as electromagnetic radiation.  The energy released is over a broad 
range of wavelengths from X-rays to ultraviolet and visible light.  Depending on the 
insertion device a range of X-rays may be produced, which travel into the 
Cooling Water 
X-ray beam X-ray beam 
Cathode 
Rotating anode 
Electron beam 
Beryllium  
Window 
Beryllium  
Window 
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experimental station where a series of mirrors and a monochromator produce a 
focused beam of a single wavelength. 
5.1.2 Diffraction Theory 
When a sufficiently ordered crystal is placed in an X-ray beam diffraction effects can 
be observed.  This diffraction is caused by the X-rays being absorbed by electrons and 
re-emitted in all directions.  Since the crystal is a regularly repeating structure these 
emitted X-rays may reach the detector in phase leading to constructive interference 
and producing a peak on the detector.  The structure of the crystal is related by 
reciprocal space to the diffraction pattern observed on the detector; the spacing 
between peaks has an inverse relationship to the spacing of the lattice points of the 
crystal. 
When in 1913 Lawrence Bragg solved the first X-ray structure he reasoned that the 
repeating structure within the crystal formed as a series of lattice planes which acted 
like mirrors reflecting the X-rays.  The lattice planes can be described by the indices 
h, k and l. When the spacing between these planes was such that the reflected waves 
were in phase constructive interference would be observed (Fig 5.2).  This became 
known as Braggs law (Eq. 5.1) and states that two planes will scatter in phase if the 
difference in path length is equal to a whole number of wavelengths. 
 
Where n is an integer, λ is the wavelength, dhkl is the spacing between a particular set 
of planes hkl and θ is the glancing angle of the beam. 
nλ = 2dhkl sinθ 
 
Eq 5.1 
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Fig 5.2.  Figure showing reflection of incident X-ray beams from a pair of parallel 
lattice planes.  a) When an incident beam is reflected from a lattice plane by the 
glancing angle θ the beam reflecting off the second plane travels an extra distance 
equal to 2dsinθ.  b) Example where Bragg‟s law is satisfied; the lower beam travels an 
extra 2λ and is therefore in phase with the upper beam resulting in constructive 
interference. 
 
To calculate the electron density for the crystal, first the diffraction data must be 
converted into structure factors.  The structure factor is a description of a wave written 
as a complex number such that, 
 
Where F is the structure factor, |F| is the amplitude of the structure factor obtained 
from experimentally observed intensities and α is its phase.  The structure factor Fhkl 
for a particular reflection hkl can be expressed as the atomic scattering contribution 
for each atom within the unit cell. 
F = |F| eiα Eq 5.2 
 
d θ 
d sin θ 
Incident beam Reflected beam 
θ 
a) 
b) 
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Where fj is the scattering factor of atom j and xj, yj and zj are the fractional coordinates 
of atom j within the unit cell. 
 
The scattering (electron) density at a point x,y,z can then be calculated from the 
inverse Fourier transform of the structure factors. 
 
ρ(x,y,z) is the scattering density at a point x,y,z and V the volume of the unit cell.  The 
structure factor is usually expressed as electrons per unit cell where as the density is 
expressed as electrons per unit volume, hence the term 1/V. 
ρ(x,y,z) =     ∑ Fhkl e
-2πi (hx + ky + lz) 
  hkl 
1 
V 
Eq 5.4 
Fhkl = ∑ fj e
2πi (hxj + kyj + lzj) 
 
     j=0 
Eq 5.3 
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5.1.3 Phase Problem 
During a diffraction experiment we are able to measure the intensity of the reflections 
which can be converted into the amplitudes of the structure factors, however another 
piece of information is missing, that of the phase, which we cannot measure directly.  
This missing piece of information has become known as the phase problem, and 
various different methods exist for solving it. 
Two techniques, molecular replacement (MR) and multi-wavelength anomalous 
dispersion (MAD) have been used here to solve the AKR and Bacterioferritin 
structures respectively and will be explained in more detail below.  In addition to 
these two techniques multiple isomorphous replacement (MIR) can also be used to 
generate phases and solve the structure.  MIR utilises a native crystal and also a series 
of crystals either grown in the presence of or soaked in a heavy metal solution.  When 
placed in the X-ray beam the presence of a heavy metal in the unit cell produces 
differences in the structure factor amplitudes between each derivative and the native 
crystal.  Identification of the heavy metal sites via a Patterson map allows for 
identification of two potential phases for each derivative, by the use of two or more 
derivatives the wrong phase can be ruled out and the correct phase identified. 
5.1.3.1 Multi-wavelength Anomalous Dispersion (MAD) 
Multi-wavelength anomalous dispersion can be used to experimentally derive phases 
and exploits the ability of heavy atoms to absorb X-rays at specific wavelengths.  Any 
particular atom can absorb energy and promote an electron from one orbital to a 
higher orbital, and subsequently release this energy again as the electron returns to its 
normal transition state.  The electrons in certain orbitals of heavy elements (Fe and 
above) are able to absorb X-rays of wavelengths convenient for diffraction 
experiments and produces an effect called anomalous scattering.  We are able to 
experimentally derive phases from this effect since anomalous dispersion creates a 
violation of Friedel‟s law which states that a pair of symmetrical reflections hkl has 
the same amplitude and opposite phase as the corresponding reflection -h-k-l.  When 
anomalous dispersion occurs this law is broken (Fig 5.3) and -h-k-l has a different 
intensity to the reflection hkl, this pair of reflections are known as a bijvoet pair and 
the difference in their amplitudes (ΔF) the bijvoet difference. 
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Fig 5.3.  Figure demonstrating Friedel‟s law and its disruption by anomalous 
scattering effects.  a) Normal components of reflections hkl (FT
+
) and –h-k-l (FT
-
) 
obeying Friedel‟s law, amplitudes are equal and phases are opposite. b) The 
anomalous component FA contributes to the normal scattering resulting in the total 
observed scattering 
λ
F no longer obeying Friedel‟s law. 
 
The total scattering is a result of the normal scattering and anomalous scattering and 
can be expressed as 
 
Where f0 is the normal atomic scattering factor, f ′ is the dispersive term and real part 
of the anomalous scattering component and f ′′ is the imaginary component of 
anomalous scattering.  The values of f ′ and f ′′ vary with the wavelength (Fig 5.4) 
with f ′′ having a maximum value at the absorption edge and f ′ being at its minimum 
at the inflection point of the absorption peak. 
f(λ) = f0 + f ′ (λ) + if ′′ (λ) Eq 5.5 
FT
- 
FT
+ 
λF+ 
λF- 
FA
- 
FA
+ 
FT
- 
FT
+ 
b) a) 
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Fig 5.4.  Theoretical X-ray absorption curve for the Fe K edge, showing change in 
anomalous scattering components f ′ and f ′′.  Figure produced from 
http://skuld.bmsc.washington.edu/scatter/AS_form.html 
 
In the 1980s Hendrickson was able to use anomalous dispersion to solve to a protein 
structure (Hendrickson, 1985) by using the equations of Karle (1980).  Accounting for 
the anomalous difference the structure factor equation becomes, 
 
Where 
λ
F(h) is the structure factor at wavelength λ, 0FT(h) is the structure factor from 
all normal scatterers and 
0
FAk(h) is the normal contribution from all anomalous 
scatterers.  The final part of the equation defines the amount of anomalous scattering 
dependant upon the values of f ′ and f ′′ which are dependant upon the wavelength.  
By collecting datasets at multiple wavelengths and therefore differing contributions of 
anomalous scattering components we are able to solve the equation to provide us with 
values for FT, FA and Δφ, the difference in phase angle between normal and 
anomalous components.  At least two different wavelengths are required to solve the 
equations but it is preferable to have three or four to provide a more reliable solution.  
These datasets are usually collected at wavelengths corresponding to the maximum 
value of f ′′ (maximum absorption), the minimum value of f ′ (minimum normal 
scattering), and one or two remote data sets where f ′ is close to its normal value. 
λF(h) = 0FT(h) + ∑ 
0FAk(h) [(f′k/f
0
k)+(if′′k/ f
0
k)] 
  k 
Eq 5.6 
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Heavy atom positions may be identified from an anomalous difference Patterson map 
using the square of the Bijvoet differences. This map contains peaks at the vectors 
corresponding to the heavy atom positions and can be used to give estimates for heavy 
atom positions within the unit cell.  Once positions of the anomalous scatterers are 
known their phases, φA, can be calculated and used to calculate phases for the whole 
structure, φT, since φT = φA + Δφ. 
5.1.3.2 Molecular Replacement (MR) 
Experimental phasing and the collection of multiple datasets is not always necessary.  
If the protein of interest is sufficiently similar to another protein which has a structure 
available the situation arises where it may be possible to use the phases of the known 
structure as initial phases for the unknown structure.  Solving the phase problem in 
this way is known as molecular replacement.  Molecular replacement requires the 
model structure to be sufficiently similar to the unknown structure, usually sharing at 
least 25% amino acid identity.  In performing a molecular replacement we need to 
initially calculate 6 parameters, 3 rotation angles and 3 translation vectors.  These 6 
parameters describe how the known molecular structure relates to the unknown.  To 
speed up the computation of these parameters the calculations are separated into two 
stages (two 3 dimensional searches, rather than one 6 dimensional search).  The first 
stage concerns describing the 3 rotation angles, this is done by exploiting the 
Patterson map which does not depend upon any choice of origin for the molecule or 
require any phase information.  The origin of the Patterson is where vectors between 
atoms are zero and allows the rotation to be searched for, independent of any 
translation which may exist.  By taking the Patterson of the known molecule and 
rotating it over the Patterson of the unknown structure we can identify where the two 
Pattersons agree with each other and therefore the rotation angle between the two 
molecules.  The second stage is to find where the origin of the model should be placed 
in the unit cell of the unknown structure to derive a diffraction pattern similar to that 
of the unknown structure.  The method is to place the model at all points in the unit 
cell and calculate the corresponding Patterson function and compare that to the actual 
Patterson from the unknown structure. 
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5.1.4 Model building and refinement 
Once the phase problem has been solved and electron density calculated, the model 
can be improved by manually altering the positions of the atoms to better fit the 
density.  Some features may be observed in the electron density map and allow 
positioning of atoms.  Also the use of a „difference‟ (F0-FC) map can give an 
indication as to atom positions.  The F0-FC map represents the difference between the 
observed (F0) and calculated (FC) structure factors and shows areas where the model 
disagrees with the observed experimental data. 
After the electron density has been interpreted and the model altered to take this into 
account, structural refinement may take place.  Structural refinement is carried out 
computationally to alter the model to give the best fit to the observed structure factors.  
To refine the position of every atom individually would require four variables (x, y, z, 
B-factor) per atom and become computationally expensive, instead by placing 
restraints on the positions of atoms this can be reduced to an average of four per 
residue.  The peptide bond is planar allowing restraints to be imposed to retain this 
geometry and in doing so allows the main chain of each residue to be defined by only 
two variables, the φ and ψ angles around the Cα atom.  Each side chain can also be 
represented by a series of dihedral angles, χ1, χ2 etc… dependant on the length of the 
side chain.  At the end of the structural refinement a new map is calculated for the 
model, interpreted and the model altered accordingly.  This cyclical procedure is 
repeated until no further appreciable improvement is seen.  
Throughout the refinement procedure the quality of the model is followed by 
monitoring the R factor which is used as a measure of the fit of the model to the 
observed data. 
 
Where Fobs is the observed structure factors and Fcalc is the calculated structure factors 
from the model over set of reflections h.  Throughout refinement the R factor 
decreases as the model improves, with a value of zero representing perfect agreement 
between the observed intensities and the model.  The R factor can provide an 
indication as to when refinement has finished, by monitoring it‟s progress and 
observing when its value no longer improves.  The R factor suffers from bias 
∑h ||Fobs| - |Fcalc|| 
 
∑h |Fobs| 
 
R = Eq 5.7 
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introduced by using the same data for refinement as well as for monitoring.  The Free 
R factor (Rfree) can be used to overcome this bias and takes a set of the diffraction data 
(usually 5%) which is not used for the refinement procedure and treats it in the same 
way as for the R factor.  Rfree is typically larger than the R factor but is a more reliable 
estimate of model quality. 
5.1.4 Validation 
The R factor and Rfree are both commonly used to assess model quality throughout the 
refinement procedure.  When the R factors do not improve any further then 
refinement is normally terminated and a final model produced.  To further assess the 
quality of this final model several programs such as PROCHECK (Laskowski et al., 
1993) and SFCHECK (Vaguine et al., 1999) may be used.  These programs analyse 
the final structure to check parameters such as bond angles, bond lengths, 
stereochemistry and planarity of peptide bonds and cyclic side chains.  These values 
are compared to expected values for the appropriate resolution. 
A Ramachandran plot is usually also produced which plots the phi and psi bond 
angles for the main chain.  Due to steric hindrance the main chain may only adopt 
certain angles and residues should not appear in the disallowed regions of the plot, 
and should be seen in certain regions relating to different types of secondary structure. 
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5.2 Materials and Methods 
5.2.1 TmAKR 
5.2.1.1 Cryoprotectants 
Single crystals of TmAKR were harvested from the crystallisation drop and placed 
into appropriate mother liquor (Table 5.1) for 1 minute prior to flash freezing in liquid 
nitrogen.  Crystals were stored under liquid nitrogen until required. 
Crystal Si18 SCW1 SCW10 
Glycerol %(v/v) 30 30 30 
Ammonium sulfate %(Sat.) 20 30 30 
NADPH (Molar eq.) 0 1.2 1.2 
Acetic Acid (mM) 0 50 50 
Citric Acid (mM) 50 0 0 
Buffer pH 5.1 4.5 4.5 
Table 5.1.  Composition of mother liquors used for soaking crystals of TmAKR prior 
to flash freezing. 
5.2.1.2 Data collection 
5.2.1.2.1 ‘Apo’ TmAKR 
Initial data were collected at the SRS at Daresbury with the crystal „Si18‟, 
cryo-cooled at 100K.  This crystal was grown in the absence of NADPH and 
represents the apo form of the enzyme.  The crystal diffracted to 2.64Å and data were 
collected with an oscillation range of 0.5°, crystal to detector distance of 247 mm and 
slit widths of 0.2x0.2 mm.   
5.2.1.2.2 ‘Holo’ TmAKR 
Data were collected from crystals co-crystallised in the presence of NADPH cofactor.  
All data for crystals co-crystallised with NADPH were collected at the SRS at 
Daresbury using single cryo-cooled crystals.  Data set SCW10 was collected with 
smaller slit widths (0.1x0.1 mm) than previous data sets to reduce spot size and 
number of overlaps, improving measurements for this data set.  Data collection 
parameters for holo crystals are summarised in table 5.2. 
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Crystal SCW1 SCW10 
X-ray wavelenth (Å) 1.1200 1.2200 
Oscillation (°) 0.25 0.25 
Detector distance (mm) 180 180.08 
Slit widths (mm) 0.2 0.1 
Max resolution (Å) 2.2 2.4 
Table 5.2.  Data collection parameters for „holo‟ crystals of TmAKR. 
5.2.1.3 Data Processing 
All data sets were processed using DENZO and SCALEPACK (Otwinowski, 1997).  
„Si18‟ was indexed in space group P422 and molecular replacement performed by 
MOLREP (Vagin, 1997) using 1PZ0 (AKR11A1 from B. subtilis; 34% sequence 
identity) as a search model.  Two monomers were found in the asymmetric unit and 
the model sequence altered manually according to an amino acid sequence alignment 
of TmAKR and 1PZ0 (Bioedit; Hall, 1999; Appendix 5).  This model was used for 
further model building and refinement using COOT (Emsley and Cowtan, 2004) and 
REFMAC (Murshudov, 1997), to produce an intermediate model. 
Data set SCW1 was processed in space group P422 and the intermediate model of 
Si18 was used as a search model for molecular replacement using MOLREP Which  
was unsuccessful.  Data were submitted to the Zanuda server 
(http://www.ysbl.york.ac.uk/) to correct space group assignment.  SCW10 data were 
processed in P222 and molecular replacement performed using MOLREP and the 
intermediate Si18 model as a search model as for data set SCW1, and was also 
unsuccessful.  The program REINDEX (CCP4, 1994) was used with the operator h, k, 
l/3 to reduce the unit cell of SCW10.  Molecular replacement was performed as before 
using the intermediate Si18 model with the reindexed SCW10 data.  Two monomers 
were found in the asymmetric unit, and model building and refinement was performed 
with COOT and REFMAC. 
The final model of SCW10 was used as a search model for molecular replacement 
with the Si18 data.  Model building and refinement were performed with COOT and 
REFMAC to produce the final TmAKR model. 
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5.2.2 Bacterioferritin 
Single crystals of bacterioferritin were harvested from the crystallisation drop and 
placed into a mother liquor of 30% (v/v) glycerol, 60% (Sat.) ammonium sulfate, 
20mM Tris-HCl pH 7.5 for 1 minute prior to flash freezing in liquid nitrogen.  
Crystals were stored under liquid nitrogen until required.  
X-ray data were collected at the SRS at Daresbury, using a single cryo-cooled crystal 
at 100K and a MAR225 CCD detector.  An EXAFS (Extended X-ray Absorption Fine 
Structure) scan at the Fe K edge was performed using a C-TRAIN Fluorescence 
detector to confirm the presence of iron as suggested by the red colour of the crystals 
and the peak absorption was found to correspond to a wavelength of 1.739Å.  Data 
were collected at a peak wavelength of 1.739Å and a remote wavelength of 1.729Å.  
Both data sets were collected with 30 second exposures using an oscillation angle of 
0.3°, crystal to detector distance of 90 mm and slit widths of 0.1x0.1 mm.  Data were 
processed using DENZO and SCALEPACK (Otwinowski, 1997).  The program 
TRUNCATE (French, 1978) was used to calculate structure factors and MLPHARE 
(CCP4, 1994) for phase calculation.  Averaging and phase combination was 
performed with DM (Cowtan, 1994). 
Iron atom positions were identified using SHELXD of the SHELX package 
(Sheldrick, 2008) and used to create MAD phases.  A partial model made up of 
polyalanine α-helices was manually build into the density using COOT (Emsley and 
Cowtan, 2004); phased refinement of partial model phases and combination with 
anomalous phases was performed using the program REFMAC (Murshudov, 1997).  
Several rounds of model building and refinement were carried out to produce a model 
containing four helices.  Sidechains were then identified and built into the model.  The 
putative amino acid sequence determined from the electron density was then input 
into BLAST (Altschul, 1990) to allow identification of the protein as E. coli 
bacterioferritin. 
A dimer of E. coli bacterioferritin (PDB: 1BFR) was used as a model for molecular 
replacement using MOLREP (Vagin, 1997).  Further dimers, to produce a total of 12 
monomers, were found neighbouring the first using molecular replacement and the 
symmetry operators from the iron positions using LSQKAB (Kabsch, 1976).  This 
model was used for further refinement using COOT and REFMAC, and ordered water 
molecules were added using COOT and ARP/wARP (Perrakis, 1997). 
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5.2.3 Proton Induced X-ray Emission (µPIXE) 
µPIXE measurements were performed at the Ion Beam Centre at the University of 
Surrey.  A 2.0 MeV 1.5 μm diameter proton beam was used to induce X-ray emission 
from 0.2 μL liquid protein samples dried onto 2 μm thick mylar film in a vacuum.  X-
rays were detected by a high energy resolution solid-state lithium-drifted silicon 
detector. The proton beam was scanned across the drop in X and Y, and by defining 
software windows round the X-ray peaks, the signal from elements of interest were 
sorted into elemental maps. In order to try to quantify the element concentrations, 
point spectra were collected at four selected points in the sample and also at points on 
the buffer and the backing foil. The spectra were analysed by the DAN32 (Grime, 
2004) and GUPIX software (Campbell et al., 2000).  
The µPIXE method has been used successfully in both identifying elements in 
proteins and in measuring their stoichiometric ratio to an accuracy of between 10 and 
20% on over 70 samples (Garman and Grime, 2005).  Using the sulfur peak to give an 
internal normalisation of the sulfur atoms from the known cysteines and methionines, 
the method is calibrated per protein molecule.  This work was performed in 
collaboration with Elspeth Garman (University of Oxford) 
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5.3 Results and Discussion 
5.3.1 TmAKR 
5.3.1.1 Data Collection 
For the crystal „Si18‟ diffraction was observed to 2.64Å and 174 frames of data 
collected.  The data were indexed in space group P422 with the unit cell parameters a 
= 141.1Å, b = 141.1Å, c = 84.1Å,  =  =  = 90.0. 
Data sets were also collected from crystals formed in the presence of NADPH.  The 
crystal „SCW1‟ diffracted to 2.2Å and 174 frames of data were collected.  The data 
were indexed in space group P422 with the unit cell parameters a = 141.6Å, b = 
141.6Å, c = 169.5Å,  =  =  = 90.0.  This crystal was indexed in the same space 
group as the apo form with a doubling of unit cell parameter c (84.1Å – 169.5Å).  
Data collection for this crystal was not completed due to a synchrotron failure and has 
a final completeness of 82%.  A further holo data set was collected from crystal 
„SCW10‟ which diffracted to 2.4Å and 421 frames of data were collected.  The data 
were indexed in space group P222 with the unit cell parameters a = 140.9Å, b = 
140.9Å, c = 252.7Å,  =  =  = 90.0.  This crystal was indexed in a lower symmetry 
space group than the former two, and with a tripling of the unit cell parameter in b 
(84.1Å – 252.7Å) relative to Si18.  Data collection statistics for all three data sets are 
shown in table 5.3.  Representative X-ray diffraction frame for dataset Si18 is shown 
in figure 5.5, and for dataset SCW10 in figure 5.6. 
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Crystal Si18 SCW1 SCW10 
Space group P4 21 2 P4 21 2 P21 21 2 
Unit cell lengths 
(a,b,c) Å 
141.1, 141.1, 84.1 141.6, 141.6, 
169.5 
140.9, 104.9, 
252.7 
Unit cell angles 
(α,β,γ) ° 
90, 90, 90 90, 90, 90 90, 90, 90 
Resolution (Å) 2.64 2.24 2.77 
Completeness (%) 99.5 (97.2) 82.9 (85.5) 87.6 (86.2) 
Redundancy 6.0 3.0 2.4 
No. of reflections 142327 189463 393453 
No. of unique 
reflections 
23900 59252 167009 
Wilson B-factor (Å
2
) 61.8 63.2 63.1 
Rsym (%) 8.5 (50.8) 9.3 (57.7) 12.9 (57.5) 
<I>/<σI> 20.9 (2.90) 10.4 (1.7) 7.67 (1.64) 
I>3σI (%) 77.5 (36.1) 49.2 (12.9) 44.6 (12.4) 
Table 5.3.  Table showing the data collection statistics for three TmAKR data sets.  
Values in parenthesis are for highest resolution shell. Rsym = ∑|I - <I>| / ∑(I) where I 
is the intensity of a reflection. 
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Fig 5.5.  Figure showing a single representative X-ray diffraction image for dataset 
Si18 collected at Daresbury SRS, showing diffraction to 2.64Å resolution. 
 110 
 
Fig 5.6.  Figure showing a single Representative X-ray diffraction image for dataset 
SCW10 collected at Daresbury SRS, showing diffraction to 2.4Å resolution. 
 
 111 
5.3.1.2 Structure Solution and Refinement 
Molecular replacement was performed for the Si18 data set by MOLREP using the 
AKR11A1 structure from B. subtilis (PDB: 1PZ0) as a search model, and two 
monomers were found in the asymmetric unit.  The amino acid sequence alignment 
(Appendix 5) for TmAKR and 1PZ0, was used to manually alter the model sequence 
to match that of the TmAKR.  This model was used for further model building and 
refinement using COOT and REFMAC.  The intermediate model at this stage (R = 
0.263; Rfree = 0.321)  consisted of 276 amino acids (333 sequence total) with two 
loops (27-32 and 212-245) and the C-terminus (316-333) not appearing in the density 
which are presumed to be disordered. 
The SCW1 data set was input into MOLREP using the intermediate model of Si18 as 
a search model.  MOLREP detected pseudotranslation at 0.5c + 0.1a.  No correct 
solution was found which would refine well in REFMAC.  Despite the failure of 
molecular replacement it was still desirable to know if the co-factor, NADPH, was 
present in the structure.  Therefore the data were submitted to the Zanuda server  
which suggested the space group to be P212121 and implies perfect twinning by 
hemihedry (personal communication, A. Lebedev). 
Molecular replacement for the SCW10 data were performed using MOLREP and the 
intermediate Si18 model as a search model.  MOLREP also detected 
pseudotranslation in the data (0.33c; 0.66c), and initial molecular replacement was not 
successful.  The data were submitted to the Zanuda server , and the space group P4212 
identified as the most likely space group.  In contrast to crystal SCW1, SCW10 was 
not twinned, and the program REINDEX (CCP4, 1994) was used with the operator 
(h,k,l/3) to reduce the unit cell according to pseudotranslation to similar dimensions to 
that of the apo form.  Molecular replacement was performed as before using the Si18 
model with the reindexed SCW10 data.  Two monomers were found in the 
asymmetric unit with an R-factor of 0.255 (Rfree = 0.298).  Model building and 
refinement was performed with COOT and REFMAC, and the missing loops were 
extended according to the electron density.  An additional piece of density was found 
in each subunit, and a short polyalanine chain build into the density.  The amino acids 
in these extra chains were assigned on the basis of the electron density present, and by 
comparison with the amino acid sequence are thought to be from one of the missing 
loops (225-230). 
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After model building for SCW10 was complete, final R = 0.211 (Rfree = 0.277), this 
final SCW10 model was used as a search model for molecular replacement with the 
Si18 data in an attempt to extend loops missing from the previous intermediate model.  
In the final Si18 model, subunit A contained 287 amino acids and subunit B contained 
292 amino acids (333 total amino acids per subunit).  In subunit A three loops (27-32, 
216-224 and 231-243) and the C-terminus (316-333) were not found in the density, 
and in subunit B three loops (29-32, 216-223 and 230-241) and the C-terminus (318-
333) were also not found in the density.  Final refinement statistics for „Si18‟ are 
presented in table 5.4. 
 
R value (%) 21.1 
Free R value (%) 27.7 
Mean B value (Å
2
) 49.1 
Total No. of atoms 4695 
No. observations 23048 
No. water atoms 124 
Average B-factor (Protein: Å
2
) 48.6 
Average B-factor (Solvent: Å
2
) 61.8 
RMS deviations from ideality  
Bond lengths (Å) 0.012 (0.022) 
Bond angles (deg.) 1.557 (1.997) 
Planar groups (Å) 0.007 (0.021) 
Table 5.4.  Refinement statistics for final model of TmAKR.  Values in parenthesis 
are target values. 
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5.3.1.3 Data Validation 
The final TmAKR structure was analysed with the programs PROCHECK and 
SFCHECK, to validate bond lengths, bond angles, planar groups, chirality and overall 
stereochemical quality of the model.  The final R-factor for the TmAKR model was 
21.3% (Rfree = 27.7%), in the resolution range 28.7 - 2.70Å.  The Cruickshank DPI 
(Diffraction-component Precision Index) was 0.340Å for the coordinate error of an 
atom with average B-factor. The stereochemical quality of the model proved to be 
good with a G-factor of -0.2, which is better than expected (-0.7) for the resolution.  
All main chain and side chain parameters were found to be within or better than the 
expected range for the resolution (Appendix 6). 
A Ramachandran plot (Fig 5.7) was produced using the program PROCHECK to 
assess the quality of the model with respect to the phi-psi bond angles of the main 
chain backbone.  The plot showed that out of 481 (non-pro/gly) amino acids, 88.6% of 
these were present in the most favoured regions and 10.2% in the additionally allowed 
regions.  Five residues (1%) were found in the generously allowed regions and one 
residue (0.2%) found in the disallowed regions.  88.1% of residues in the favoured 
regions is higher than expected (72.9%) for the resolution range. 
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Fig 5.7.  Ramachandran plot for TmAKR dimer, showing 88.6% of all residues in 
most favoured regions.  Those residues in generously allowed regions and disallowed 
regions are labelled.  Figure produced using PROCHECK. 
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5.3.2 Bacterioferritin 
5.3.2.1 Structure Solution and Refinement 
The Fluorescence scan at the Fe K edge (Fig 5.5) showed the presence of iron and 
identified the wavelength to collect the „peak‟ data set, where f′′ has its maximum 
value.  Both peak and remote data sets were collected to a maximum resolution of 
1.9Å (Fig 5.6) and were indexed using DENZO in the space group P42212, with unit 
cell parameters a=208.1 b=208.1 c=142.8Ǻ and α=β=γ=90.00°.  Processing statistics 
are presented in table 5.5.  Anomalous phasing with MLPHARE provided initial 
phases for the structure with a figure of merit of 0.136 to 1.9Å (0.27 to 3.5Å) allowing 
identification of 12 iron sites within the asymmetric unit.  Six fold averaging was 
applied to improve the phases further and allow identification of helices and the 
backbone to be traced.  Helices were built into the electron density one by one, model 
phases were combined with anomalous phases and averaged, and new electron density 
maps calculated after addition of each segment of α-helix.  After addition of 4 helices 
it was possible to build loops connecting the helices and putatively identify a number 
of side chains.  This putative amino acid sequence identified from the electron density 
was used as a search sequence with BLAST.  E. coli bacterioferritin was found have 
the highest similarity to the putative input sequence. 
Data set  Remote Peak 
Wavelength (Å) 1.729 1.739 
Resolution range 
(Å) 
25 - 1.9 
(1.93-1.90) 
25 - 1.9 
(1.93-1.90) 
Completeness (%) 99.2 (90.34) 97.7 (78.9) 
No. of reflections 1741445 1763956 
No. of unique 
reflections* 
470876 460546 
Wilson B value (A
3
) 15.4 18.8 
<I>/<σI> 10.7 (1.02) 11.0 (2.14) 
I>3σI (%) 48.9 (11.3) 60.8 (25.2) 
Rsym (%) 12.8 (78.9) 10.0 (37.7) 
Table 5.5.  Processing statistics for peak and remote data sets of E. coli 
bacterioferritin.  Rsym=∑h∑J|<Ih>-IJ(h)|/∑h∑JI(h), where I(h) is the intensity of 
reflection h. ∑h is the sum over all reflections and ∑J is the sum over J measurements 
of the reflection.  *Anomalous equivalents were scaled separately.  Values in 
parentheses are for the highest resolution shell. 
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Fig 5.8.  EXAFS scan of the Fe K edge used to identify the wavelengths used for data 
collection for E. coli bacterioferritin.  Red line shows X-ray fluorescence. 
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Fig 5.9.  Figure showing a representative X-ray diffraction image for E. coli 
bacterioferritin peak data set collected at Daresbury SRS, showing diffraction to 1.9Å 
resolution. 
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Since a structure of E. coli bacterioferritin already existed (PDB: 1BFR), this was 
used as a model for molecular replacement.  Twelve monomers were built into the 
density by MOLREP.  Each monomer at this stage contained two manganese atoms as 
found in 1BFR, and a heme molecule located at the two fold axis between two 
monomers.  Side chain positions were altered where appropriate and ordered water 
molecules added and their positions manually checked.  Manganese atoms were 
replaced with zinc as suggested by µPIXE and analysis of the X-ray data (Section 
5.3.2.2).  Refinement statistics are presented in table 5.6. 
R value 0.181 
Free R value 0.217 
Mean B value Å
2
 18.9 
Total No. of atoms 18819 
No. water atoms 2209 
No. Iron atoms 6 
No. Zinc atoms 24 
Average B-factor (Protein: Å
2
) 18.0 
Average B-factor (Solvent: Å
2
) 26.9 
Average B-factor (Heme: Å
2
) 23.2 
Average B-factor (Iron: Å
2
) 21.5 
Average B-factor (Zinc1: Å
2
) 21.3 
Average B-factor (Zinc2: Å
2
) 24.2 
RMS deviations from ideality  
Bond lengths (Å) 0.020 (0.021) 
Bond angles (deg.) 1.704 (2.071) 
Planar groups (Å) 0.007 (0.020) 
  
Table 5.6.  Refinement statistics for E. coli bacterioferritin.  Values in parenthesis are 
target values.  Rcryst=∑||Fo|-|Fc||/∑|Fo| 
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5.3.2.2 Proton Induced X-ray Emission (µPIXE) 
The presence of iron in the bacterioferritin was confirmed by EXAFS prior to data 
collection.  Solution of the structure revealed the presence of two heavy metal atom 
sites in close proximity to each other per monomer.  Analysis of the elemental content 
of the bacterioferritin by µPIXE (Fig 5.7) shows iron, zinc and copper to be present in 
the sample.  The buffer and backing alone were completely clean of iron, zinc and 
copper.  Due to the presence of chloride in the buffer which gave a large X-ray peak 
next to the sulfur peak, it was not possible to quantify the amounts of iron, zinc and 
copper present.   
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Fig 5.10.  Figure showing the µPIXE point spectra for E. coli bacterioferritin.  
Statistical analysis shows iron, copper and zinc to be the only metals present. 
 
Analysis of the X-ray data including the co-ordination geometry of the ions, their B-
factors and the absence of strong difference peaks at the K-absorption edge of iron 
calculated at 10-1.9Å resolution with phases from the refined model, all suggest that 
zinc is bound to the ferroxidase site. The peak height for the heme iron was 62σ while 
the peak height of ions at the dinuclear site was in the range of 7-8σ which is 
comparable with sulfur peaks of 6-9σ.  The absence of strong difference peaks 
suggests that iron is not bound, leaving zinc and copper as potential candidates.  Both 
copper and zinc are capable of binding to the ferroxidase site, zinc however has a 
much higher affinity to that of copper (Kd, Zn ≈ 1x10
-7 M, Cu ≈ 2x10-5 M) (Baaghil et. 
al. 2002) and given the higher concentration of zinc, the metal sites are likely 
occupied by zinc.  In addition to binding to the ferroxidase site, copper is also thought 
to bind to low affinity sites on the interior of bacterioferritin (Baaghil et. al. 2002).  
Given the levels of copper observed and the inability of copper to displace zinc from 
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the ferroxidase site it is suspected that copper is present at such low affinity sites, at 
low occupancy, rather than a mixed copper/zinc species in the ferroxidase site. 
 
5.3.2.3 Structure Validation 
The final bacterioferritin structure was analysed with the programs PROCHECK and 
SFCHECK, to validate bond lengths, bond angles, planar groups, chirality and overall 
stereochemical quality of the model.  The final R-factor for the bacterioferritin model 
was 18.1% (Rfree = 22%), in the resolution range 23.8 - 1.91Å.  The Cruickshank DPI 
(Diffraction-component Precision Index) was 0.120Å for the coordinate error of an 
atom with average B-factor. The stereochemical quality of the model proved to be 
good with a G-factor of 0.2, which is better than expected (-0.3) for the resolution 
observed.  All main chain and side chain parameters were found to be within or better 
than the expected range for the resolution (Appendix 7). 
A Ramachandran plot (Fig 5.8) was produced using the program PROCHECK to 
assess the quality of the model with respect to the phi-psi bond angles of the main 
chain backbone.  The plot showed that out of 1728 (non-pro/gly) amino acids from all 
twelve protein chains, 96.2% of these were present in the most favoured regions, the 
remaining 3.8% were in the additionally allowed regions, and none were found in the 
generously allowed or disallowed regions. 
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Fig 5.11.  Ramachandran plot for E. coli bacterioferritin showing 96.2% of all 
residues in most favoured regions of the plot.  Figure produced with PROCHECK. 
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6 TmAKR Structure 
6.1 Overall Structure 
6.1.1 Monomer 
The TmAKR protein consists of 333 amino acid residues (287 and 292 found in the 
final structure for subunits A and B respectively) which fold into a single domain 
structure with an α8/β8 fold (Fig 6.1), common to all members of the AKR family.  In 
most AKRs the eight β-sheets are arranged into a central barrel surrounded by eight α-
helices, in TmAKR the sheets do not however form a fully closed barrel structure.  
The barrel also does not close in the related (34% identity) AKR11A1 structure 
(Ehrensberger and Wilson, 2004).  This enzyme was shown to have reduced catalytic 
activity partially due to binding an alternate conformation of NADPH.  Reduced 
activity was not observed in TmAKR (See chapter 3).  Each monomer of TmAKR 
consists of 16.9% β-sheet, 39.7% α-helix and 2.2% 3,10-helix, which form 12 sheets 
and 10 helices.  Eight sheets and eight helices form the α8/β8 motif (α1-α8, β1-β8); the 
four remaining β-strands (S1-S4) form two β-hairpin structures, one at the N-terminal 
end underneath the barrel, and the other as part of loop 3.  The two remaining helices 
(H1 and H2) are located outside the barrel; H1 is located within loop 7 and H2 in the 
C-terminal section.  Loops are numbered according to the sheet and helix they 
connect, e.g. loop 1 connects β1 to α1.  A topology diagram showing secondary 
structure numbering is shown in figure 6.2, and a secondary structure/sequence 
summary is shown in figure 6.3. 
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Fig 6.1.  Figure showing the overall fold of TmAKR.  a) a stereoview of the Cα trace 
for a single monomer with every tenth amino acid labelled.  b) a stereoview of the 
secondary structure, with α-helices in red, β-sheets in yellow and loop regions in 
green.  (Figure produced with PyMol, Delano Scientific, USA) 
H1
H2
S1
S2
S3
S4
α1 α2 α3 α4 α5 α6 α7 α8β1 β2 β3 β4 β5 β6 β7 β8
 
Fig 6.2.  A topology diagram of TmAKR.  The β-sheets and α-helices from the barrel 
structure are labelled β1-β8 and α1-α8, respectively.  Other β-sheets and α-helices are 
labelled S1-S4 and H1-H2 respectively.  The helices are coloured in red and the sheets 
in yellow.  (Figure created with Topdraw; Bond, 2003) 
a) 
b) 
 124 
....|....| ....|....| ....|....| ....|....| ....|....|  
         10         20         30         40         50 
 
MGIPKRKLGE RGPEVSAIGL GCMRMSFGQK KLPDRKEMIK LIRTAVELGI  
....EEETTT TT.EEETTTE ETTTTT       ..HHHHHH HHHHHHHH.. 
    S1        S2    β1                  α 1  
 
. . . . | . . . . |  . . . . | . . . . |  . . . . | . . . . |  . . . . | . . . . |  . . . . | . . . . |   
         6 0          7 0          8 0          9 0         1 0 0  
 
N F F D T A E V Y G  P Y T N E E L V G E  A L E P F K G E V V  I A T K F G F E L Y  E D G R P G W K G L   
. E E E . T T T T T  T T H H H H H H H H  H T T T T T T T . E  E E E E E . E E . T  T T T . . . . . E E  
 β 2            α 2                  β 3     S 3            S 4  
 
. . . . | . . . . |  . . . . | . . . . |  . . . . | . . . . |  . . . . | . . . . |  . . . . | . . . . |   
        1 1 0         1 2 0         1 3 0         1 4 0         1 5 0  
 
N S N P E H I K K A  V E G S L R R L R V  E A I D I L Y Q H R  V D P N V P I E E V  A G A V K E L I E E   
. . . H H H H H H H  H H H H H H H H . T  T T E E E E E E T T  T T T T T T H H H H  H H H H H H H H H .  
      α 3                    β 4                α 4  
 
. . . . | . . . . |  . . . . | . . . . |  . . . . | . . . . |  . . . . | . . . . |  . . . . | . . . . |   
        1 6 0         1 7 0         1 8 0         1 9 0         2 0 0  
 
G K V K H F G L C E  A S A E T I R R A H  K V C P V D V V Q Y  E Y S M W W R K P E  E E L L P T C E E L   
. . E E E E E E E T  T . H H H H H H H H  H H . . E E E E E E  E . T T T T T G G G  T T H H H H H H H H  
   β 5          α 5            β 6                    α 6  
 
. . . . | . . . . |  . . . . | . . . . |  . . . . | . . . . |  . . . . | . . . . |  . . . . | . . . . |   
        2 1 0         2 2 0         2 3 0         2 4 0         2 5 0  
 
G I G F V A Y S P L  G K G F L T G A I G  E N S K F D E E D S  R S R I P R F Q K E  N L R E N L A L V E   
. . E E E E E T T T  T T T             . . . . . .                . H H H H H H  
   β 7                                              α 7  
 
. . . . | . . . . |  . . . . | . . . . |  . . . . | . . . . |  . . . . | . . . . |  . . . . | . . . . |   
        2 6 0         2 7 0         2 8 0         2 9 0         3 0 0  
 R  T                                           N  
L L K K I A E R K G  A T P S Q I A L A W  L L A Q K P W I V P  I P G T T K L S H L  L E T I G G A F V E   
H H H H H H H H H .  . . H H H H H H H H  H H H H T T T E E E  . . . . . . H H H H  H H H H G G G . . .  
               H 1              β 8          α 8  
 
. . . . | . . . . |  . . . . | . . . . |  . . . . | . . . . |  . . .  
        3 1 0         3 2 0         3 3 0  
 
L T P E E L Q E I N  D A L S R I E I K G  S R Y P E D M E K M  T Y L  
. . H H H H H H H H  H H H H . .  
    H2  
Fig 6.3.  The secondary structure summary for TmAKR.  The residues shown in green 
were not observed in the structure and the residues shown in red are mutations from 
the genome sequence.  The original residue coded by the genome sequence is shown 
above the actual sequence.  H – α-helix, E – strand, G – 3,10-helix and T – hydrogen 
bonded turn. 
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6.1.1.1 Missing Loops 
There are three sections of the protein that are not observed in the final structure, 
which all correspond to disordered loop regions.  The missing sections are from loop 
1, loop 7 and the C-terminal loop.  The central α8β8 motif is well ordered and has low 
B-factors whereas the disordered loop regions and helices H1 and H2 which lie 
outside the central core are associated with higher B-factors and higher disorder (Fig 
6.4).  Loops 1 and 7 form the „safety belt‟ in other AKR structures, interacting with 
each other and locking the cofactor into place.  Loops 1 and 7, along with the C-
terminal loop and loop 4, help to form the substrate binding pocket in other AKR 
structures (Jez et al., 1997).  When no substrate or cofactor is bound these loops 
appear to adopt an alternate disordered conformation.  A short section of loop 7 has 
been located in the active site of the protein interacting with the catalytic tyrosine; the 
implications of this interaction are unclear and are discussed in Section 6.2.2.  The N-
terminal methionine is also not observed in the final structure and is likely to be 
cleaved after translation since the following amino acid is glycine (Sherman et al., 
1985). 
 
Fig 6.4.  Figure showing the Cα-backbone trace of TmAKR, coloured and contoured 
by the B-factor value.  The beginning (a) and end (b) of the missing loops (1, 7 and C) 
are numbered and a section of loop 7 found in the active site is marked with an arrow.  
The thin blue lines represent the lower B-factors and more ordered structure, and the 
heavier orange/red lines represent higher B-factors and a more disordered region.  
(Figure produced with PyMol, Delano Scientific, USA) 
1a 
1b 7a 
7b 
C 
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6.1.2 Dimer 
6.1.2.1 Crystallographic Dimer 
Two subunits were found in the asymmetric unit (Fig 6.5) with one positioned above 
the other in a head-to-head configuration.  The two monomers mainly interact through 
loop 4 situated near the two-fold non-crystallographic symmetry axis.  The symmetry 
related Pro133 residues from loop 4 interacts on the two-fold axis.  The other main 
interaction is between loop 4 and loop 5 where Asn134 interacts with Thr165 and 
Arg168, through its amide nitrogen and backbone oxygen respectively.  This small 
numbers of interactions present on the dimer interface mediated through substrate 
binding loops suggests that this is not the real biological unit of the protein. 
 
 
Fig 6.5.  The asymmetric unit showing the crystallographic dimer a) viewed down the 
two-fold non-crystallographic axis, b) as in a), with a 90° rotation around the y-axis.  
(Figure produced with PyMol, Delano Scientific, USA) 
a) b) 
 
     y 
 
90° 
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6.1.2.2 Biological Unit 
The true biological dimer (Fig 6.6) is centred between the helix two α8s from 
symmetry related subunits with the interface mainly consisting of hydrophobic 
interactions.  Approximately 2000Å
2
 (7.5%) of the solvent accessible surface area is 
buried upon dimerisation.  Helices α1 and α8 form the majority of this contact area 
which contains a large hydrophobic patch and a number of ionic interactions.  Helix 
α8 forms ionic interactions to loop 7 and helix α1 through hydrogen bonds between 
Ser288 (helix α8) backbone nitrogen and Gly260 (loop 7) backbone oxygen, and 
between Phe298 (helix α8) backbone oxygen and Lys40 (helix α1) ε-amino.  Helix α1 
also forms ionic interactions with the N-terminal glycine (Gly2) amino group through 
the backbone oxygen and the terminal carboxyl group of Glu47.  A salt bridge is also 
observed between the two subunits of the biological dimer from Asp34 (loop 1) to 
Arg258 (Helix H1).  This salt bridge forms part of a four-residue ion-pair network, 
linking Asp34-Arg258-Glu305-Lys259 (Fig 6.7) which probably serves to increase 
the stability of the subunit interaction. 
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Fig 6.6.  Figure showing the biological unit of TmAKR.  a) viewed down the two-fold 
non-crystallographic symmetry axis.  b) as in a) with a 90° rotation around the x-axis.  
(Figure produced with PyMol, Delano Scientific, USA) 
a) 
 
 x 90° 
b) 
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Fig 6.7.  The ion-pair network present at the subunit interface in TmAKR between 
Asp34 and Arg258 on the dimer interface and extending to include Glu305 and 
Lys259.  (Figure produced with PyMol, Delano Scientific, USA) 
   Asp34 
Arg258 
Glu305 
Lys259 
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6.2 Active site 
6.2.1Catalytic tetrad 
The catalytic tetrad of tyrosine, lysine, aspartic acid and histidine found in other AKR 
structures is present within the structure presented here.  This tetrad (Fig 6.8) consists 
of Tyr59, Lys84, Asp54 and His129.  The catalytic tyrosine is hydrogen bonded to the 
lysine, which in turn forms a salt bridge with the aspartic acid.  This arrangement 
serves to lower the pKa of the catalytic tyrosine and enhance the catalytic activity as 
shown by mutagenesis studies (Tarle et al., 1993; Bohren et al., 1994).  The histidine 
is positioned near to the tyrosine but does not directly hydrogen bond to it.  This 
residue is thought to form an oxyanion hole which may stabilise an oxyanion 
intermediate.  This histidine is often found to hydrogen bond to the catalytic tyrosine 
in other AKRs via a water molecule.  In this structure Glu227 is found positioned in 
the active site providing the linking hydrogen bonds between His129 and Tyr59.  
Asp54 is found to form a further hydrogen bond with Gln179 which also hydrogen 
bonds to Tyr127, extending the proton relay system present in the basic catalytic 
tetrad to include seven residues.  The catalytic significance of Gln179 and Tyr127 are 
not known and no appropriate mutagenesis studies have been performed.  Gln179 is 
well conserved throughout the AKRs and is often found to interact with the 
nicotinamide substituent of the NADPH cofactor.  Tyr127 is conserved in AKR11A1 
(Tyr123) but not in other AKRs which generally have a leucine at this position.  Since 
Tyr127 is four hydrogen bonds from the catalytic tyrosine and is not well conserved, 
this probably has little effect on catalysis.  Gln179 however may affect catalysis but 
this is more likely to be due to altered cofactor binding rather than catalytic efficiency. 
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Fig 6.8.  The arrangement of residues forming the catalytic tetrad.  The tetrad residues 
are shown as sticks with the other interacting residues shown as lines.  The ionic 
interactions are shown as black dashed lines.  Tyr59 is the catalytic residue and 
Glu227 occupies the site of substrate binding.  (Figure produced with PyMol, Delano 
Scientific, USA) 
Try59 
Asp54 
Lys84 
His129 
Glu227 
Gln179 
Tyr127 
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6.2.2 Active Site Density 
A portion of unexplained electron density was found to be present within the active 
site of TmAKR (Fig 6.9).  This unexplained density could not be accounted for by 
NADPH cofactor or any known substrate of the enzyme.  Due to the shape of the 
density a short section of a polyalanine chain was build into the density and after 
further refinement putative side chain identities assigned.  By comparison of the 
assigned amino acid sequence with the sequence of the missing loops the unexplained 
density was identified to be part of the missing loop 7 (224-229).  From this loop 
Glu227 interacts with the catalytic tetrad residues Tyr59 and His129.  The carboxyl 
group of the glutamate occupies a position similar to that which the substrate carbonyl 
would occupy between the catalytic tyrosine and histidine.  The conformation adopted 
by the glutamate carboxyl would be excluded by NADPH binding due to steric 
hindrance.  Therefore upon cofactor binding the loop 7 would be expected to leave the 
active site and allow assembly of the substrate binding site to occur.  The effect of 
binding this glutamate at the active site may reduce the conformational entropy of 
loop 7, and stabilise this loop and the whole protein when no cofactor is bound. 
 
Fig 6.9.  A stereoview of the density found within the active site showing the 2Fo-Fc 
map in red contoured at 2σ and Fobs map in blue contoured at 1.5σ and generated with 
residues 224-229 omitted from the calculations.  The omitted residues are shown in 
cyan and the neighbouring residues are shown in green.  (Figure produced with 
PyMol, Delano Scientific, USA) 
6.2.3 Cofactor binding site 
In all AKR structures available the NADPH cofactor binds in a well defined cleft, 
with the nicotinamide positioned in the active site at the centre of the barrel and the 
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pyrophosphate positioned across the lip of the barrel between loops 7 and 8.  In the 
TmAKR structure no cofactor was found, and it appears to have been displaced by 
two sulfate molecules.  One of these sulfates is found in a position which would 
usually be occupied by the pyrophosphate and the other in a position usually occupied 
by the adenosine 2' monophosphate.  These two sulfates are chelated by similar 
residues to those found in other AKRs interacting with the phosphates of the cofactor.  
The sulfate in the pyrophosphate position interacts with backbone amides from 
Lys212 and Leu210 in a similar fashion to most other AKRs.  The other sulfate also 
interacts with two backbone nitrogens (from Lys286 and Thr285), and also with 
His289.  This histidine is usually a well conserved arginine (Jez et al., 1997) but 
adopts a conformation which should still be able to bind the adenosine 2' 
monophosphate.  Both sulfates form hydrogen bonds with the side chain of Arg24, 
which adopts a position close to that of Arg270 in the rat 3α-hydroxysteroid 
dehydrogenase (3α-HSD; AKR1C9) structure, which interacts only with the 
pyrophosphate bridge and not the monophosphate.  Tyr207 is found in a position 
where it would be able to stack with the nicotinamide ring and orientate it correctly 
within the active site.  The most highly conserved residues in the cofactor binding site 
are found in similar positions in TmAKR.  Asp54 and Gln179 are amongst the most 
strictly conserved residues for cofactor binding and are also conserved in TmAKR.  
Asp54 hydrogen bonds to the ribose 2' hydroxyl and Gln179 interacts with the 
carboxamide of the nicotinamide group.  Some other residues which are usually 
highly conserved across the AKR cofactor binding sites are however not conserved 
here.  Glu160 is strictly conserved as asparagine in all other AKRs and donates a 
hydrogen bond to the nicotinamide‟s carboxamide group.  Here it is seen in a position 
rotated away from the cofactor binding site.  Arg130 is found instead in a position 
able to provide a hydrogen bond to the nicotinic carboxamide.  Gly283 is usually 
found as either a lysine or arginine which hydrogen bonds to the pyrophosphate 
bridge.  Arg24 occupies a similar position to this residue and is found hydrogen 
bonding to both the sulfate molecules.  The well defined and highly conserved 
cofactor binding site across the AKR family allows for the prediction of the potential 
cofactor contacts within TmAKR (Fig 6.10). 
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Fig 6.10.  A schematic representation of the predicted hydrogen bonds and other 
significant contacts between NADP
+
 and TmAKR.  Hydrogen bonds shown as dashed 
bars. 
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6.3 Thermostability 
The enzymes obtained from thermophilic and hyperthermophilic organisms are active 
and stable at higher temperatures that their mesophilic counterparts.  As the number of 
high resolution structures available increases it is possible to compare similar 
enzymes from organisms with differing growth temperatures to provide an insight into 
thermostabilisation mechanisms.  No clear set of rules have been found to define how 
thermophilic enzymes gain their stability at increased temperature.  Thermostability is 
achieved by employing a variety of mechanisms which vary between organisms and 
enzymes.  A range of common mechanisms have been reported to be used and these 
are discussed in section 1.4. 
Most AKRs studied are either from humans and other animals, due to their therapeutic 
applications, or from yeasts for their ability to convert xylose to xylitol.  A number of 
AKRs from bacterial sources have also been investigated and their structures solved.  
However the number of bacterial AKR structures (18 structures for 12 unique 
proteins) is limited compared to other sources.  Thermophilic and hyperthermophilic 
AKR structures are also not well investigated with only a single structure for a 
hyperthermophilic AKR present in the PDB.  This single available structure, also 
from Thermot. maritima (25% identity to TmAKR; 27% identity to AKR11B1) was 
the product of a structural genomics project (Canaves et al., 2004), and has therefore 
had very little functional characterisation.  To allow for identification of 
thermostabilisation mechanisms utilised by TmAKR, the structure has been compared 
to AKRs from mesophilic organisms.  The other AKR from Thermot. maritima 
(TM1009; PDB: 1VP5) has been included to assess if these two enzymes have 
evolved to use similar thermostabilisation mechanisms.  Three AKR11 family 
enzymes (AKR11A1, B1 and C1), which represent the structures with the highest 
identity to TmAKR, have been used as mesophilic examples with which to provide a 
comparison.  The AKR11A1 enzyme from B. subtilis has the highest similarity to 
TmAKR (34% identity) but has reduced catalytic activity and binds NADPH in an 
alternate conformation; therefore comparision with AKR11B1 also from B. subtilis 
(32% identity) has been concentrated upon.  AKR11C1 is from B. halodurans (31% 
identity to TmAKR). 
 136 
6.3.1 Amino Acid Composition 
The overall amino acid composition of a protein was thought to correlate with 
thermostability.  Genome sequencing projects have shown however that there are no 
global trends, but thermophilic proteins may show a preference for certain amino 
acids.  In general these are only minor trends and are organism dependant.  The amino 
acid composition of the two Thermot. maritima AKRs (TmAKR, TM1009) and the 
three AKR11 family members studied are shown in table 6.1. 
  TmAKR TM1009 AKR11A1 AKR11B1 AKR11C1 
Growth Temperature 80°C 80°C 25-35°C 25-35°C 25-35°C 
Ala (A)   6.60% 5.90% 6.70% 7.80% 7.10% 
Arg (R)  6.30% 5.90% 4.50% 5.10% 7.40% 
Asn (N)  3.00% 3.50% 6.70% 3.60% 2.70% 
Asp (D)  3.00% 4.20% 7.10% 6.30% 6.10% 
Cys (C) 1.20% 1.00% 0.00% 0.30% 0.70% 
Gln (Q) 2.10% 4.50% 2.20% 3.90% 5.40% 
Glu (E) 12.90% 10.50% 9.00% 9.00% 9.10% 
Gly (G) 8.70% 5.90% 6.70% 7.20% 7.10% 
His (H) 1.50% 2.10% 2.60% 1.50% 2.40% 
Ile (I) 6.90% 8.40% 7.40% 8.10% 6.40% 
Leu (L) 9.90% 6.60% 9.90% 9.00% 11.10% 
Lys (K) 7.50% 7.30% 8.70% 6.00% 5.70% 
Met (M)  2.10% 3.50% 1.00% 2.40% 1.70% 
Phe (F) 3.60% 4.50% 5.40% 2.70% 1.70% 
Pro (P) 6.00% 4.20% 4.50% 5.10% 3.70% 
Ser (S) 4.20% 3.50% 3.80% 4.20% 5.10% 
Thr (T) 3.90% 3.80% 4.50% 7.80% 4.00% 
Trp (W) 1.50% 1.70% 0.30% 2.10% 1.30% 
Tyr (Y) 2.70% 4.20% 3.20% 3.60% 4.70% 
Val (V) 6.30% 8.40% 5.80% 4.20% 6.70% 
Charged 31.20% 30.00% 31.90% 27.90% 30.70% 
Uncharged polar 5.10% 8.00% 8.90% 7.50% 8.10% 
Aromatic 7.80% 10.40% 8.90% 8.40% 7.70% 
Table 6.1.  The amino acid composition of the two hyperthermophilic Thermot. 
maritima AKRs (TmAKR and TM1009) and the three mesophilic AKR11 family 
enzymes. 
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The TmAKR enzyme has a reduced proportion of uncharged polar amino acids than 
the mesophilic enzymes which may reduce the occurrence of deamidation.  This 
reduction in uncharged polar residues is often observed in hyperthermophilic proteins 
and is often accompanied by an increase in charged amino acids which may increase 
the opportunities to form ionic bonds; in TmAKR only an increase in glutamate is 
observed.  An increase in proline and glycine residues is also observed.  Increasing 
the proportion of proline may provide an increase in stability by increasing rigidity of 
the protein particularly in loop regions.  Whilst increasing the glycine content may 
serve to release conformational strain in certain parts of the structure.  The TM1009 
enzyme has a differing amino acid composition to TmAKR.  TM1009 has increased 
amounts of aromatic and hydrophobic residues (particularly valine) compared to both 
TmAKR and the AKR11s.  Other trends in the TM1009 enzyme compared with the 
mesophilic enzymes are for more glutamate and methionine along with reduced 
aspartate.  These alterations in composition may have more of an evolutionary 
significance rather than an effect on thermostability.  Interestingly both the T. 
maritima enzymes have increased cysteine content; thermophilic enzymes usually 
contain fewer cysteine residues due to their reactivity, and susceptibility to auto-
oxidation. 
6.3.2 Structural Features 
The α-helices within a protein carry an inherent dipole where the amino terminus 
carries a partial positive charge and the carboxyl terminus carries a partial negative 
charge.  Stabilisation of these charges by placing oppositely charged residues at either 
end may stabilise the helices and prevent unfolding of the secondary structure.  
TmAKR has more of its helices stabilised at both N and C termini compared to the 
three AKR11 structures and TM1009 (Table 6.2), suggesting that this may be a 
mechanism of stabilisation which the TmAKR enzyme utilises.  In contrast to 
TmAKR the other Thermot. maritima AKR, TM1009, has a similar number of termini 
stabilised to the AKR11s.  In addition to having more helices stabilised, TmAKR has 
more N-termini stabilised by the presence of proline residues.  This correlates well 
with the increased presence of proline in the primary sequence of the enzyme.  Other 
additional prolines occur near to the ends of β-sheets, presumably reducing flexibility 
and conformational entropy and therefore reducing the likelihood of these secondary 
structural elements unfolding. 
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Helices stabilised TmAKR AKR11A1 AKR11B1 AKR11C1 TM1009 
At N-terminus 9 7 6 7 7 
At C-terminus 4 0 2 3 3 
Total 13 7 8 10 10 
By Proline 5 3 2 2 2 
Table 6.2.  A table showing the α-helix stabilisation with the number of N-termini, C-
termini and total termini of the α-helices that are stabilised by an opposite charged 
residue, with the occurrence of proline residues at the N-termini also shown. 
 
Most microbial AKRs are found as monomers in solution with the exception of some 
yeast xylose reductases (Yokoyama et al., 1995).  Both of the Thermot. maritima 
AKRs are dimeric in nature which may contribute towards their increased stability.  
The TmAKR was shown to be dimeric by gel filtration chromatography (Section 
2.3.2) and TM1009 is predicted to be dimeric by the EBI Protein Quaternary Structure 
(PQS) server (www.ebi.co.uk; CCP4, 1994; Vriend, 1990).  Both enzymes form their 
dimers with quite different interfaces, TmAKR has its dimer interface centred around 
helices α1 and α8, with an angle of approximately 90° created between the monomers 
(Fig 6.6).  The TM1009 enzyme has its dimers rotated 180° relative to each other (Fig 
6.11) with the dimer interface mainly composed of helices α4 and α5.  The two dimer 
interfaces are also varied in their nature with the TmAKR interface being mainly 
composed of hydrophobic interactions with all water excluded and only a small 
number of ionic interactions (see section 6.1.2.2).  In contrast the TM1009 dimer 
interface contains two small hydrophobic patches and many hydrogen bonded 
interactions which are mostly water mediated (4 direct hydrogen bonds).  All three of 
the AKR11 members studied are monomeric in solution. 
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Fig 6.11.  Figure showing the TM1009 dimer as predicted by the EBI PQS server 
(www.ebi.co.uk).  a) the view down the non-crystallographic two-fold axis on the 
dimer interface,  b)  as in a) with a 90° rotation about the x-axis.  (Figure produced 
with PyMol, Delano Scientific, USA). 
 
Ion-pair networks are often found to have a higher occurrence and to be larger in 
thermophilic proteins.  The TmAKR monomer possesses two more ionic interactions 
than AKR11B1, and both contain two networks with three residues suggesting that an 
increase in the size and occurrence of ion-pair networks is not a major contributory 
factor to the stabilisation of TmAKR.  The ion-pairs present in TmAKR are however 
more often found between adjacent secondary structural elements, thereby connecting 
a) 
 
 x 90° 
b) 
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two parts of the structure together which are distant in the primary sequence, which 
may offer a stabilising effect (Perutz and Raidt, 1975).  If we consider the TmAKR 
dimer then one of the three residue networks is extended to four residues through the 
dimer interface.  This four residue ion-pair network is further extended through 
hydrogen bond interactions to provide N-terminal helix stabilisation to helix H2 in 
one subunit and to helix α1 in the other subunit (Fig 6.12). 
 
 
Fig 6.12.  Figure showing the ion-pair network at the dimer interface in TmAKR 
consisting of four residues (Asp34-Arg258-Glu305-Lys259), which interacts with the 
N-termini of helix α1 and helix H2 to provide stabilisation to the helix dipoles.  
(Figure produced with PyMol, Delano Scientific, USA). 
 
Asp34 
Arg258 
Lys259 
Thr302 
Glu305 
Lys36 
H2 
α1 
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In TM1009 there is the same overall number of ion-pair interactions compared with 
TmAKR but more of these are found in larger networks.  Two networks of three 
residues are found in addition to a four residue network and a five residue network.  
Unlike TmAKR none of these ion-pair networks cross the dimer interface.  This 
suggests that TM1009 utilises larger ion-pair networks as a general stabilising 
mechanism, whereas TmAKR utilises more single ions-pairs separated in sequence to 
provide a stabilising effect in addition to using an ion-pair network to stabilise the 
dimer interface. 
The two Thermot. maritima AKRs appear to gain their thermostability by differing 
mechanisms.  TmAKR utilises increased helix dipole stabilisation, long distance ion-
pair interactions and dimer formation to achieve its increased stability.  In contrast the 
TM1009 enzyme predominantly utilises increased size of ion-pair networks in 
addition to dimer formation to achieve its increased stability.  The analysis of 
TM1009 thermal stabilisation has been carried out relative to TmAKR and the 
AKR11A1, B1 and C1 enzymes, but TM1009 is most closely related to the AKR5 
family and comparison with this family may further reveal which mechanisms are 
utilised to achieve stabilisation.  However the analysis performed here does suggest 
that the Thermot. maritima AKRs have evolved distinctly different 
thermostabilisation mechanisms. 
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7 Bacterioferritin Structure 
7.1 Introduction 
Bacterioferritin from E. coli is an iron storage protein consisting of 24 identical 
subunits (18 kDa each) with 432 symmetry, which form a roughly spherical structure 
approximately 120Å in diameter, with an 80Å hollow core.  Iron is deposited within 
the core by the ferroxidase reaction which occurs in 3 distinct kinetic steps as 
determined by EPR spectroscopy (Le Brun, 1993).  1) the binding of two Fe(II) ions 
per subunit; 2) the fast oxidation of Fe(II) to Fe(III) by reduction of O2 or H2O2; 3) 
slow core formation phase where iron is deposited as an insoluble ferric oxyhydride 
phosphate mineral.  The presence of phosphate during core formation has a significant 
enhancing effect upon phase 3 by increasing the transfer rate of electrons from the 
core surface to the ferroxidase centre (Aitken-Rogers et al., 2004).  
As well as the heme binding bacterioferritin, E. coli also possesses another iron 
storage protein in the form of the non-heme binding ferritin.  Ferritin is an iron 
storage protein with a similar overall architecture to bacterioferritin but lacking heme.  
It is made up of 24 identical subunits of approximately 18 kDa, binds two non-heme 
metals per subunit and also exhibits 432 point group symmetry.  It has been suggested 
that the ferritin and bacterioferritin monomers are the bacterial equivalents of the H 
and L chains of the mammalian ferritin system (Stillman, 2001).   
7.1.1 Ferroxidation Mechanism 
The mechanism of core formation and the contribution which the ferroxidase centre 
makes is not clear.  A variety of mechanisms have been suggested; one where iron is 
oxidised at the ferroxidase centre followed by release to the core where nucleation and 
growth can occur.  Evidence for this mechanism comes from the structures of 
Azotobacter vinlandii (Liu et al., 2004; Swartz et al., 2006) and Desulfovibrio 
desulfuricans (Macedo et al., 2003) bacterioferritins where there is a concerted 
movement of His130 (His59 in D. desulfuricans) allowing release of Fe(III) into the 
core.  This is supported by the observation of partial occupancy in the corresponding 
(FE2) iron site.  In the E. coli structures described to date, this movement of His130 is 
not observed, however in the mixed iron/zinc structure (van Eerde et al., 2006) and 
the manganese bound structures (Frowlow & Kalb, 2001) partial occupancy of the 
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FE2 site (ligated by His130) was observed and was attributed to a similar mechanism 
as seen in A. vinlandii and D. desulfuricans bacterioferritins. 
An alternative mechanism has been proposed where the iron at the ferroxidase site 
acts like a cofactor.  Fe(II) is oxidised to Fe(III) at the ferroxidase site by reduction of 
O2 or H2O2.  Fe(II) which has already entered the core (via alternate channels in the 
protein) is oxidised either at nucleation sites on the protein inner surface or on the 
growing core surface, where electrons are channelled back through the ferric 
oxyhydrite phosphate core to the ferroxidase site where Fe(III) is reduced to Fe(II) 
and the cycle can begin once more.  Therefore by this mechanism oxidation of iron 
and reduction of oxygen/peroxide become spatially separated.  Evidence for this 
mechanism comes from the requirement for a functional ferroxidase site throughout 
the whole core formation process and the dependence of the rate of core formation on 
the surface area of the growing core, an observation which indicates the involvement 
of the core surface in the catalytic mechanism (Baaghil et al., 2003; Lewin et al., 
2005). 
7.1.2 Heme 
The bacterioferritins bind 12 heme molecules per icositetramer but little is known 
about their function.  The heme is ligated by two Met52 residues from neighbouring 
subunits within what appears to be a symmetrical hydrophobic pocket. The 
neighbouring Glu51 residue forms a ligand to each of the metals within the 
ferroxidase centre thereby providing the potential for interaction between the two 
metal centres.  Mutation of the Met52 residues to histidine or leucine prevented heme 
binding and showed that heme was not required for iron accumulation (Andrews, 
1995).  These mutants accumulated more iron than their heme containing counterparts 
suggesting that the heme may regulate iron release from the core.  Furthermore when 
horse spleen ferritin is loaded with heme, iron reduction and release is accelerated by 
increasing the rate at which electrons are delivered to the core (Kadir et al., 1992) 
7.1.3 Role in Oxidative Stress 
In comparison to the ferritins, the primary role of bacterioferritins may not be for iron 
storage and they may play a role in oxidative stress resistance.  Evidence comes from 
the time of expression of ferritins and bacterioferritins (Andrews, 1998), where as 
ferritins are expressed during the growth phase, bacterioferritins are expressed in the 
stationary phase. This is consistent with ferritin having a role in general house 
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keeping and growth function, where as the late expression of bacterioferritin points to 
a role in regulation of stress. 
Ferritin knock-outs have shown a reduction in intracellular iron and a decrease in 
iron-restricted growth, pointing to an iron storage function.  Whereas knock-out 
studies of bacterioferritin failed to show any phenotype relating to iron storage 
(Andrews et al., 2003).  This lack of a phenotype suggests an alternate or dual role for 
bacterioferritin.   
The mechanism of bacterioferritin also points to a role in oxidative stress resistance 
(Bou-Abdallah et al., 2002).  By utilising pairwise oxidation of Fe(II) in the 
ferroxidase centre, the bacterioferritin prevents the production of harmful radicals 
from the Fenton reaction (Eq. 7.1).  The ferroxidation mechanism is capable of 
removing the potentially harmful combination of Fe(II), O2 and H2O2 from the cell.  
Given O2 as an oxidant the bacterioferritin will produce H2O2 as an intermediate 
(Eq. 7.2), but this is not released into the bulk solvent and is rapidly utilised as an 
oxidant by a neighbouring ferroxidase site (Yang et al., 2000) (Eq. 7.3). 
 
[Fe(II)2-P] represents iron bound to the ferroxidase site. 
 
By this mechanism of pair wise oxidation and subsequent elimination of 
intermediates, the net reaction (Eq. 7.4) gives two oxidised ferroxidase centres with 
no net release of by-products.  In comparison ferritins have been shown to release 
some of the peroxide intermediate into the bulk solvent, suggesting removal of 
reactive oxygen species is not as functionally important for the ferritins as it is for 
bacterioferritins (Lewin et al., 2005). 
 
2[Fe(II)2-P] + O2               2[Fe(III)2O-P] Eq. 7.4 
Fe
2+
 + H2O2             Fe
3+
 + HO
-
 +HO Eq. 7.1 
[Fe(II)2-P] + O2 + H2O              [Fe(III)2O-P] + H2O2  
[Fe(II)2-P] + H2O2            [Fe(III)2O-P] + H2O 
Eq. 7.2 
Eq. 7.3 
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7.1.4 Previous Structures 
The X-ray structure of E. coli bacterioferritin has previously been solved (Frolow et 
al., 1994; Dautant et al., 1998) to 2.9Å (PDB: 1BCF, 1BFR) and more recently to 
2.5Å (van Eerde et al., 2006; PDB: 2HTN).  The arrangement of the subunits exhibits 
432 point group symmetry, with channels at the 4-fold and 3-fold axis connecting the 
inner core to the outside environment (Dautant et al., 1998).  Previous structures 
showed the heme binding in a symmetrical hydrophobic pocket located on the 2-fold 
axes between two symmetry related subunits. Also two metal ions are shown binding 
to each monomer at the ferroxidase centre and have previously been assigned as 
manganese (Frolow et al., 1994; Dautant et al., 1998), or as a mixture of iron and zinc 
(van Eerde et al., 2006). 
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7.2 X-ray Structure 
7.2.1 Overall structure 
7.2.1.1 Monomer 
Each subunit of the E. coli bacterioferritin consists of 158 amino acids which fold up 
into an all α-helical structure.  The monomer (Fig 7.1) consists of a 4 helix bundle 
with a short 5
th
 helix at the C-terminal end.  The 4 helix bundle is composed of 2 anti-
parallel helix pairs AB and CD linked by a loop L, which passes over the top of the 4-
helix bundle and forms the back of the heme binding site.  The helices are arranged so 
that A and C are paired together on the external face and B and D are paired together 
on the internal face below A and C.  A total of 78% of the structure is composed of α-
helices.  A summary of the secondary structure is provided in figure 7.2.  γ-turns are 
found between helices A and B (residues 36-38) and helices C and D (residues 112-
114).  Between helices B and C is a type IV β-turn (residues 70-73), which leads into 
a γ-turn (residues 72-74).  Each monomer binds two metal atoms in the centre of the 4 
helix bundle, and contributes one ligand towards chelation of the heme. 
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Fig 7.1a) Topology diagram of the E. coli bacterioferritin monomer (figure produced 
using Topdraw, Bond, 2003). b) Cartoon representation of bacterioferritin monomer 
(figure produced using PyMOL, Delano Scientific USA).  Helices (A-E), coloured A 
– Blue, B – Cyan, C – Green, D – Yellow and E – Red. 
A 
B 
C 
D 
E 
 
L a) 
b) 
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         10         20         30         40         50 
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         60         70         80         90        100 
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 α2        α3 
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    α4       α5 
 
....|... 
       
QAQIREEG 
H....... 
 
Fig 7.2.  Structure sequence summary of E. coli bacterioferritin.  Showing helices (H) 
and turns (T). Helices labelled α1 – α5.  Residues coloured green were not observed in 
the structure.  (Figure produced using Bioedit; Hall, 1999) 
 
7.2.1.2 Dimer 
The dimer (Fig 7.3) consists of two monomers in a head to tail arrangement centred 
on the local two-fold axis.  The subunit interface for the dimer is formed by helices A 
and B from both symmetry related subunits and includes the heme binding site in the 
centre of the interface.  In addition to the heme binding site the interface consists of a 
number of salt bridges and hydrophobic patches.  Ionic interactions are found 
connecting the two loops from symmetry related subunits, with the carboxamide of 
Gln72 interacting with Leu77 and Gly75 backbone nitrogen and oxygen respectively.  
Also holding the two loops together is a hydrophobic interaction between two Leu74s 
positioned on the two-fold axis.  The loop L also interacts with helix A from the 
opposite monomer through the backbone oxygen of Leu71 hydrogen bonding with the 
ND2 of Asn23.  There are also salt bridges formed between helices A and B from 
opposite monomers, the terminal oxygens of Asp56 (helix B) form salt bridges with 
the NE and NH2 of Arg30 (helix A) as does the OE2 of Glu60 (helix B) with the NZ 
of Lys33 (helix A).  These interactions between helices A and B are located together, 
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where Glu60 also has the potential to form a salt bridge with Arg30, providing a 
strongly interacting site between the two monomers.  There is also a large 
hydrophobic patch located either side of the heme binding site composed of Phe26 
and Leu27 (helix A), Ile59 and Leu63 (helix B) and Pro69, Leu71 and Leu77 (loop 
L), further serving to bring together helices A and B and loop L and tighten the 
interaction of the dimer interface.  Due to its symmetrical nature all the interactions 
discussed (except Leu77-Leu77) occur twice on each dimer interface. 
 
 
Fig 7.3.  Dimer of E. coli bacterioferritin, viewed down local two-fold non-
crystallographic symmetry axis, shown as: a) stereo view of Cα trace with Met1 and 
Glu157 labelled and b) cartoon representation coloured from N-terminus (Blue) to C-
terminus (Red).  Zinc ions are shown as grey spheres and heme as stick 
representation.  (Figure produced using PyMOL, Delano Scientific USA). 
a) 
b) 
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7.2.1.3 Icositetramer (24mer) 
The biological unit of bacterioferritin consists of 24 subunits (icositetramer), or 
alternatively can be thought of as 12 dimers.  The icositetramer forms a roughly 
spherical shape with a diameter of approximately 120Å containing an 80Å hollow 
core, where Fe(III) may be deposited.  The bacterioferritin molecule shows extensive 
non-crystallographic symmetry exhibiting 432 point group symmetry.  There are 12 
two-fold axes (Fig 7.3b), 3 four-fold axes (Fig 7.4), and 4 three-fold axes (Fig 7.5).  
The two-fold axes are found on the dimer interfaces where heme binding occurs, the 
three-fold and four fold axes lie on channels thought to connect the internal and 
external environments and allow metal atoms to pass through to the core. 
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Fig. 7.4. A view along a 3-fold axis of the E. coli bacterioferritin.  a) Showing the 
whole bacterioferritin icositetramer.  b) Closeup view from a) showing Asp109 and 
Arg117 from each symmetry related subunit and a sulfate molecule in centre of the 
channel.  c) As in b) with a 90° rotation around the x-axis.  (Figure produced using 
PyMOL, Delano Scientific, USA) 
a) 
b) c) 
 90° 
Asp109 
Arg117 Asp109 
Arg117 
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Fig 7.5.  A view down a 4-fold axis of the E. coli bacterioferritin.  a) View down the 
4-fold axis showing the whole bacterioferritin icositetramer.  b) Closeup view from a) 
showing Asn148 and Gln151 from each symmetry related subunit and 3 water 
molecules lined up along the non-crystallographic symmetry axis.  c) As in b) with a 
90° rotation around the x-axis.  (Figure produced using PyMOL, Delano Scientific 
USA) 
a) 
b) c) 
  90° 
Asn148 
Gln151 
Asn148 
Gln151 
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7.2.2 Heme Site 
The heme molecule in bacterioferritin is bound between two symmetry related 
monomers on the dimer interface and is chelated by two equivalent Met52 residues, 
one from each subunit.  The heme binding pocket (Fig 7.6) is mainly hydrophobic 
consisting of Leu19, Ile22, Asn23, Phe26, Tyr45, Ile49, Met52, Lys53, Ala55 and 
Ile59 from each subunit.  The heme is bound in the pocket with its two propionate 
chains protruding into the internal cavity and is bound in two symmetry related 
conformations.  In the structure presented here the electron density for the heme (Fig 
7.7) appears to show no preference for binding in either conformation, in contrast to 
what was seen for the manganese bound structure (Frolow et al., 1994) where binding 
in one predominant conformation was observed.  The extra density visible in Fig 7.7 
can be filled by rotating the heme 180°, thereby placing the vinyl groups of C3 and 
C8 into the extra observed electron density.  In addition the electron density around 
C8 shows this vinyl group to face in two orientations and has been modelled as such. 
The electron density of the heme molecule shows no preference for either of the two 
conformations observed and is reflected by the symmetrical nature of the interactions 
between the heme and the residues lining the pocket.  An analysis of the atomic 
contacts made by heme binding in the two alternate conformations (Table 7.1; 
performed using the WHAT IF web server; Rodriquez et al., 1998) shows there is 
little difference in the number of contacts made by the two alternate conformations, 
with heme A making 61 atomic contacts and heme B making 64.  This represents less 
than a 5% difference in the number of contacts made by either possible conformation.  
The largest differences can be seen with the interaction of Phe26 which makes 9 
interactions with heme A, 7 from subunit A and only 2 from subunit B.  Likewise a 
similar situation is observed with heme B having 10 interactions in total, 4 from 
subunit A and 6 from subunit B.  The overall numbers of interactions are similar, but 
there are differences in the number of interactions contributed by each subunit.  This 
is due to the Phe26 of one subunit interacting with the methyl at C2 of the heme, 
where the other interacts with the vinyl group at C8 of the heme, producing more 
interactions.  Further small variations in the number of interactions are observed, but 
these generally represent differences of <0.2Å where one interaction is not recognised 
since it falls just outside the range to be recognised as an atomic contact.  It is 
 154 
believed that this apparent asymmetry would disappear at higher resolution where 
more precise measurement of the atomic positions can be made. 
 
Residue 
Heme A 
  
No. of 
contacts 
with 
Heme A 
Heme B 
  
No. of 
contacts 
with 
Heme B 
Subunit 
A 
Subunit 
B 
Subunit 
A 
Subunit 
B 
Leu 19 1 1 2 0 1 1 
Ile 22 2 1 3 2 1 3 
Asn23 0 0 0 1 0 1 
Phe 26 7 2 9 4 6 10 
Tyr 45 0 1 1 0 1 1 
Ile 49 1 2 3 1 2 3 
Met 52 20 21 41 20 21 41 
lys 53 1 1 2 1 1 2 
Ala 55 0 0 0 1 0 1 
Ile 59 0 0 0 1 0 1 
Total 32 29 61 31 33 64 
Table 7.1.  Summary of the atomic contacts made by the two alternate conformations 
of heme with subunits A and B of E. coli bacterioferritin.  Inter-atomic contacts 
calculated using the WHAT IF www servers (Rodriguez et al., 1998). 
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Fig 7.6.  A stereo view of the heme in E. coli bacterioferritin and all of the interacting 
residues demonstrating the symmetrical nature of the heme binding site, as viewed 
from the internal cavity.  (Figure produced using PyMOL, Delano Scientific, USA). 
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Fig 7.7.  2FC-F0 map of E. coli bacterioferritin contoured at 1.5σ, showing one of the 
two orientations that the heme can adopt.  The other orientation is a 180° rotation 
about the y-axis through the iron.  The C8 vinyl also adopts an additional 2
nd
 position, 
pointing downwards in the diagram.  C3 and C8 are labelled for reference on the 
green molecule.  The internal cavity is located at the top of the diagram indicated by 
arrow (IC).  (Picture produced using PyMOL, Delano Scientific, USA). 
  C8 
 IC 
 C3 
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A water filled pocket is located at the top of the heme binding site and has access to 
the external medium via two symmetry related pores (Fig 7.8) which pass between 
loop L and helix A in each subunit.  The cavity contains four waters observed in all 
previous structures of E. coli bacterioferritin, but in addition a chain of waters are 
observed passing from these four waters located deep in the cavity towards the 
external environment thereby providing a potential link between internal and external 
environments.  This is the only structure to date of all the bacterioferritins to show a 
direct link between the heme and the external environment.  In the D. desulfuricans 
bacterioferritin structures the analogous water cavity is connected to the external 
environment but is separated from the heme by a pair of symmetry related His28 
residues.  In the E. coli sequence this histidine is conserved, but structurally it is 
replaced by Asn23.  These four waters form an extensive hydrogen bond network 
within the cavity (Fig 7.9).  A pair of Leu19 residues donate one hydrogen bond each 
from their backbone carbonyls to the lower waters whilst the Asn23 residues form two 
hydrogen bonds each, one with an upper water and one with a lower water. The lower 
pair of waters also hydrogen bond with the upper pair of waters which in addition to 
hydrogen bonding with each other also form hydrogen bonds with waters residing in 
both symmetry related channels linking them to the external environment.  This link 
between the heme and the external environment may be important for the function of 
the protein.  In horse spleen ferritin loaded with heme an increase in the rate of iron 
reduction and release from the core was observed due to an increase in the rate of 
electron transfer to the core mediated by the heme (Kadir et al., 1992).  The heme in 
E. coli bacterioferritin can therefore interact with the internal and external 
environments and mediate the transfer of electrons to the internal core and potentially 
regulate iron release. 
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Fig 7.8. Location of the heme water channel in the E. coli bacterioferritin is indicated 
by a black arrow.  The symmetrically related pore (not visible) connecting to same 
heme molecule is indicated by a white arrow.  (Figure created using PyMOL, Delano 
Scientific USA) 
 
Fig 7.9. The hydrogen bonding network within the heme water cavity of E. coli 
bacterioferritin, showing interacting residues and two additional water molecules 
residing in the symmetry related pores.  Hydrogen bonds are shown as dashed lines.  
Those connecting the four waters within the cavity are shown in red.  (Figure created 
using PyMOL, Delano Scientific USA) 
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7.2.3 Ferroxidase Centre 
Within the centre of the 4 helix bundle lies a binuclear metal site ligated by residues 
from helices A, B, C and D.  This site usually binds Fe(II) and oxidises it to the 
insoluble Fe(III) form.  The ferroxidase centre has also been shown to bind 
manganese (Frolow et al., 1994), zinc (Le Brun et al., 1995) and cobalt (Keech et al., 
1997).  In the structure presented here zinc is seen bound to the ferroxidase centre.  
The binuclear zinc is coordinated by four glutamates and two histidines (Fig 7.10).  
His54 from helix B and His130 from helix D both coordinate one zinc each from 
beneath with their ND1 nitrogens.  Glu51 from helix B and Glu127 from helix D both 
provide axial bridging ligands to both zincs.  Glu18 from helix A offers two ligands to 
the zinc in site 1, whereas the equivalent, Glu94, from helix C offers one ligand for 
the zinc in site 2.  Therefore Zn1 has five protein ligands and a near square pyramidal 
coordination geometry, Zn2 has four protein ligands and more tetragonal coordination 
geometry. 
 
Fig. 7.10.  The ferroxidase centre in E. coli bacterioferritin, showing the zinc atoms 
and all of the interacting amino acid residues with interatomic distances shown.  
(Figure created using PyMOL, Delano Scientific USA) 
 
This difference in the ligands for sites one and two has been seen previously in crystal 
structures of E. coli bacterioferritin (1BFR, 2HTN).  The non-equivalence of the metal 
sites has been demonstrated in kinetic studies where mutants of Glu18 and Glu 94 
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responded differently to the uptake of metal ions (Keech et al., 1997).  Partial 
occupancy of the metal atoms in the ferroxidase site has been observed in previous 
structures of E. coli bacterioferritin (van Eerde et al., 2006) and bacterioferritin from 
other organisms (Liu et al., 2004; Swartz et al., 2006; Macedo et al., 2003).  The B-
factors of the zinc atoms show only a very small difference suggesting that both metal 
atoms are of a similar occupancy.  The Zn1 has an average B-factor of 21.27Å
3
 
(21.34-21.75) where as Zn2 has an average B-factor of 24.19Å
3
 (23.76-24.65).  In 
addition the OE1 and OE2 of Glu51 and Glu127 also display a similar asymmetry in 
B-factors.  Zn2 may have a slightly lower occupancy to that of Zn1, but this has not 
been reflected in the final model since the B-factors are reasonably close and any 
reduction in occupancy is only likely to be marginal. 
7.2.4 Iron Entry and Exit Paths 
There are many potential routes for iron entry and exit from the core.  The 
bacterioferritins, bacterial ferritins, and mammalian ferritins all vary dramatically at 
these pores potentially leading to different mechanisms of core formation.  The 
bacterioferritins from different organisms also vary amongst themselves and may use 
these pores in different ways. 
Situated directly above the ferroxidase site are a large cavity and a channel linking to 
the outside environment (Fig 7.11).  This cavity is approximately 16Å long in the 
Zn1-Zn2 direction, and 9Å across in the zinc-heme direction and encloses on average 
9 waters (8-10).  This cavity and its entrance are highly negatively charged and would 
therefore be able to attract cations such as Fe
2+
 towards the ferroxidase centre.  It has 
been suggested that through a concerted movement of His130 and release of at least 
one iron from the ferroxidase site would open up a clear channel allowing access to 
the core (Macedo et al., 2003).  Partial occupancy of site 2 in the manganese and 
mixed iron/zinc structures suggest this may occur but neither have shown movement 
of His130 and opening up of a clear channel.  In the zinc bound form presented here 
both sites appear to be fully occupied, which may not be surprising given the high 
affinity of zinc for the ferroxidase site (Keech et al., 1997). 
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Fig 7.11.  The ferroxidase cavity and channel of E. coli bacterioferritin shown as a 
surface representation in cross section.  Zinc atoms are shown in grey.  (Figure 
created using PyMOL, Delano Scientific USA) 
 
Located at the 3-fold and 4-fold symmetry axis are subunit interfaces where it has 
been previously suggested (Dautant et al., 1998) that channels exist and provide a 
route for Fe(II) to pass from the external environment to the core and vice versa.  The 
3-fold channel (Fig 7.4) consists of three Asp109 residues on the external surface and 
three Arg117 residues from symmetry related subunits lying underneath these with 
access to the internal solvent.  Further into the centre is a sulfate interacting with the 
three arginine residues and a large cavity containing 16 water molecules.  At the 
internal entrance to this cavity (Fig 7.12) are three Asp118 and three Glu122 residues 
providing a highly negatively charged environment. 
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Fig 7.12, View of a 3-fold axis channel of E. coli bacterioferritin from the internal 
cavity.  The figure shows Asp109 and Arg117 (background, not labelled), and Asp118 
and Glu122 (foreground, labelled) from 3 symmetry related subunits, and a central 
sulfate ion bound at the top of the channel. 
 
The 4-fold axis is at the point where four short E helices meet (Fig 7.5) with the 
channel entrance consisting of Asn148 and Gln151 from four symmetry related 
subunits with Asn148 lying on the outer surface and Gln151 lying underneath 
contributing to the inner surface.  Manganese has been observed to be bound in the 
centre of this channel by Gln151s (Dautant et al., 1998).  Metal atoms were also 
found within this channel in the A. vinlandii bacterioferritin structures (Swartz et al., 
2006; Liu et al., 2004).  No metal atoms were observed in this structure at this 
position, presumably due to the absence of any heavy metals in the crystallisation 
solutions.  This position between the glutamines and asparagines is occupied by a 
single water molecule 3.8Å from a water located on the outer surface and 5.5Å from a 
Asp118 
Glu122 
Asp118 
Glu122 
Asp118 
Glu122 
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water located on the inner surface within a cavity containing 11 waters. In comparison 
to the 3-fold channel the surfaces of the 4-fold channel are relatively uncharged 
(Carrondo, 2003).  The 3-fold and 4-fold channels in ferritins and bacterioferritins 
from other organisms vary considerably.  The 4-fold axis in mammalian L chain 
ferritins is highly hydrophobic, whilst mammalian H chain ferritins have some 
histidine and methionine residues compared with the hydrophilic channels in E. coli 
bacterioferritin.  The 3-fold channel of D. desulfuricans bacterioferritin is highly 
positively charged on the external surface, the opposite to what is observed for the E. 
coli bacterioferritin. 
Another potential channel is located where a dimer meets another, head to side on 
(Fig 7.14a), and have been termed B-channels.  These channels were identified in D. 
desulfuricans bacterioferritin (Macedo et al., 2003) due to the large concentration of 
negatively charged residues around the channel.  The B-channel (Fig 7.14b) in E. coli 
bacterioferritin consists of Met1, Phe64 and Glu66 from one subunit, Asn34 and 
Trp35 from the second, making a dimer with the first and Asp132, Glu135, Thr136, 
and Asp139 from the third subunit.  This channel provides the most easily accessible 
route of entry for iron directly to the core and consisting of predominantly negatively 
charged amino acids would strongly attract cations. 
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Fig 7.13.  An external view of the B-channel in E. coli bacterioferritin.  a) showing 
the whole icositetramer with the 4-fold (4), 3-fold (3) and B-channel (B) labelled.  b) 
view of all the amino acids surrounding the channel. 
Thr136 
Asp139 
Asp132 
Glu135 
Glu66 
Met1 
Phe64 
Trp35 
Asn34 
4 
B 
3 
a) 
b) 
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Whilst it has been postulated that there are a variety channels linking the internal and 
external environments, it has not been shown which channels are capable of allowing 
Fe(II) ions to pass through in the E. coli bacterioferritin.  The ferroxidase channel is 
very likely to supply the ferroxidase site with Fe
2+
 ions, the mechanistic fate of which 
is still rather unclear.  The 3-fold, 4-fold and B-channels in E. coli bacterioferritin 
have a similar amino acid composition to those in the A. vinlandii bacterioferritin, the 
structures of which have shown metals bound at all of these channels (Swartz et al., 
2006; Liu et al., 2004), the metals bound at the 4-fold channel are bound in a similar 
fashion to the manganese found in previous E. coli bacterioferritin structures (Frolow 
et al., 1994) suggesting the 4-fold channel acts as a route for iron entry and/or exit in 
these bacterioferritins.  The A. vinlandii bacterioferritin structures also provide clues 
to the function of the 3-fold channels.  Rather than being a route for iron entry it has 
been suggested (Liu et al., 2004) that during core formation the bottom of the channel 
may become positively charged and build up a large electrostatic gradient allowing 
phosphate ions to flow into the core.  In the E. coli bacterioferritin structure described 
here, a sulfate molecule was found located in the middle of the 3-fold channel.  
Sulfate is of a similar size and co-ordination geometry to phosphate, although it has 
+2 formal charge rather than +3 of phosphate, suggesting phosphate may be able to 
occupy a similar position en-route to the core.  The B-channel possesses many 
negatively charged residues and provides a good candidate for iron entry or exit.  
However this channel lacks much of the specificity shown by the other channels, and 
its specific function is yet to be established. 
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8 Structural basis of AKR substrate specificity 
8.1 Cofactor binding 
All the members of the AKR superfamily with three dimensional structures bind the 
NADPH cofactor in the same orientation, ready to donate the 4-pro-R hydride from 
the cofactor nicotinamide.  The only exception to this is the AKR11A1 (Ehrensberger 
and Wilson, 2004) which binds cofactor with the ribose and the nicotinamide rotated 
by 180° relative to the other AKR family members (Fig 8.1) which positions the 4-
pro-S hydride ready for transfer to the substrate, and has reduced catalytic activity.   
 
Fig 8.1.  Figure showing the alternate binding conformation of NADPH in AKR11A1 
(green), with the ribose and nicotinamide moiety rotated by 180° relative to the 
cofactor in AKR11B1 (cyan).  (Figure produced with PyMol, Delano Scientific, USA) 
 
The TmAKR cofactor binding site is devoid of NADPH and instead binds two 
sulphate molecules from the crystallisation medium.  These occupy positions 
analogous to the phosphates of the NADPH cofactor (Fig 8.2), and are bound by 
similar residues which bind the cofactor phosphates in other AKR family members.  
The cofactor binding site is highly conserved in sequence and structure (Jez et al., 
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1997) to such an extent that we are able to superimpose the active site from 
AKR11B1 and its NADPH cofactor onto the TmAKR structure (Fig 8.3).  The 
superimposed cofactor sits in a clearly defined cofactor binding pocket, and interacts 
with residues conserved across the AKR superfamily (See Chapter 6). 
 
 
Fig 8.2.  Superimposition of NADPH from AKR11B1 (1PZ1) and the two sulphates 
(shown in blue) bound in the cofactor binding site of TmAKR.  (Figure produced with 
PyMol, Delano Scientific, USA) 
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Fig 8.3.  Superimposition of TmAKR with AKR11B1 showing NADPH cofactor 
binding site and its structural conservation.  The catalytic tetrad and stacking tyrosine 
and shown as sticks, other residues neighbouring NADPH are shown as lines. (Figure 
produced with PyMol, Delano Scientific, USA) 
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8.2 Loop structures 
The three dimensional structure of the AKRs is highly conserved across all 
superfamily members, particularly the central core composed of the α8β8 barrel.  Most 
of the variability across the AKRs is present within the loop regions (See section 6.1.1 
for nomenclature scheme) and the C-terminal loop.  These variable portions of the 
AKRs are responsible for the substrate specificity of the enzyme (Jez et al., 1997). 
A sequence alignment of AKRs structurally related to the TmAKR enzyme (Appendix 
8) shows the conservation of the core structure and the variability present in the loop 
regions.  This variability in loop sequence and size correlates with the substrate 
specificity of the AKRs.  The most obvious difference in loop structure occurs on 
loops 3 and 4 (Fig 8.4), where loop 4 of AKR1A1 occupies the same three 
dimensional space as loop 3 of TmAKR.  TmAKR and the AKR11 family members 
all possess a longer loop 3 and shorter loop 4 than most other AKRs, TmAKR also 
has a longer Loop 6 and shorter C-terminal loop.  The loop 4 has been implicated to 
have an important role in substrate binding (Jez et al., 1997), and alteration of the 
sequence and/or size of this loop may be expected to have an impact upon substrate 
binding.  In contrast to TmAKR, AKR1A2 has the largest loop 4 of those investigated 
and binds a much larger substrate than TmAKR (C15 compared with C8).  TmAKR 
along with the related AKR11A and B (not 11C) and the E. coli TAS protein all have 
a longer loop 6 than the other AKRs in appendix 8 along with a shorter C-terminal 
loop.  The C-terminal loop also has an important role in substrate binding, it maybe 
that with a reduction in the C-terminal loop and loop 4, some of the substrate 
specificity has been transferred to loops 6 and 3 respectively and thereby producing an 
alteration in the overall substrate specificity. 
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Fig 8.4.  Variation in Loops 3 and 4 of the AKRs.  TmAKR shown in greens, with 
loop 3 in light green and loop 4 in dark green.  AKR1A1 shown in blues with loop 3 
in light blue and loop 4 in dark blue.  (Figure produced with PyMol, Delano 
Scientific, USA) 
 
 
8.3 Substrate binding 
The binding of cofactor to the active site partially assembles the substrate binding site, 
and it becomes fully formed upon substrate binding as the substrate binding loops 
enclose around the substrate (Sanli & Blaber 2001, Sotriffer et al., 2004, Couture et 
al., 2005).  The substrate binding loops make a significant contribution towards the 
substrate binding site, and since these are missing in the TmAKR structures it is hard 
to predict which loop residues interact with the substrate.  In hydroxysteroid 
dehydrogenases the steroid substrate is either bound pointing directly upwards away 
from the active site or lying across the top of the catalytic tyrosine (Fig 8.5).  In the 
TmAKR structure there is space for the phenyl ring of the substrate to bind near to the 
catalytic tyrosine and Phe87/Trp97 (Site B in Fig 8.6), a space analogous to epi-
testosterone binding shown in Fig 8.5. 
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Fig 8.5.  Steroid substrate binding in the hydroxysteroid dehydrogenases.  
Testosterone binding in 1q13 shown in green, and epi-testosterone binding in 2ipf 
shown in cyan.  (Figure produced with PyMol, Delano Scientific, USA) 
 
The substrate specificity of TmAKR has been shown to be specific for aldehydes and 
not ketones (Chapter 3).  This presents the prospect of engineering the substrate 
specificity to accept ketones, allowing for the production of secondary alcohols.  
There are many methods available to engineer an enzymes activity, these can broadly 
be separated into rational design and directed evolution.  Rational design requires 
knowledge of the three dimensional structure of the protein of interest either in the 
form of an X-ray or NMR structure, or a homology model, we also need to be able to 
make accurate predictions of the mutation effects which is not always easy.  In the 
case of TmAKR we lack information on the mode of substrate binding, which 
decreases the chances of success with rational design. 
Directed evolution can be a very efficient method to engineer an enzymes properties.  
However an efficient screening/selection method is required to allow easy 
identification of positive mutants (Bershtein & Tawfik, 2008).  Selection methods rely 
on the presence of a relevant auxotrophic strain to allow genetic complementation 
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with positive mutants (Boersma et. al., 2007), but allows larger library sizes to be 
screened (up to 10
13
 variants) compared to selection methods (≈104 variants) (Cipolla 
2004).  If screening is to be employed an efficient assay is required to allow analysis 
of every mutant, and is often the rate limiting step in the evolution experiment. 
Error prone PCR (epPCR) is often performed as an initial step during directed 
evolution.  epPCR uses non-optimal conditions to amplify the gene of interest and 
introduce mutations at a set frequency.  The drawback of epPCR is the screening 
effort which is required, for an enzyme the size of TmAKR (333 aa‟s) with a 
frequency of one amino acid change per mutant, there are 6327 possible mutants, if 
the frequency is increased to two or three mutations then the possible number of 
mutants rises to 16 million or 30 billion respectively (Arnold & Georgiou, 2003), 
representing an unrealistic screening effort.  In reality however it is not possible to 
generate all these mutants, due to the bias introduced from the genetic code (Wong et 
al., 2006).  Despite these drawbacks, epPCR is an effective method for directed 
evolution as it allows exploration of sequence space across the whole gene and 
identification of hot spots which can be exploited in further rounds of directed 
evolution. 
Saturation mutagenesis may be carried out at these identified hot spots or at 
predetermined sites from the structural information available.  Combinatorial active-
site saturation testing (CASTing) randomises two or three amino acids adjacent to the 
active site in combination (Clouthier et al., 2006, Reetz et al., 2007).  In this way we 
are able to identify mutations which are additive in nature and combinations which 
would otherwise be missed from epPCR.  Using a CASTing approach the screening 
effort is greatly reduced since only two or three amino acids are focused upon rather 
than the whole protein.  Iterative saturation mutagenesis (ISM) builds upon the 
concept of CASTing (Reetz and Carballeira, 2007).  Sites are identified in much the 
same way as for CASTing and subjected to saturation mutagenesis; the method varies 
by identifying multiple sites and creating a library individually for each site.  The 
most successful mutant from the first round across all sites/libraries is identified for 
use in the next round.  During further rounds the remaining sites are again subjected 
to saturation mutagenesis, allowing for identification of new mutants with additive 
effects.  The effectiveness of this method has been demonstrated by the case of 
Aspergillus niger epoxide hydrolase where the enantioselectivity was increased 25-
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fold from screening 20,000 clones (Reetz et al., 2006), where as screening a similar 
number of clones from epPCR produced a 2.5-fold enhancement (Reetz, et al., 2005). 
CASTing and ISM have the potential to enable the engineering of the TmAKR 
activity to allow it to accept ketone substrates and also produce an enzyme with high 
enantioselectivity (Reetz, 2004).  Sites within the TmAKR active site have been 
identified (Fig 8.6) which could be the subject of an ISM experiment.  Glutamate 227 
occupies a position within the active site analogous to the binding site of the substrate 
carbonyl and has been used as the centre of the active site for the purpose of 
identifying relevant ISM sites.  Target residues have been identified based on 
proximity to Glu227, and grouped into seven sites (Table 8.1).  Those residues which 
are part of the catalytic tetrad or have an important role in cofactor binding have been 
excluded from these groups as they would be expected to reduce or remove all 
catalytic activity. 
 
A
C
B
E
D
F
G
 
Fig 8.6.  Sites identified for iterative saturation mutagenesis (ISM).  Essential catalytic 
and cofactor binding residues excluded from ISM are shown in black.  Glu227 
occupying the site of substrate binding shown in grey.  (Figure produced with PyMol, 
Delano Scientific, USA) 
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Site A B C D E F G 
Residues Thr55 Phe87 Cys159 Gln179 Ser208 Ile281 Met23 
 Ala56 Trp97 Gln160 Tyr180    
 Val58   Glu181    
Table 8.1.  Summary of sites identified for iterative saturation mutagenesis. 
 
Possibly the best approach to take with the directed evolution of TmAKR to achieve 
activity towards ketones may be a combination approach of epPCR followed by ISM.  
Despite the drawbacks of epPCR it is often used effectively as a first step in a directed 
evolution process.  This is because residues are sampled across the whole sequence 
and may identify residues not considered during ISM.  The success of epPCR can also 
be attributed to long range effects (Reetz, 2002 & Bocola et al., 2004), which may 
produce effects which may not be predictable.  In this way epPCR may be able to 
identify mutations in TmAKR which are able to introduce activity towards ketones.  
Once mutations which are capable of altering the activity towards ketones have been 
identified, then ISM may be used to further explore these newly identified sites and 
those previously identified around the active site (Fig 8.6).  In this way the desired 
activity may be induced during epPCR, followed by optimisation of the activity and 
chiral specificity enabling the producing of two evolved enzymes with opposite 
enantioselectivities.  
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Appendix 1. ExPASy output for TmAKR 
 
 
Number of amino acids: 333 
 
Molecular weight: 37538.2 
 
Theoretical pI: 5.56 
 
Amino acid composition:  
Ala (A) 22 6.6% 
Arg (R) 21 6.3% 
Asn  (N) 10 3.0% 
Asp  (D)  10 3.0% 
Cys  (C) 4 1.2% 
Gln  (Q) 7 2.1% 
Glu  (E) 43 2.9% 
Gly  (G)  29 8.7% 
His  (H) 5 1.5% 
Ile  (I)   23  6.9% 
Leu  (L)  33 9.9% 
Lys  (K)  25 7.5% 
Met  (M)  7 2.1% 
Phe  (F) 12 3.6% 
Pro  (P) 20 6.0% 
Ser  (S) 14 4.2% 
Thr  (T) 13 3.9% 
Trp  (W) 5 1.5% 
Tyr  (Y) 9 2.7% 
Val  (V) 21 6.3% 
 
Total number of negatively charged residues (Asp + Glu): 53 
Total number of positively charged residues (Arg + Lys): 46 
 
Extinction coefficients: 
Extinction coefficients are in units of M
-1
 cm
-1
, at 280 nm measured in water. 
 
Ext. coefficient    41160 
Abs 0.1% (=1 g/l)   1.096, assuming ALL Cys residues appear as half cystines 
 
Ext. coefficient    40910 
Abs 0.1% (=1 g/l)   1.090, assuming NO Cys residues appear as half cystines 
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Appendix 2.  Gel Filtration Calibration Curve 
 
 
 
Superdex 200 Calibration
y = -0.3804x + 2.3045
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Calibration curve for Superdex200 gel filtration column. 
 
Ribonuclease 
13.7kDa 
Chymotrypsinogen 
25kDa 
Ovalbumin 
45kDa 
Albumin 
67kDa 
Aldolase 
158kDa 
Catalase 
250kDa 
Ferritin 
474kDa 
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Appendix 3. Substrate structures 
O
1,2,3,6-tetrahydrobenzaldehyde
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Appendix 4. Crystallisation screen contents 
 
MDL Structure Screen 1 
 Additive Buffer Precipitant 
 1 0.02M Calcium chloride dihydrate 0.1M Na Acetate trihydrate pH 4.6 30% v/v 2-methyl-2,4 pentanediol 
2 0.2M Ammonium acetate 0.1M Na Acetate trihydrate pH 4.6 30% w/v PEG 4000 
3 0.2M Ammonium sulfate  0.1M Na acetate trihydrate pH 4.6 25% w/v PEG 4000 
4 None  0.1M Na acetate trihydrate pH 4.6  2.0M Sodium formate 
5 None  0.1M Na acetate trihydrate pH 4.6 2.0M Ammonium sulfate 
6 None  0.1M Na acetate trihydrate pH 4.6 8% w/v PEG 4000  
7 0.2M Ammonium acetate 0.1M tri-sodium citrate dihydrate pH 5.6 30% w/v PEG 4000 
8 0.2M Ammonium acetate  0.1M tri-sodium citrate dihydrate pH 5.6 30% v/v 2-methyl-2,4-pentanediol 
9 None  0.1M tri-Sodium citrate dihydrate pH 5.6 20% w/v 2-propanol, 20% w/v PEG 4000 
10 None  0.1M Na Citrate pH 5.6 1.0M Ammonium dihydrogen phosphate 
11 0.2M Calcium chloride dihydrate 0.1M Na acetate trihydrate pH 4.6 20% v/v 2-propanol 
12 None 0.1M Na Cacodylate pH 6.5 1.4M Na acetate trihydrate 
13 0.2M tri-sodium citrate dihydrate 0.1M Na Cacodylate pH 6.5 30% v/v 2-propanol 
14 0.2M Ammoniium sulfate  0.1M Na Cacodylate pH 6.5 30% w/v PEG 8000 
15 0.2M Magnesium acetate 
tetrahydrate 
0.1M Na Cacodylate pH 6.5 20% PEG 8000 
16 0.2M Magnesium acetate 
tetrahydrate  
0.1M Na Cacodylate pH 6.5 30% v/v 2-methyl-2,4-pentanediol 
17 None 0.1M Imidazole pH 6.5 1.0M Sodium acetate trihydrate 
18 0.2M Sodium acetate trihydrate 0.1M Na Cacodylate pH 6.5 30% w/v PEG 8000 
19 0.2M Zinc acetate dihydrate  0.1M Na Cacodylate pH 6.5 18% w/v PEG 8000 
20 0.2M Calcium acetate hydrate 0.1M Na Cacodylate pH 6.5 18% w/v PEG 8000 
21 0.2M tri-sodium citrate dihydrate 0.1M Na Hepes pH 7.5 30% v/v 2-methyl-2,4-pentanediol 
22 0.2M Magnesium chloride 
hexahydrate 
0.1M Na Hepes pH 7.5 30% v/v 2-propanol 
23 0.2M Calcium chloride dihydrate 0.1M Na Hepes pH 7.5  28% v/v PEG 400 
24 0.2M Magnesium chloride 
hexahydrate  
0.1M Na Hepes pH 7.5 30% v/v PEG 400 
25 0.2M tri-sodium citrate dihydrate  0.1M Na Hepes pH 7.5 20% v/v 2-propanol 
26 None  0.1M Na Hepes pH 7.5 0.8M K, Na tartrate tetrahydrate 
27 None 0.1M Na Hepes pH 7.5 1.5M Lithium sulfate monohydrate 
28 None 0.1M Na Hepes pH 7.5 0.8M Na dihydrogen phosphate 
29 None  0.1M Na Hepes pH 7.5  1.4M tri-Sodium citrate dihydrate 
30 None  0.1M Na Hepes pH 7.5  2% v/v PEG 400, 2.0M Amm sulfate 
31 None  0.1M Na Hepes pH 7.5 10% v/v 2-propanol, 20% w/v PEG 4000 
32 None 0.1M Tris-HCl pH 8.5 2.0M Ammoniium sulfate 
33 0.2M Magnesium chloride 
hexahydrate 
0.1M Tris-HCl pH 8.5 30% w/v PEG 4000 
34 0.2M tri-sodum citrate dihydrate 0.1M Tris-HCl pH 8.5 30% v/v PEG 400 
35 0.2M Lithium sulfate monohydrate 0.1M Tris-HCl pH 8.5 30% w/v PEG 4000 
36 0.2M Ammonium acetate 0.1M Tris-HCl pH 8.5 30% v/v 2-propanol 
37 0.2M Sodium acetate trihydrate  0.1M Tris-HCl pH 8.5 30% w/v PEG 4000 
38 None  0.1M Tris-HCl pH 8.5 8% w/v PEG 8000 
39 None  0.1M Tris-HCl pH 8.5 2.0M Ammonium dihydrogen phosphate 
40 None None 0.4M K, Na Tartrate tetrahydrate 
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41 None  None 0.4M Ammonium dihydrogen phosphate 
42 0.2M Ammonium sulfate None  30% w/v PEG 8000 
43 0.2M Ammonium sulfate  None  30% w/v PEG 4000 
44 None  None  2.0M Ammonium sulfate 
45 None  None  4.0M Sodium formate 
46 0.05M Potassium dihydrogen 
phosphate 
None 20% w/v PEG 8000 
47 None  None 30% w/v PEG 1500 
48 None  None  0.2M Magnesium formate 
49 1.0M Lithium sulfate monohydrate None 2% w/v PEG 8000 
50 0.5M Lithium sulfate monohydrate None 15% w/v PEG 8000 
Components of crystallisation screen solutions in Structure Screen 1 (Molecular 
Dimensions Ltd) 
 
 
 
 
MDL Structure Screen 2 
  Additive Buffer Precipitant 
1 0.1M Sodium chloride 0.1M Bicine pH 9.0 30% w/v PEG monomethylether 550 
2 None  0.1M Bicine pH 9.0 2.0M Magnesium chloride hexahydrate 
3 2% w/v Dioxane 0.1M Bicine pH 9.0 10% w/v PEG 20,000  
4 0.2M Magnesium chloride hexahydrate 0.1M Tris pH 8.5 3.4M 1,6 Hexanediol 
5 None 0.1M Tris pH 8.5 25% v/v tert-Butanol 
6 0.01M Nickel chloride hexahydrate 0.1M Tris pH 8.5 1.0M Lithium sulfate 
7 1.5M Ammonium sulfate 0.1M Tris pH 8.5 12% v/v Glycerol 
8 0.2M Ammonium phosphate monobasic 0.1M Tris pH 8.5 50% v/v MPD 
9 None  0.1M Tris pH 8.5 20% v/v Ethanol 
10 0.01M Nickel chloride hexahydrate 0.1M Tris pH 8.5 20% w/v PEG monomethylether 2000 
11 0.5M Ammonium sulfate 0.1M Hepes pH 7.5 30% v/v MPD 
12 None  0.1M Hepes pH 7.5 10% w/v PEG 6000, 5% v/v MPD 
13 None  0.1M Hepes pH 7.5 20% v/v Jeffamine M-600 
14 0.1M Sodium chloride 0.1M Hepes pH 7.5 1.6M Ammonium sulfate 
15 None 0.1M Hepes pH 7.5 2.0M Ammonium formate 
16 0.05M Cadmium sulfate octahydrate 0.1M Hepes pH 7.5 1.0M Sodium acetate 
17 None 0.1M Hepes pH 7.5 70% v/v MPD 
18 None 0.1M Hepes pH 7.5 4.3M Sodium chloride 
19 None 0.1M Hepes pH 7.5 10% w/v PEG 8000 
20 None 0.1M MES pH 6.5 1.6M Magnesium sulfate heptahydrate 
21 0.1M Na phosphate monobasic 0.1M MES pH 6.5 2.0M Sodium Chloride 
22 None 0.1M MES pH 6.5 12% w/v PEG 20,000 
23 1.6M Ammonium sulfate 0.1M MES pH 6.5 10% v/v Dioxane 
24 0.05M Cesium chloride 0.1M MES pH 6.5 30% v/v Jeffamine M-600 
25 0.01M Cobalt chloride hexahydrate 0.1M MES pH 6.5 1.8M Ammonium sulfate 
26 0.2M Ammonium sulfate 0.1M MES pH 6.5 30% w/v PEG monomethylether 5000 
27 0.01M Zinc sulfate heptahydrate 0.1M MES pH 6.5 25% v/v PEG monomethylether 550 
28 None 0.1M Hepes pH 7.5 20% w/v PEG 10,000 
29 0.2M K/Na Tartrate 0.1M Sodium citrate pH 5.6 2.0M Ammonium sulfate 
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30 0.5M Ammonium sulfate 0.1M Sodium citrate pH 5.6 1.0M Lithium sulfate 
31 0.5M Sodium chloride 0.1M Sodium citrate pH 5.6 4% v/v polyethyleneimine 
32 None 0.1M Sodium citrate pH 5.6 35% v/v tert-butanol 
33 0.01M Ferric chloride hexahydrate 0.1M Sodium citrate pH 5.6 10% v/v Jeffamine M-600 
34 0.01M Manganese chloride tetrahydrate 0.1M Sodium citrate pH 5.6 2.5M 1,6 Hexanediol 
35 None  0.1M Sodium acetate pH 4.6 2.0M Sodium chloride 
36 0.2M Sodium Chloride 0.1M Sodium acetate pH 4.6 30% v/v MPD 
37 0.01M Cobalt Chloride hexahydrate 0.1M Sodium acetate pH 4.6 1.0M 1,6 Hexanediol 
38 0.1M Cadmium chloride 0.1M Sodium acetate pH 4.6 30% v/v PEG 400 
39 0.2M Ammonium sulfate 0.1M Sodium acetate pH 4.6 30% w/v PEG monomethylether 2000 
40 2.0M Sodium Chloride None 10% w/v PEG 6000 
41 0.01M Cetyl trimethyl ammoniumbromide None 0.5M Sodium chloride 
0.1M Magnesium chloride hexahydrate 
42 None  None 25% v/v Ethylene glycol 
43 None  None 35% v/v Dioxane 
44 2.0M Ammonium Sulfate None 5% v/v Isopropanol 
45 None  None  1.0M Imidazole pH 7.0 
46 None None 10% w/v PEG 1000, 10% w/v PEG 8000 
47 1.5M Sodium Chloride None 10% v/v Ethanol 
48 None None 1.6M Sodium citrate pH 6.5 
49 15% w/v Polyvinylpyrolidone None None 
50 2.0M Urea None None 
Components of crystallisation screen solutions in Structure Screen 2 (Molecular 
Dimensions Ltd) 
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pHclear I 
No. Buffer  Precipitant  pH   No. Buffer  Precipitant  pH 
1 0.1 M Citric acid  1.0 M NaCl 4.0   49 0.1 M Citric acid  0.8 M NH4SO4 4.0 
2 0.1 M Citric acid  1.0 M NaCl 5.0   50 0.1 M Citric acid  0.8 M NH4SO4 5.0 
3 0.1 M MES 1.0 M NaCl 6.0   51 0.1 M MES 0.8 M NH4SO4 6.0 
4 0.1 M HEPES 1.0 M NaCl 7.0   52 0.1 M HEPES 0.8 M NH4SO4 7.0 
5 0.1 M TRIS 1.0 M NaCl 8.0   53 0.1 M TRIS 0.8 M NH4SO4 8.0 
6 0.1 M BICINE 1.0 M NaCl 9.0   54 0.1 M BICINE 0.8 M NH4SO4 9.0 
7 0.1 M Citric acid  2.0 M NaCl 4.0   55 0.1 M Citric acid  1.6 M NH4SO4 4.0 
8 0.1 M Citric acid  2.0 M NaCl 5.0   56 0.1 M Citric acid  1.6 M NH4SO4 5.0 
9 0.1 M MES 2.0 M NaCl 6.0   57 0.1 M MES 1.6 M NH4SO4 6.0 
10 0.1 M HEPES 2.0 M NaCl 7.0   58 0.1 M HEPES 1.6 M NH4SO4 7.0 
11 0.1 M TRIS 2.0 M NaCl 8.0   59 0.1 M TRIS 1.6 M NH4SO4 8.0 
12 0.1 M BICINE 2.0 M NaCl 9.0   60 0.1 M BICINE 1.6 M NH4SO4 9.0 
13 0.1 M Citric acid  3.0 M NaCl 4.0   61 0.1 M Citric acid  2.4 M NH4SO4 4.0 
14 0.1 M Citric acid  3.0 M NaCl 5.0   62 0.1 M Citric acid  2.4 M NH4SO4 5.0 
15 0.1 M MES 3.0 M NaCl 6.0   63 0.1 M MES 2.4 M NH4SO4 6.0 
16 0.1 M HEPES 3.0 M NaCl 7.0   64 0.1 M HEPES 2.4 M NH4SO4 7.0 
17 0.1 M TRIS 3.0 M NaCl 8.0   65 0.1 M TRIS 2.4 M NH4SO4 8.0 
18 0.1 M BICINE 3.0 M NaCl 9.0   66 0.1 M BICINE 2.4 M NH4SO4 9.0 
19 0.1 M Citric acid  4.0 M NaCl 4.0   67 0.1 M Citric acid  3.2 M NH4SO4 4.0 
20 0.1 M Citric acid  4.0 M NaCl 5.0   68 0.1 M Citric acid  3.2 M NH4SO4 5.0 
21 0.1 M MES 4.0 M NaCl 6.0   69 0.1 M MES 3.2 M NH4SO4 6.0 
22 0.1 M HEPES 4.0 M NaCl 7.0   70 0.1 M HEPES 3.2 M NH4SO4 7.0 
23 0.1 M TRIS 4.0 M NaCl 8.0   71 0.1 M TRIS 3.2 M NH4SO4 8.0 
24 0.1 M BICINE 4.0 M NaCl 9.0   72 0.1 M BICINE 3.2 M NH4SO4 9.0 
25 0.1 M Citric acid  5 %(w/v) PEG 6000 4.0   73 0.1 M Citric acid  10 %(v/v) MPD 4.0 
26 0.1 M Citric acid  5 %(w/v) PEG 6000 5.0   74 0.1 M Sodium acetate  10 %(v/v) MPD 5.0 
27 0.1 M MES 5 %(w/v) PEG 6000 6.0   75 0.1 M MES 10 %(v/v) MPD 6.0 
28 0.1 M HEPES 5 %(w/v) PEG 6000 7.0   76 0.1 M HEPES 10 %(v/v) MPD 7.0 
29 0.1 M TRIS 5 %(w/v) PEG 6000 8.0   77 0.1 M TRIS 10 %(v/v) MPD 8.0 
30 0.1 M BICINE 5 %(w/v) PEG 6000 9.0   78 0.1 M BICINE 10 %(v/v) MPD 9.0 
31 0.1 M Citric acid  10 %(w/v) PEG 6000 4.0   79 0.1 M Citric acid  20 %(v/v) MPD 4.0 
32 0.1 M Citric acid  10 %(w/v) PEG 6000 5.0   80 0.1 M Sodium acetate  20 %(v/v) MPD 5.0 
33 0.1 M MES 10 %(w/v) PEG 6000 6.0   81 0.1 M MES 20 %(v/v) MPD 6.0 
34 0.1 M HEPES 10 %(w/v) PEG 6000 7.0   82 0.1 M HEPES 20 %(v/v) MPD 7.0 
35 0.1 M TRIS 10 %(w/v) PEG 6000 8.0   83 0.1 M TRIS 20 %(v/v) MPD 8.0 
36 0.1 M BICINE 10 %(w/v) PEG 6000 9.0   84 0.1 M BICINE 20 %(v/v) MPD 9.0 
37 0.1 M Citric acid  20 %(w/v) PEG 6000 4.0   85 0.1 M Citric acid  40 %(v/v) MPD 4.0 
38 0.1 M Citric acid  20 %(w/v) PEG 6000 5.0   86 0.1 M Sodium acetate  40 %(v/v) MPD 5.0 
39 0.1 M MES 20 %(w/v) PEG 6000 6.0   87 0.1 M MES 40 %(v/v) MPD 6.0 
40 0.1 M HEPES 20 %(w/v) PEG 6000 7.0   88 0.1 M HEPES 40 %(v/v) MPD 7.0 
41 0.1 M TRIS 20 %(w/v) PEG 6000 8.0   89 0.1 M TRIS 40 %(v/v) MPD 8.0 
42 0.1 M BICINE 20 %(w/v) PEG 6000 9.0   90 0.1 M BICINE 40 %(v/v) MPD 9.0 
43 0.1 M Citric acid  30 %(w/v) PEG 6000 4.0   91 0.1 M Citric acid  65 %(v/v) MPD 4.0 
44 0.1 M Citric acid  30 %(w/v) PEG 6000 5.0   92 0.1 M Sodium acetate  65 %(v/v) MPD 5.0 
45 0.1 M MES 30 %(w/v) PEG 6000 6.0   93 0.1 M MES 65 %(v/v) MPD 6.0 
46 0.1 M HEPES 30 %(w/v) PEG 6000 7.0   94 0.1 M HEPES 65 %(v/v) MPD 7.0 
47 0.1 M TRIS 30 %(w/v) PEG 6000 8.0   95 0.1 M TRIS 65 %(v/v) MPD 8.0 
48 0.1 M BICINE  30 %(w/v) PEG 6000 9.0 
  
96 0.1 M BICINE  65 %(v/v) MPD 9.0 
Components of crystallisation screen solutions in pHclear I (Qiagen) 
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pHclear II 
No. Salt Buffer  Precipitant  pH    No. Salt Buffer  Precipitant  pH  
1 1.0 M LiCl 0.1 M Citric acid    4.0   49     0.8 M Na/K phosphate 5.0 
2 1.0 M LiCl 0.1 M Citric acid    5.0   50     0.8 M Na/K phosphate 5.6 
3 1.0 M LiCl 0.1 M MES   6.0   51     0.8 M Na/K phosphate 6.3 
4 1.0 M LiCl 0.1 M HEPES   7.0   52     0.8 M Na/K phosphate 6.9 
5 1.0 M LiCl 0.1 M TRIS   8.0   53     0.8 M Na/K phosphate 7.5 
6 1.0 M LiCl 0.1 M BICINE   9.0   54     0.8 M Na/K phosphate 8.2 
7 1.0 M LiCl 0.1 M Citric acid  10 %(w/v) PEG 6000 4.0   55     1.0 M Na/K phosphate 5.0 
8 1.0 M LiCl 0.1 M Citric acid  10 %(w/v) PEG 6000 5.0   56     1.0 M Na/K phosphate 5.6 
9 1.0 M LiCl 0.1 M MES 10 %(w/v) PEG 6000 6.0   57     1.0 M Na/K phosphate 6.3 
10 1.0 M LiCl 0.1 M HEPES 10 %(w/v) PEG 6000 7.0   58     1.0 M Na/K phosphate 6.9 
11 1.0 M LiCl 0.1 M TRIS 10 %(w/v) PEG 6000 8.0   59     1.0 M Na/K phosphate 7.5 
12 1.0 M LiCl 0.1 M BICINE 10 %(w/v) PEG 6000 9.0   60     1.0 M Na/K phosphate 8.2 
13 1.0 M LiCl 0.1 M Citric acid  20 %(w/v) PEG 6000 4.0   61     1.4 M Na/K phosphate 5.0 
14 1.0 M LiCl 0.1 M Citric acid  20 %(w/v) PEG 6000 5.0   62     1.4 M Na/K phosphate 5.6 
15 1.0 M LiCl 0.1 M MES 20 %(w/v) PEG 6000 6.0   63     1.4 M Na/K phosphate 6.3 
16 1.0 M LiCl 0.1 M HEPES 20 %(w/v) PEG 6000 7.0   64     1.4 M Na/K phosphate 6.9 
17 1.0 M LiCl 0.1 M TRIS 20 %(w/v) PEG 6000 8.0   65     1.4 M Na/K phosphate 7.5 
18 1.0 M LiCl 0.1 M BICINE 20 %(w/v) PEG 6000 9.0   66     1.4 M Na/K phosphate 8.2 
19 1.0 M LiCl 0.1 M Citric acid  30 %(w/v) PEG 6000 4.0   67     1.8 M Na/K phosphate 5.0 
20 1.0 M LiCl 0.1 M Citric acid  30 %(w/v) PEG 6000 5.0   68     1.8 M Na/K phosphate 5.6 
21 1.0 M LiCl 0.1 M MES 30 %(w/v) PEG 6000 6.0   69     1.8 M Na/K phosphate 6.3 
22 1.0 M LiCl 0.1 M HEPES 30 %(w/v) PEG 6000 7.0   70     1.8 M Na/K phosphate 6.9 
23 1.0 M LiCl 0.1 M TRIS 30 %(w/v) PEG 6000 8.0   71     1.8 M Na/K phosphate 7.5 
24 1.0 M LiCl 0.1 M BICINE 30 %(w/v) PEG 6000 9.0   72     1.8 M Na/K phosphate 8.2 
25   0.1 M Citric acid  5 %(v/v) Isopropanol 4.0   73     1.0 M Sodium malonate 4.0 
26   0.1 M Citric acid  5 %(v/v) Isopropanol 5.0   74     1.5 M Sodium malonate 4.0 
27   0.1 M MES 5 %(v/v) Isopropanol 6.0   75     1.9 M Sodium malonate 4.0 
28   0.1 M HEPES 5 %(v/v) Isopropanol 7.0   76     2.4 M Sodium malonate 4.0 
29   0.1 M TRIS 5 %(v/v) Isopropanol 8.0   77     2.9 M Sodium malonate 4.0 
30   0.1 M BICINE 5 %(v/v) Isopropanol 9.0   78     3.4 M Sodium malonate 4.0 
31   0.1 M Citric acid  10 %(v/v) Isopropanol 4.0   79     1.0 M Sodium malonate 5.0 
32   0.1 M Citric acid  10 %(v/v) Isopropanol 5.0   80     1.5 M Sodium malonate 5.0 
33   0.1 M MES 10 %(v/v) Isopropanol 6.0   81     1.9 M Sodium malonate 5.0 
34   0.1 M HEPES 10 %(v/v) Isopropanol 7.0   82     2.4 M Sodium malonate 5.0 
35   0.1 M TRIS 10 %(v/v) Isopropanol 8.0   83     2.9 M Sodium malonate 5.0 
36   0.1 M BICINE 10 %(v/v) Isopropanol 9.0   84     3.4 M Sodium malonate 5.0 
37   0.1 M Citric acid  20 %(v/v) Isopropanol 4.0   85     1.0 M Sodium malonate 6.0 
38   0.1 M Citric acid  20 %(v/v) Isopropanol 5.0   86     1.5 M Sodium malonate 6.0 
39   0.1 M MES 20 %(v/v) Isopropanol 6.0   87     1.9 M Sodium malonate 6.0 
40   0.1 M HEPES 20 %(v/v) Isopropanol 7.0   88     2.4 M Sodium malonate 6.0 
41   0.1 M TRIS 20 %(v/v) Isopropanol 8.0   89     2.9 M Sodium malonate 6.0 
42   0.1 M BICINE 20 %(v/v) Isopropanol 9.0   90     3.4 M Sodium malonate 6.0 
43   0.1 M Citric acid  30 %(v/v) Isopropanol 4.0   91     1.0 M Sodium malonate 7.0 
44   0.1 M Citric acid  30 %(v/v) Isopropanol 5.0   92     1.5 M Sodium malonate 7.0 
45   0.1 M MES 30 %(v/v) Isopropanol 6.0   93     1.9 M Sodium malonate 7.0 
46   0.1 M HEPES 30 %(v/v) Isopropanol 7.0   94     2.4 M Sodium malonate 7.0 
47   0.1 M TRIS 30 %(v/v) Isopropanol 8.0   95     2.9 M Sodium malonate 7.0 
48   0.1 M BICINE 30 %(v/v) Isopropanol 9.0 
  
96     3.4 M Sodium malonate 7.0 
Components of crystallisation screen solutions in pHclear II (Qiagen) 
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PEG Screen I 
No. Salt Buffer  Precipitant  
1   0.1 M Sodium acetate pH 4.6 40 %(v/v) PEG 200 
2   0.1 M Sodium acetate pH 4.6 30 %(v/v) PEG 300 
3   0.1 M Sodium acetate pH 4.6 30 %(v/v) PEG 400 
4   0.1 M Sodium acetate pH 4.6 25 %(v/v) PEG 550 MME 
5   0.1 M Sodium acetate pH 4.6 25 %(w/v) PEG 1000 
6   0.1 M Sodium acetate pH 4.6 25 %(w/v) PEG 2000 MME 
7   0.1 M MES pH 6.5 40 %(v/v) PEG 200 
8   0.1 M MES pH 6.5 30 %(v/v) PEG 300 
9   0.1 M MES pH 6.5 30 %(v/v) PEG 400 
10   0.1 M MES pH 6.5 25 %(v/v) PEG 550 MME 
11   0.1 M MES pH 6.5 25 %(w/v) PEG 1000 
12   0.1 M MES pH 6.5 25 %(w/v) PEG 2000 MME 
13   0.1 M HEPES pH 7.5 40 %(v/v) PEG 200 
14   0.1 M HEPES pH 7.5 30 %(v/v) PEG 300 
15   0.1 M HEPES pH 7.5 30 %(v/v) PEG 400 
16   0.1 M HEPES pH 7.5 25 %(v/v) PEG 550 MME 
17   0.1 M HEPES pH 7.5 25 %(w/v) PEG 1000 
18   0.1 M HEPES pH 7.5 25 %(w/v) PEG 2000 MME 
19   0.1 M TRIS.HCl pH 8.5 40 %(v/v) PEG 200 
20   0.1 M TRIS.HCl pH 8.5 30 %(v/v) PEG 300 
21   0.1 M TRIS.HCl pH 8.5 30 %(v/v) PEG 400 
22   0.1 M TRIS.HCl pH 8.5 25 %(v/v) PEG 550 MME 
23   0.1 M TRIS.HCl pH 8.5 25 %(w/v) PEG 1000 
24   0.1 M TRIS.HCl pH 8.5 25 %(w/v) PEG 2000 MME 
25   0.1 M Sodium acetate pH 4.6 25 %(w/v) PEG 3000 
26   0.1 M Sodium acetate pH 4.6 25 %(w/v) PEG 4000 
27   0.1 M Sodium acetate pH 4.6 25 %(w/v) PEG 6000 
28   0.1 M Sodium acetate pH 4.6 25 %(w/v) PEG 8000 
29   0.1 M Sodium acetate pH 4.6 20 %(w/v) PEG 10000 
30   0.1 M Sodium acetate pH 4.6 15 %(w/v) PEG 20000 
31   0.1 M MES pH 6.5 25 %(w/v) PEG 3000 
32   0.1 M MES pH 6.5 25 %(w/v) PEG 4000 
33   0.1 M MES pH 6.5 25 %(w/v) PEG 6000 
34   0.1 M MES pH 6.5 25 %(w/v) PEG 8000 
35   0.1 M MES pH 6.5 20 %(w/v) PEG 10000 
36   0.1 M MES pH 6.5 15 %(w/v) PEG 20000 
37   0.1 M HEPES pH 7.5 25 %(w/v) PEG 3000 
38   0.1 M HEPES pH 7.5 25 %(w/v) PEG 4000 
39   0.1 M HEPES pH 7.5 25 %(w/v) PEG 6000 
40   0.1 M HEPES pH 7.5 25 %(w/v) PEG 8000 
41   0.1 M HEPES pH 7.5 20 %(w/v) PEG 10000 
42   0.1 M HEPES pH 7.5 15 %(w/v) PEG 20000 
43   0.1 M TRIS.HCl pH 8.5 25 %(w/v) PEG 3000 
44   0.1 M TRIS.HCl pH 8.5 25 %(w/v) PEG 4000 
45   0.1 M TRIS.HCl pH 8.5 25 %(w/v) PEG 6000 
46   0.1 M TRIS.HCl pH 8.5 25 %(w/v) PEG 8000 
47   0.1 M TRIS.HCl pH 8.5 20 %(w/v) PEG 10000 
48   0.1 M TRIS.HCl pH 8.5 15 %(w/v) PEG 20000 
Cont... 
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PEGs Screen I cont... 
No. Salt Buffer  Precipitant  
49 0.2 M Sodium fluoride   20 %(w/v) PEG 3350 
50 0.2 M Potassium fluoride   20 %(w/v) PEG 3350 
51 0.2 M Ammonium fluoride   20 %(w/v) PEG 3350 
52 0.2 M Lithium chloride   20 %(w/v) PEG 3350 
53 0.2 M Magnesium chloride   20 %(w/v) PEG 3350 
54 0.2 M Sodium chloride   20 %(w/v) PEG 3350 
55 0.2 M Calcium chloride   20 %(w/v) PEG 3350 
56 0.2 M Potassium chloride   20 %(w/v) PEG 3350 
57 0.2 M Ammonium chloride   20 %(w/v) PEG 3350 
58 0.2 M Sodium iodide   20 %(w/v) PEG 3350 
59 0.2 M Potassium iodide   20 %(w/v) PEG 3350 
60 0.2 M Ammonium iodide   20 %(w/v) PEG 3350 
61 0.2 M Sodium thiocyanate   20 %(w/v) PEG 3350 
62 0.2 M Potassium thiocyanate   20 %(w/v) PEG 3350 
63 0.2 M Lithium nitrate   20 %(w/v) PEG 3350 
64 0.2 M Magnesium nitrate   20 %(w/v) PEG 3350 
65 0.2 M Sodium nitrate   20 %(w/v) PEG 3350 
66 0.2 M Potassium nitrate   20 %(w/v) PEG 3350 
67 0.2 M Ammonium nitrate   20 %(w/v) PEG 3350 
68 0.2 M Magnesium formate   20 %(w/v) PEG 3350 
69 0.2 M Sodium formate   20 %(w/v) PEG 3350 
70 0.2 M Potassium formate   20 %(w/v) PEG 3350 
71 0.2 M Ammonium formate   20 %(w/v) PEG 3350 
72 0.2 M Lithium acetate   20 %(w/v) PEG 3350 
73 0.2 M Magnesium acetate   20 %(w/v) PEG 3350 
74 0.2 M Zinc acetate   20 %(w/v) PEG 3350 
75 0.2 M Sodium acetate    20 %(w/v) PEG 3350 
76 0.2 M Calcium acetate   20 %(w/v) PEG 3350 
77 0.2 M Potassium acetate   20 %(w/v) PEG 3350 
78 0.2 M Ammonium acetate   20 %(w/v) PEG 3350 
79 0.2 M Lithium sulfate   20 %(w/v) PEG 3350 
80 0.2 M Magnesium sulfate   20 %(w/v) PEG 3350 
81 0.2 M Sodium sulfate   20 %(w/v) PEG 3350 
82 0.2 M Potassium sulfate   20 %(w/v) PEG 3350 
83 0.2 M Ammonium sulfate   20 %(w/v) PEG 3350 
84 0.2 M di-Sodium tartate   20 %(w/v) PEG 3350 
85 0.2 M K/Na tartrate   20 %(w/v) PEG 3350 
86 0.2 M di-Ammonium tartrate   20 %(w/v) PEG 3350 
87 0.2 M Sodium phosphate    20 %(w/v) PEG 3350 
88 0.2 M di-Sodium phosphate   20 %(w/v) PEG 3350 
89 0.2 M Potassium phosphate   20 %(w/v) PEG 3350 
90 0.2 M di-Potassium phosphate   20 %(w/v) PEG 3350 
91 0.2 M Ammonium phosphate   20 %(w/v) PEG 3350 
92 0.2 M di-Ammonium phosphate   20 %(w/v) PEG 3350 
93 0.2 M tri-Lithium citrate   20 %(w/v) PEG 3350 
94 0.2 M tri-Sodium citrate   20 %(w/v) PEG 3350 
95 0.2 M tri-Potassium citrate   20 %(w/v) PEG 3350 
96 0.2 M di-Ammonium citrate   20 %(w/v) PEG 3350 
Components of crystallisation screen solutions in PEGs Screen I (Qiagen) 
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Appendix 5.  TmAKR /1PZ0 Sequence Alignment 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                      10         20         30         40         50 
TmAKR        MGIPKRKLGE RGPEVSAIGL GCMRMS-FGQ KKLPDRKEMI KLIRTAVELG  
1PZ0         --MKKAKLGK SDLQVFPIGL GTNAVGGHNL YPNLNEETGK ELVREAIRNG  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                      60         70         80         90        100 
TmAKR        INFFDTAEVY GPYTNEELVG EALEPFKG-E VVIATKFGFE LYEDGRPGWK  
1PZ0         VTMLDTAYIY GIGRSEELIG EVLREFNRED VVIATKAAHR KQGND----F  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     110        120        130        140        150 
TmAKR        GLNSNPEHIK KAVEGSLRRL RVEAIDILYQ HRVDPNVPIE EVAGAVKELI  
1PZ0         VFDNSPDFLK KSVDESLKRL NTDYIDLFYI HFPDEHTPKD EAVNALNEMK  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     160        170        180        190        200 
TmAKR        EEGKVKHFGL CEASAETIRR AHKVCPVDVV QYEYSMWWRK PEEELLPTCE  
1PZ0         KAGKIRSIGV SNFSLEQLKE ANKDGLVDVL QGEYNLLNRE AEKTFFPYTK  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     210        220        230        240        250 
TmAKR        ELGIGFVAYS PLGKGFLTGA IGENSKFDEE DSRSRIPRFQ KENLRENLAL  
1PZ0         EHNISFIPYF PLVSGLLAGK YTEDTTFPEG DLRNEQEHFK GERFKENIRK  
 
 
             ....|....| ....|....| ....|....| ....|....| ....|....|  
                     260        270        280        290        300 
TmAKR        VELRKTIAER KGATPSQIAL AWLLAQKPWI VPIPGTTKLS HLLENIGGAF  
1PZ0         VNKLAPIAEK HNVDIPHIVL AWYLARPEID ILIPGAKRAD QLIDNIKTAD  
 
 
             ....|....| ....|....| ....|....| ....| 
                     310        320        330  
TmAKR        VELTPEELQE INDALSRIEI KGSRYPEDME KMTYL 
1PZ0         VTLSQEDISF IDKLFAPG-- ---------- ----- 
 
Sequence alignment of TmAKR and 1PZ0, created using Bioedit (Hall et al., 1999) 
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Appendix 6.  Stereochemical quality of final TmAKR model 
- Main chain parameters 
 
 203 
- Side chain parameters (TmAKR) 
  
Stereochemical quality of the final TmAKR model.  Plots created using Procheck 
(Laskowski et al., 1993) 
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Appendix 7.  Stereochemical quality of Bacterioferritin 
model 
- Main chain parameters 
 
 205 
- Side chain parameters (Bacterioferritin) 
 
Stereochemical quality of the final bacterioferritin model.  Plots created using 
Procheck (Laskowski et al., 1993) 
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Appendix 8.  AKR sequence alignment 
                10        20        30        40        50          
       ....|....|....|....|....|....|....|....|....|....| 
TmAKR  -MGIPKRKLGERGPEVSAIGLG-CMRMSFGQKKLPDRKEMIKLIRTAVEL  
1pz0   ---MKKAKLGKSDLQVFPIGLGTNAVGGHNLYPNLNEETGKELVREAIRN  
2alr   --MAASCVLLHTGQKMPLIGLGT---WKSEPGQ------VKAAVKYALSV  
2ao0   --MAASCVLLHTGQKMPLIGLGT---WKSEPGQ------VKAAIKYALTV  
1pz1   ---MEYTSIADTGIEASRIGLGTWAIGG-TMWGGTDEKTSIETIRAALDQ  
1ynp   ---MKKRQLGTSDLHVSELGFGCMSLGTDETKAR-------RIMDEVLEL  
1lqa   ---MQYHRIPHSSLEVSTLGLGTMTFGEQNSEAD-----AHAQLDYAVAQ  
1mzr   -MANPTVIKLQDGNVMPQLGLGV---WQASNEE------VITAIQKALEV  
2he5   MNSKCHCVILNDGNFIPVLGFGTALPLECPKSK------AKELTKIAIDA  
 
        LOOP 1 
 
 
                60        70        80        90       100         
       ....|....|....|....|....|....|....|....|....|....| 
TmAKR  GINFFDTAEVYGPYT-------NEELVGEALEPFK--GEVVIATKFGFEL  
1pz0   GVTMLDTAYIYGIGR-------SEELIGEVLREFN-REDVVIATKAAHRK  
2alr   GYRHIDCAAIYGN----------EPEIGEALKEDVGPGKAVPREELFVTS  
2ao0   GYRHIDCAAIYGN----------ELEIGEALTETVGPGKAVPREELFVTS  
1pz1   GITLIDTAPAYGFGQ-------SEEIVGKAIKEYGKRDQVILATKTALDW  
1ynp   GINYLDTADLYNQGLN-------EQFVGKALKGRR--QDIILATKVGNRF  
1lqa   GINLIDVAEMYPVPPRPETQGLTETYVGNWLAKHGSREKLIIASKVSGPS  
1mzr   GYRSIDTAAAYKN----------EEGVGKALKN-----ASVNREELFITT  
2he5   GFHHFDSASVYNT----------EDHVGEAIRSKIADG-TVRREDIFYTS  
 
   LOOP 2        LOOP 3 
 
 
               110       120       130       140       150     
       ....|....|....|....|....|....|....|....|....|....| 
TmAKR  YEDGRPGWKGLNSNPEHIKKAVEGSLRRLRVEAIDILYQHRVDPNVP---  
1pz0   QGND----FVFDNSPDFLKKSVDESLKRLNTDYIDLFYIHFPDEHTP---  
2alr   KLWN------TKHHPEDVEPALRKTLADLQLEYLDLYLMHWPYAFERGDN  
2ao0   KLWN------TKHHPEDVEPALRKTLADLQLEYLDLYLMHWPYAFERGDN  
1pz1   KNNQ----LFRHANRARIVEEVENSLKRLQTDYIDLYQVHWPDPLVP---  
1ynp   EQGKEG--WWWDPSKAYIKEAVKDSLRRLQTDYIDLYQLHGGTIDDP---  
1lqa   RNNDKGIRPDQALDRKNIREALHDSLKRLQTDYLDLYQVHWPQRPTNCFG  
1mzr   KLWN------DDHK--RPREALLDSLKKLQLDYIDLYLMHWPVPAID---  
2he5   KVWC------TSLHPELVRASLERSLQKLQFDYVDLYLIHYPMALKPGEE  
 
  LOOP 3         LOOP 4 
 
 
               160       170       180       190       200     
       ....|....|....|....|....|....|....|....|....|....| 
TmAKR  ----------------IEEVAGAVKELIEEGKVKHFGLCEASAETIRRAH  
1pz0   ----------------KDEAVNALNEMKKAGKIRSIGVSNFSLEQLKEAN  
2alr   PFPKNADGTICYDSTHYKETWKALEALVAKGLVQALGLSNFNSRQIDDIL  
2ao0   PFPKNADGTIRYDATHYKDTWKALEALVAKGLVRALGLSNFSSRQIDDVL  
1pz1   ----------------IEETAEVMKELYDAGKIRAIGVSNFSIEQMDTFR  
1ynp   ----------------IDETIEAFEELKQEGVIRYYGISSIRPNVIKEYL  
1lqa   KLG--YSWTDSAPAVSLLDTLDALAEYQRAGKIRYIGVSNETAFGVMRYL  
1mzr   ---------------HYVEAWKGMIELQKEGLIKSIGVCNFQIHHLQRLI  
2he5   NFPVDEHGKLIFDRVDLCATWEAMEKCKDAGLTKSIGVSNFNYRQLEMIL  
 
          LOOP 5 
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               210       220       230       240       250     
       ....|....|....|....|....|....|....|....|....|....| 
TmAKR  KVCPVD------VVQYEYSMWWRKPEEELLPTCEELGIGFVAYSPLGKGF  
1pz0   KDGLVD------VLQGEYNLLNREAEKTFFPYTKEHNISFIPYFPLVSGL  
2alr   SVASVR------PAVLQVECHPYLAQNELIAHCQARGLEVTAYSPLGSSD  
2ao0   SVASVR------PAVLQVECHPYLAQNELIAHCQARGLEVTAYSPLGSSD  
1pz1   AVAPLH------TIQPPYNLFEREMEESVLPYAKDNKITTLLYGSLCRGL  
1ynp   KRSNIV------SIMMQYSILDRRPEE-WFPLIQEHGVSVVVRGPVARGL  
1lqa   HLADKHDLPRIVTIQNPYSLLNRSFEVGLAEVSQYEGVELLAYSCLGFGT  
1mzr   DETGVT------PVINQIELHPLMQQRQLHAWNATHKIQTESWSPLAQGG  
2he5   NKPGLKYK----PVCNQVECHPYLNQMKLLDFCKSKDIVLVAYGVLGTQR  
 
      LOOP 6     LOOP 7 
 
 
               260       270       280       290       300     
       ....|....|....|....|....|....|....|....|....|....| 
TmAKR  LTGAIGENSKFDEEDSRSRIPRFQKENLRENLALVELRKTIAERKG--AT  
1pz0   LAGKYTEDTTFPEGDLRNEQEHFKGERFKENIRKVNKLAPIAEKHN--VD  
2alr   R-AWRDPDEPVLLEEP--------------------VVLALAEKYG--RS  
2ao0   R-AWRDPNEPVLLEEP--------------------VVQALAEKYN--RS  
1pz1   LTGKMTEEYTFEGDDLRNHDPKFQKPRFKEYLSAVNQLDKLAKTRYG-KS  
1ynp   LSRRPLPEGEGYLNYR------------------YDELKLLRESLPTDRP  
1lqa   LTGKYLNGAKPAGARN-TLFSRFTRYSGEQTQKAVAAYVDIARRHG--LD  
1mzr   K---------GVFDQK--------------------VIRDLADKYG--KT  
2he5   YGGWVDQNSPVLLDEP--------------------VLGSMAKKYN--RT  
 
  LOOP 7 
 
 
               310       320       330       340       350     
       ....|....|....|....|....|....|....|....|....|....| 
TmAKR  PSQIALAWLLAQKPWIVPIPGTTKLSHLLENIGGAFVE-LTPEELQEIND  
1pz0   IPHIVLAWYLARPEIDILIPGAKRADQLIDNIKTADVT-LSQEDISFIDK  
2alr   PAQILLRWQVQRK--VICIPKSITPSRILQNIKVFDFT-FSPEEMKQLNA  
2ao0   PAQILLRWQVQRK--VICIPKSVTPSRIPQNIQVFDFT-FSPEEMKQLDA  
1pz1   VIHLAVRWILDQPGADIALWGARKPGQLEALSEITGWT-LNSEDQKDINT  
1ynp   LHELALQYCLAHDVVATVAAGASSIDQVKANVQAVEATPLTAEERQHIQK  
1lqa   PAQMALAFVRRQPFVASTLLGATTMDQLKTNIESLHLE-LSEDVLAEIEA  
1mzr   PAQIVIRWHLDSG--LVVIPKSVTPSRIAENFDVWDFR-LDKDELGEIAK  
2he5   PALIALRYQLQRG--IVVLNTSLKEERIKENMQVFEFQ-LSSEDMKVLDG  
 
     LOOP 8 
 
 
               360       370       380         
       ....|....|....|....|....|....|....|. 
TmAKR  ALSRIEIKGSRYP-----------EDMEKMTYL---  
1pz0   LFA---------------------------------  
2alr   LNKNWRYIVPMLTVDGKRVPRDAGHPLYPFNDPY--  
2ao0   LNKNLRFIVPMLTVDGKRVPRDAGHPLYPFNDPY--  
1pz1   ILENTIS-DPVGP-----------EFMAPPTREEI-  
1ynp   LAKAAVYEQHRE------------------------  
1lqa   VHQVYTYPAP--------------------------  
1mzr   LDQ--------------------GKRLGPDPDQFGG  
2he5   LNRNMRYIPAAIFK---------GHPNWPFLDEY— 
 
 
Protein sequence alignment of TmAKR and closely related structures.  Loop regions 
are highlighted in red 
